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IDENTIFICATION OF VIRULENCE DETERMINANTS FOR STREPTOCOCCUS
SANGUINIS INFECTIVE ENDOCARDITIS
By Lauren Senty Turner, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2008
Major Director: Todd O. Kitten, Ph.D.
Associate Professor, Philips Institute, School of Dentistry

Streptococcus sanguinis is the second most common causative agent of bacterial
infective endocarditis (IE). Risk of S. sanguinis IE is dependent on pre-disposing damage
to the heart valve endothelium, which results in deposition of clotting factors for formation
of a sterile thrombus (referred to as vegetation). Despite medical advances, high mortality
and morbidity rates persist. Molecular characterization of S. sanguinis virulence
determinants may enable development of prevention methods. In a previous screen for S.
sanguinis virulence determinants by signature-tagged mutagenesis (STM) an attenuated
mutant was identified with a transposon insertion in the nrdD gene, encoding an anaerobic
xvi

xvii
ribonucleotide reductase. Evaluation of this mutant, as well as an nrdD in-frame deletion
mutant, JFP27, by a soft-agar growth assay confirmed the anaerobic growth sensitivity of
these strains. These studies suggest that an oxygen gradient occurs at the site of infection
which selects for expression of anaerobic-specific genes at the nexus of the vegetation. The
random STM screen failed to identify any favorable streptococcal surface-exposed
prophylactic candidates. It was also apparent that additional genetic tools were required to
facilitate the in vivo analyses of mutant strains. As it was desirable to insert antibiotic
resistance markers into the chromosome, we identified a chromosomal site for ectopic
expression of foreign genes. In vitro and in vivo analyses verified that insertion into this
site did not affect important cellular phenotypes. The genetic tools developed facilitated
further in vivo screening of S. sanguinis cell wall-associated (Cwa) protein mutants. A
directed application of STM was employed for a comprehensive analysis of this surface
protein class in the rabbit model of IE. Putative sortases, upon which Cwa proteins are
dependent for cell surface localization, were also evaluated. No single S. sanguinis Cwa
protein was determined essential for IE by STM screening; however competitiveness for
colonization of the infection site was reduced for the mutant lacking expression of sortase
A. The studies described here present a progressive picture of S. sanguinis IE, beginning
with surface protein-dependent colonization of the vegetation in early IE, that later shifts to
a bacterial persistence in situ dependent on condition-specific housekeeping genes,
including nrdD.

INTRODUCTION
The human oral flora
More than 700 different bacterial species and phylotypes have been detected in
the human oral cavity; roughly 50 % of detected species (spp.) are uncultivable ex vivo
by current laboratory methods. Bacterial spp. native to the oral cavity typically exhibit a
predilection for specific anatomical sites within the mouth, so that certain sites have a
subset of commonly associated isolates. The largest biomasses of oral bacteria in the
mouth exist on the teeth and at the back of the tongue (referred to as the dorsum of the
tongue). Bacteria on the teeth, which comprise dental plaque, can accumulate to ~1011
organisms per gram wet weight. The actual content and density of dental plaque is
dependent on host factors including oral hygiene, and food intake. Epithelial cells
sloughed from the surface of the tongue often contain greater than 100 organisms per
cell (81). Resident oral bacteria preferentially colonize different oral surfaces through
the specific recognition of oral surface receptors by bacterial cell surface adhesins.
Species identification by 16S rRNA gene sequencing has facilitated the
detection of previously unrecognized oral species, which do not thrive once isolated
from the complex oral environment. Aas and colleagues recently described a technique
for direct extraction of DNA from plaque samples from multiple oral sites, including the
dorsum and lateral sides of the tongue, buccal fold, hard and soft palates of the mouth,
1
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labial gingiva and soft tissue surfaces, and supra- and sub-gingival plaques from the
tooth surfaces. In their comprehensive analysis the researchers identified 141 taxa from
six different bacterial phyla, including the Firmicutes (low G+C gram-positive species),
the Actinobacteria (high G+C gram-positive species), the Proteobacteria, the
Bacteroidetes (including pathogenic Porphyromonas and Prevotella spp.), the
Fusobacteria, and a phylum of uncultivatable species, TM7 (1). DNA probe detection
has also identified species that may be clustered as “bacterial complexes”, as general
indicators of oral health (237, 238). For example, species associated with clinical
aspects of periodontal disease, including Porphyromonas gingivalis, Treponema
denticola, and Prevotella intermedia typically cluster, and are exclusive from bacterial
species commonly associated with healthy oral sites, including Streptococcus gordonii,
Streptococcus intermedius, Streptococcus oralis, and Streptococcus sanguinis (237).
Indeed, a healthy oral cavity contains distinctively different flora from one afflicted
with oral disease. In healthy oral sites sampled by Aas and colleagues, neither spp.
associated with periodontal disease, nor dental caries (dental cavities) were detected (1).
Periodontitis is demarcated by the shift in dental plaque flora from gram-positive
facultative anaerobes to gram-negative obligate anaerobes (237). Dental caries is
associated with an increase in focal acidogenicity attributed to breakdown of dietary
sucrose by Streptococcus mutans and Lactobacillus spp. (150). Fluctuations in the oral
environment are in part defined by the oral microflora; however host behaviors and
physiology also influence the composition of the flora.
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Oral streptococci
The genus Streptococcus consists of more than 50 spp., the majority of which
are divisible into one of six phylogenetic clusters on the basis of 16S rRNA gene
sequence similarity. Streptococcus spp. are gram-positive and spherical or ovoid in
shape, with a diameter less than 2 µm. The pattern of cellular division in streptococci
distinguishes this genus from other gram-positive coccus shaped bacteria. In
streptococci division occurs along a single axis, resulting in chains or pairs of cocci
(233). The name Streptococcus derives from sreptos, meaning easily bent or twisted,
like a chain, and kokkos, meaning berry, as a descriptive of the spherical shape of the
cell. Streptococci are catalase-negative, facultatively anaerobic, non-motile and do not
produce spores or gas. Unlike enterococci, streptococci do not grow in 6.5 % sodium
chloride. Streptococci are also distinct from lactococci, which are Lancefield (cell
surface carbohydrate) group N organisms.
Streptococci constitute ~20 % of the normal human oral flora, and are abundant
at most oral sites, although species within the Streptococcus genera demonstrate
preferential association with different oral locales. For example, S. salivarius, S.
parasanguinis and S. australis are typically found on the dorsum of the tongue, whereas
S. sanguinis and S. gordonii exhibit a predilection for the tooth surface (1). S. mutans
associates with teeth along the gingival margin of the tooth and gum tissue, and at pits
and fissures at the surface of molars (81). In contrast, S. mitis is nearly ubiquitous in the
oral cavity (1). Among the oral microbes streptococci have been heavily investigated as
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these bacteria are readily cultivatable, are a major component of the microflora on most
oral surfaces, and in the case of S. mutans, may be relevant for oral disease.
S. sanguinis is of particular interest to the research described here. S. sanguinis
is a member of the mitis group of streptococci, which also includes S. gordonii, S.
parasanguinis, S. oralis, S. mitis, S. pneumoniae, S. pseudopneumoniae, S. infantis, S.
cristatus, S. peroris, S. australis and S. sinensis (106, 120). With the exception of S.
pneumoniae and S. pseudopneumoniae the mitis group streptococci are oral
commensals, and pioneer colonizers of the tooth surface. S. sanguinis has also been
classified as a member of its own group, the sanguinis group, in recent literature, which
was expanded to include S. gordonii and S. parasanguinis as well. In this case, the
separation between sanguinis and mitis groups is based on the predominance of
sanguinis group strains that are positive for two catalytic tests, the deamination of
arginine and the hydrolysis of esculin (71). The majority of mitis group strains are
negative for these assays.
Despite these differences in grouping, both mitis and sanguinis group
streptococci, and additional oral streptococcal groups are subgroups of a more general
classification, the viridans group of streptococci. (This term does not encompass S.
pneumoniae, however; 71.) The term viridans derives from the Latin word viridis, or
green, which refers to the coloration on blood agar resulting from partial hemolysis of
erythrocytes by α-hemolytic streptococci, due to the release of streptococcal H2O2 (10).
While S. sanguinis is positive for α-hemolysis, the designation of viridans for this group
is confusing given that members of the group have also been documented as γ-
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hemolytic (no lytic zones observed surrounding colonies on blood agar), and βhemolytic (zones of clearing surrounding colonies on blood agar due to complete
hemolysis of erythrocytes) (233). The viridans group has been described as
characteristically lacking in features which distinguish other major streptococcal
pathogens, including β-hemolysis, Lancefield typing (cell wall carbohydrate) of βhemolytic streptococci, CAMP test (for Lancefield group B streptococci), and optochin
sensitivity (S. pneumoniae) (233).
The complete genome sequences of many streptococcal species, including a few
oral streptococcal species, S. mutans UA159, S. gordonii CH1 Challis, and S. sanguinis
SK36 are currently available (3, 270, 285). The SK36 strain of S. sanguinis was chosen
for genome sequencing because this strain exhibits definitive characteristics of this
species, including robust glucan production, superior platelet adhesion and aggregation
phenotypes (relative to other sequencing candidates), genetic competence, and
infectivity in the rat model of IE comparable to virulent strains
(www.sanguinis.mic.vcu.edu/strain_selection.htm). The streptococcal chromosome is
uniformly a single circular DNA molecule. Among published streptococcal genomes, S.
sanguinis SK36 has the largest; at 2,388,435 bp, it is roughly 7 to 24 % larger than other
published genomes (285). The difference in genome size between these species is also
reflected in the number of predicted encoded proteins. S. sanguinis SK36 is predicted to
code for 2,274 proteins, whereas S. mutans UA159, and S. gordonii CH1 Challis are
predicted to encode 1,960 and 2,051 proteins, respectively (3, 270, 285). S. sanguinis
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SK36 also has the highest G+C genome content of the low G+C streptococci, at 43.4 %
(285).
S. sanguinis has a general lack of sequence elements suggestive of genetic
transfer by transposons or prophage. This may be attributed to the presence of a putative
DpnII-like system that reduces the efficiency of horizontal gene transfer (HGT) by
phage infection, conjugative plasmid transfer and plasmid transformation in S.
pneumoniae (134). However, at least 270 genes of S. sanguinis were predicted as
candidates for HGT based on phyletic patterns of gene distribution (285). It is likely
that transformation is the major method accounting for HGT in S. sanguinis SK36.
(Transformation by chromosomal DNA would be unaffected by the putative DnpII
restriction system.) S. sanguinis SK36, like several other oral streptococci encodes a
genetic system for the uptake and integration of foreign DNA in response to a strainspecific competence inducer, referred to as competence stimulating peptide (CSP) (79).
In S. pneumoniae 22 proteins are required for chromosomal transformation by this
quorum sensing system. Orthologs of 20 of these proteins were identified for S.
sanguinis (285). These reports suggest that the genetic complexity of S. sanguinis may
be attributed to the acquisition of novel genes by HGT through transformation in situ.

Streptococcal colonization of the oral cavity
Shortly after birth, bacteria appear in the mouths of infants as their oral
microflora begins to take shape. Early on, S. salivarius is detectible (primarily on the
dorsum of the tongue), and by one month of age all infants are colonized with at least
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one viridans streptococcal species (201). It is thought that most endogenous flora
microorganisms are acquired from parents or attendants of the infant. The emergence of
teeth results in more drastic changes in an infant’s oral flora. The hydroxyapatite
surface of the tooth, once covered in salivary proteins (the salivary pellicle) presents an
abundance of binding sites utilized by streptococcal colonizers for retention in the oral
cavity. S. sanguinis has been shown to bind specific salivary proteins including salivary
IgA and α-amylase, among the heterogeneous mix of salivary components and
glycoproteins on the tooth surface (40, 85). The window of colonization of the tooth
surface by S. sanguinis has been narrowed to ~9 months of age, with the first
appearance of teeth. In a study of tooth colonization by S. sanguinis, Caufield and
colleagues discovered that infants with higher salivary proportions of S. sanguinis
experienced delayed colonization by S. mutans, suggesting competition between these
streptococci for potential binding sites, nutrient resources, or by release of inter-species
inhibitors. The latter was supported by the observation that eventual emergence of S.
mutans resulted in decreased levels of S. sanguinis (40). S. sanguinis, as a major
component of dental plaque and primary colonizer of the tooth surface, is thought to act
as a scaffold to bring other bacterial species closer to the surface of the tooth for
formation of complex multi-species dental plaque. While S. mutans is also a dental
plaque species, mounting evidence supports the theory that these two species do not
complacently coexist. Comparisons of sequential colonization of S. sanguinis and S.
mutans in an in vitro mixed biofilm assay suggest that once one species gains a
foothold, the other is at a loss and can not overcome the initial disadvantage. However,
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when co-administered the two strains are capable of forming a mixed species biofilm,
and thus interact in a way that is much more complex than general antagonism. It has
been demonstrated that the effectors aiding in competitive colonization in vitro of these
two species include, for S. sanguinis, H2O2 production, and for S. mutans, production of
the bacteriocin, mutacin (132). However whether a similar interplay occurs in vivo, in
which bacteriocins may be inactivated by proteolytic enzymes of dental plaque has not
been determined. Despite the apparent benefit of S. sanguinis in the oral cavity—as an
indicator of oral health and putative competitor of pathogenic oral bacteria—S.
sanguinis is a medically relevant opportunistic agent of infective endocarditis.

Infective endocarditis
Infective endocarditis (IE) is a life threatening, non-contagious chronic infection
of the cardiac valves, or lining of the heart mainly caused by bacterial species, although
fungi can also be associated with this infection (20). Viral infections are also related to
development of IE. Cardiac complications, including IE are of great concern for HIV
patients. A risk factor for bacterial IE in this population is intravenous drug use (45,
263). Cardiac complications leading to bacterial IE have also been described following
varicella zoster virus infection (2).
A comprehensive review of 26 publications, encompassing more than 3,500
cases of IE revealed important epidemiological trends for this disease. The mean
incidence for disease was 3.6 cases per 100,000, per year. The incidence of disease
increased with age, with fewer than 5 cases per 100,000 in individuals less than 50 yrs
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to more than 15 cases per 100,000 in individuals over 65 yrs (176). The mean age of
patients ranged from 36 to 69 yrs. In the preantibiotic era this disease commonly
affected persons between 30 and 40 yrs. The emergence of antibiotic therapy and
increased longevity in developed countries has resulted in a shift to more aged IE
patients (181). The male to female ratio was determined to be roughly two-to-one.
IE may be classified as sub-acute or acute related to the severity of the clinical
presentation and progression of the disease. Additional classifications include the nature
of the valve involved (native vs. prosthetic), and the source of the causative agent, such
as community acquired infection, nosocomial IE, or IE attributed to intravenous (IV)
drug use. Risk factors for IE may be classified as cardiac risk factors or risk factors for
bacteremia. A prosthetic valve is an example of a cardiac risk factor, whereas IV drug
use and some medical procedures are considered risk factors for bacteremia.
Native-valve IE (NVE) is classically associated with congenital heat disease and
chronic rheumatic heart disease. In addition valvular lesions due to valve dysfunction—
attributed to mitral and aortic valve regurgitation, as well as aortic valve stenosis and
mitral valve prolapse—are major predisposing factors in elderly populations (186).
NVE most commonly presents as “left sided” IE, with infection of the mitral and aortic
valves of the heart most common. Prosthetic valve IE (PVE) is divided into late or early
infection depending on whether infection presents within 60 days of surgery (early) or
later. This condition is most common within the first 2 months of valve implantation,
and is often caused by S. aureus and S. epidermidis. Late PVE is more commonly
attributed to non-staphylococcal organisms, including streptococci, and gram-negative
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bacteria of the HACEK group (Haemophilus spp., Actinobacillus
actinomycetemcomitans, Cardiobacterium hominus, Eikenella corrodens, and Kingella
kingae) (181). IE resulting from IV drug use is more common among younger cohorts
(30 to 40 yrs.). IV drug users more often present with the tricuspid valve of the heart
affected. Organisms resulting in IE in this group are typically skin isolates, with S.
aureus as the most common causative agent. In nosocomial IE, many patients lack
predisposing cardiac damage associated with NVE. Predominant causative agents of
nosocomial IE include enterococci and staphylococci, which may be introduced into the
bloodstream on contaminated catheters or other indwelling devices (176).
Staphylococci are the most common causative agents of IE, accounting for 44 %
of NVE, 69 % of intravenous drug user IE, 67 % of early PVE, and 46 % of late PVE.
The second most common causative agents of NVE and late PVE are streptococci,
which account for ~31 % and 35 % of infections, respectively (176). The oral
streptococci are the most common agents of streptococcal IE, and among viridans group
streptococci, S. sanguinis is most often implicated as the cause of NVE (57, 67, 216,
272).

Progression of oral streptococcal NVE
The development of NVE proceeds in a series of general steps. As described
above, the first step is predisposing damage to heart valve endothelium. During
transient bacteremia, streptococci adhere to, and colonize the site of endothelial
damage. The characteristic lesion of IE, referred to as a vegetation, includes a platelet
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and fibrin thrombus, embedded with infective microorganisms and inflammatory
immune cells. Once attached, the bacteria become engulfed in vegetation components
as the vegetation enlarges in size, and persist at the site of infection. Dissemination of
septic emboli may then result in peripheral manifestations of this disease (reviewed in
176, 177).
Following damage to endothelia, sub-endothelial components including
endothelial matrix proteins triggering blood coagulation are exposed or secreted. During
thrombosis, induction of pro-inflammatory cytokines results in the up-regulation of
proteins mediating coagulation, such as tissue factor, a glycoprotein that in surfacebound or soluble form interacts with soluble factors to form proteolytically active
thrombin. Thrombin converts plasma fibrinogen to fibrin, which envelops and stabilizes
the developing blood clot (232).
The bacteremic event preceding IE by oral streptococci is asymptomatic and
may result from dental manipulation or less invasive daily tasks. Dental procedures
resulting in the greatest levels of subsequent bacteremic events include dental
extraction, periodontal probing in patients with periodontitis, tartar removal from the
tooth surface, endodontic procedures, and tooth scaling to remove plaque from below
the gum-line (207). Bacteremic events may also result from mundane daily activities
like eating, chewing gum, tooth brushing, flossing, or use of toothpicks (75, 86).
Development of S. sanguinis IE putatively requires adhesin-dependent bacterial
colonization of the vegetation within minutes of transient bacteremia onset. Surface
adhesins of streptococci are considered indispensable in the primary interaction with
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host proteins. Several S. sanguinis surface-exposed cell wall-anchored proteins have
been determined to be mediators of platelet interaction and activation in vitro (98, 122,
204). This phenotype has been correlated with virulence in the rabbit model of IE (97).
The capacity for adherence and aggregation of platelets could be an important factor in
colonization of the platelet and fibrin matrix during transient bacteremia, and may also
encourage further deposition of platelets and fibrin for engulfment of streptococci at the
site of infection. In spite of the course of disease progression described here, and the
observation that duplication of these conditions incites IE in the rabbit model of the
disease, there is evidence to suggest that streptococcal colonization of damaged
endothelium can occur in the absence of the pre-formed aseptic thrombus. In the study
resulting in this observation, rabbits with induced valve damage, treated with warfarin
(an inhibitor of fibrin-platelet matrix formation) still had bacterial colonization on the
surface of the valve. As expected, vegetation formation was altered in these rabbits;
however they presented with characteristic morbidities of IE, including high fever and
constant bacteremia. However, the antibiotic therapies administered to these rabbits
were more effective than in control rabbits that did not receive warfarin, therefore
suggesting that vegetation formation has an additional benefit for the infective bacteria
(104). Oral streptococci encode many surface proteins vital for maintenance in the oral
cavity; yet several proteins which bind to human salivary proteins have also been shown
to bind extracellular matrix proteins (ECM) in vitro (14, 52). Therefore these proteins
could potentially facilitate the association of oral streptococci with sub-endothelial
ECM proteins exposed at the site of tissue damage.
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Following streptococcal colonization of the vegetation, the progression of the
disease is, at least in part, due to the pro-inflammatory response initiated by monocytes
attracted to the site of infection. At the site of infection peripheral blood monocytes are
proposed to undergo activation resulting in production of pro-inflammatory cytokines
and tissue factor activity, leading to further coagulation of blood components for
engulfment of adherent streptococci (176). In the rabbit model of IE, bacteria are
completely engulfed within three hours of administration (63). In vitro assays of S.
sanguinis infected endothelial cell monolayers have indicated that pro-coagulant
activity from tissue factor production is enhanced by soluble IL-1 and TNF-α during
monocyte co-culture (268, 269). Additionally, ELISA of patient sera has revealed
increased presence of the pro-inflammatory cytokine Interleukin-6 (IL-6), and the
cytokine receptor IL-2R, which diminish during treatment with antibiotic alone, or
antibiotic and cell wall-active antibacterial agents (4, 211). In this scenario, the
progressive vegetation enlargement in response to cytokine production and tissue factor
activity would cause multiple pathologies associated with IE (181).
Transmission electron microscopy of vegetations isolated from infected rabbits
shows streptococci embedded in layers of fibrin meshwork (Fig. 1). Oftentimes
streptococci are found in multiple zones of the vegetation. Multiple rounds of
streptococcal deposition on the vegetation may occur by re-seeding of vegetation
components dislodged in the bloodstream. As streptococci are known to not only
persist, but also grow within the vegetation, it is also possible that the layers observed
are due to outgrowth from the initial colonization site (63). Within 24 hours of
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Figure 1. S. sanguinis SK36 vegetation
A transmission electron micrograph of an SK36 vegetation cross-section, resulting from
an experimental case of IE, is shown. Bacterial cells are electron dense and are spherical
or ovoid in shape. The bacterial zone is surrounded by fibrin layers.
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Figure 1. S. sanguinis SK36 vegetation
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administration, streptococci begin to exhibit biofilm-like sessile community
characteristics, including the development of antibiotic resistant microcolonies (51, 63,
64).
If left untreated, IE is uniformly fatal, with death resulting from embolization of
vegetation components to major organs, or congestive heart failure. Infection-induced
valvular damage is typically the cause of congestive heart failure in patients with IE. In
rare cases myocardial infarction results from embolization of vegetation fragments. Up
to 60 % of embolic IE events involve the central nervous system, and neurological
complications, including stroke and mycotic aneurism, occur in ~20 to 40 % of patients.
The spleen, kidney and liver are also commonly affected by systemic embolization and
seeding of septic vegetation fragments (181).

Symptoms, treatment and prevention of bacterial IE
Symptoms of IE are general and include fever, anorexia, weight loss, malaise
and night sweats. Heart arrhythmias like heart murmur are also common indicators of
IE, in conjunction with other described symptoms. However, in most cases the heart
murmur is preexisting and due to valve dysfunction (181, 186). Peripheral
manifestations include petechiae on the skin, conjunctiva, or oral mucosa owing to
small hemorrhages following embolization of vegetation pieces. In addition, Osler’s and
Janeway’s lesions, attributed to the deposition of immune complexes subcutaneously
and in small blood vessels, respectively, are pathognomonic of IE (181).
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In 1994 the “Duke Criteria” for diagnosis of IE was proposed by a group at
Duke University. The criteria were validated worldwide and then revised in 2000 for
creation of diagnostic criteria that would identify culture-negative IE with greater
accuracy (66, 147). The criteria incorporate clinical, laboratory and echocardiographic
information for informed diagnosis of IE. The proposed criteria were subdivided into
“major criteria”, including blood culture and echocardiography findings, and “minor
criteria”.
The major blood culture criteria include two positive blood cultures of a typical
IE organism drawn more than 30 minutes apart, as well as blood cultures described as
“persistently positive”, meaning two culture sets drawn at least 12 hours apart, or three
to four sets drawn over more than a 1-hour window. The culture criteria are not
applicable to culture-negative agents, which has prompted the expansion of detection
methods to include assays for DNA detection, and immunodetection.
Echocardiography may provide strong indication of the presence of a vegetation.
Transthoracic echocardiography (TTE) is a quick and non-invasive detection tool.
However some patients are not good candidates for TTE due to issues with visualization
within the chest cavity. (Obesity, chronic obstructive pulmonary disease, or chest-wall
deformities complicate the interpretation of TTE results.) Transesophageal
echocardiography, in which an ultrasound transducer probe is inserted into a patient’s
esophagus, is an alternative to TTE for enhanced visualization of the vegetation mass
(181).
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Minor criteria for IE diagnosis include predisposing cardiac conditions and
intravenous drug use, as well as the more general symptoms and peripheral indicators of
IE described above. The combination of positive factors between the major and minor
criteria sub-groups results (theoretically) in diagnoses that range from definite IE, to
possible IE, to rejection of IE being the affliction.
The treatment regimen for resolution of IE requires prolonged administration of
antibiotics. In the case of viridans streptococci the antibiotics suggested differ according
to the penicillin-susceptibility of the infective agent. The aggressive treatment strategy
implemented typically requires IV or intramuscular administration of antibiotics daily,
for a minimum of two weeks. For penicillin-sensitive streptococci ceftriaxone alone, or
in combination with netilmicin may be recommended. Alternatives include procaine
benzylpenicillin alone or with gentamycin, or vancomycin for patients allergic to βlactam antibiotics. For elimination of intermediate penicillin-resistant viridans
streptococci procaine benzylpenicillin with gentamycin, or vancomycin may be used
(176). In extreme cases surgery is required for treatment of IE. Surgical intervention
encompasses radical valve replacement and removal of the infective vegetation, or
repair of the damaged heart valve (176, 181).
As no vaccine for prevention of IE exists, the most effective prophylactic
measures include identification of at-risk patients and their education of behaviors that
might cause bacteremia. American Heart Association (AHA) recommendations for
patients at high risk for IE emphasize the maintenance of proper oral health and
antibiotic prophylaxis during dental procedures. Antibiotic prophylaxis is generally
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recommended for procedures associated with significant bleeding from hard or soft
tissues, including periodontal surgery, scaling and tooth cleaning. For efficacy
antibiotics should be administered, at the latest, 2 hours post-procedure (282). Despite
improvements in endocarditis outcome through advances in anti-microbial therapy and
better diagnostic and treatment tools, substantial morbidity and mortality still result
from IE. Therefore development of alternative preventative methods is called for.

Streptococcal virulence factors for IE
The investigation of streptococcal virulence factors for IE has included surfaceexposed proteins that would mediate the initial stages of disease. These include the
major surface-exposed protein class of gram-positive bacteria, the cell wall anchored
(Cwa) proteins. Cwa proteins are considered particularly important in pathogenesis as
many have been grouped as MSCRAMMs, or microbial surface components
recognizing adhesive matrix molecules of host tissue and host cells. The staphylococcal
MSCRAMMs, clumping factor A (ClfA) and fibronectin binding proteins A and B
(FnbA, FnbB) have been demonstrated by experimental IE to be important
pathogenicity factors (177). As their name implies, FnbA and FnbB are capable of
binding to fibronectin in vitro, and ClfA has fibrinogen binding capacity in vitro; both
of these proteins are soluble in blood, and fibronectin exists in the extracellular matrix
of most host tissues (114, 167, 206).
Streptococcal MSCRAMMs identified as mediators of IE include Hsa of S.
gordonii, and CbpA of S. sanguinis. Hsa is a serine rich protein with fibronectin binding
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capacity in vitro, and was shown to contribute to infectivity under competitive
conditions in the rabbit model of IE (248). CbpA of S. sanguinis was an identified
mediator of platelet aggregation in vitro (98). A mutant defective for expression of
CbpA also exhibited reduced infectivity in the rabbit model of IE, suggesting that the
platelet interaction phenotype contributes to development of IE (97).
Extracellular production of glucan polymers has also been linked to viridans
streptococcal adherence phenotypes in vitro and infectivity in vivo. The extracellular
glucans are synthesized by bacterially encoded glucosyltransferase (Gtf) and
fructosyltransferase (Ftf) enzymes from a sucrose substrate. In a previous study the
production of water-soluble glucan by S. sanguinis grown in 5 % sucrose enhanced
adherence to aortic, mitral and tricuspid valves in vitro, thus suggesting that
exopolysaccharide production may enhance colonization in the development of IE
(210). In vivo analysis of an S. mutans mutant deficient for glucan and fructan synthesis
confirmed that exopolysaccharide production was positively correlated with the
development of IE in the rat model of infection. In vitro phenotypic analysis suggests
that glucan and fructan production both enhance streptococcal survival postphagocytosis, and putatively mediate adherence to vegetation-like matrices (180).
However, an S. gordonii gtf mutant maintained infectivity in the rat model of IE;
therefore the role of sugar-polymer production in development of IE may differ between
Streptococcus species (277).
A family of related lipoproteins, including FimA of S. parasanguinis, has also
been implicated in streptococcal adherence and virulence phenotypes. A fimA mutant
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displayed decreased binding to fibrin monolayers in vitro, and was decreased for
infectivity in the rat model of IE (34). The fimA ortholog in S. mutans, SloC is also
important for development of IE (126, 197). FimA and SloC are members of ABC
transport systems for acquisition of extracellular manganese and iron; this specific
function has also been evidenced as important for S. mutans IE (197).
The random signature-tagged mutagenesis (STM) technique (technical details of
which are further described in Chapter V) was recently applied to S. sanguinis SK36 for
identification of virulence determinants in the rabbit model of IE. Of 800 transposon
insertion mutants screened in vivo, five were identified in which insertion mutagenesis
resulted in a drastic decrease in recovery. In the five strains, genes encoding
housekeeping functions, including amino acid and nucleic acid synthesis, and the ability
to survive in anaerobic conditions (further detail is provided in Chapter III) were
mutated (198). Genes considered virulence factors for development of IE, including
MSCRAMMs and lipoproteins were not identified in this screen.

MATERIALS AND METHODS
Bacterial strains, growth media and chemicals
Strains and plasmids used in the described studies are listed in Table 1. S. sanguinis
SK36, a human oral isolate was obtained from Mogens Killian (University of Aarhus,
Denmark) (124). S. sanguinis strains were routinely cultured under a reduced O2 condition
created by gas exchange with the final gas mixture unknown, a 6 % O2 condition (10 % H2,
10 % CO2, and 80 % N2), or in an anaerobe chamber (Forma Scientific, Marietta, Ohio)
with a palladium catalyst to maintain O2 levels less than 1 ppm. All culture media were
purchased from Difco. S. sanguinis strains were routinely cultured in brain heart infusion
(BHI) (Difco) media for liquid culture, or on Tryptic soy broth (TSB) (Difco) containing
1.5 % agar (TSA). Soft-agar studies required growth of S. sanguinis strains in TSB
supplemented with 1 % low melting point (LMP) agarose. For transformation experiments
S. sanguinis strains were cultured in Todd-Hewitt broth containing 2.5 % heat-inactivated
horse serum (TH-HS). For this purpose TH broth was adjusted to a pH of 7.6, filter
sterilized, and stored at -20 ºC. TH broth was thawed and supplemented with 2.5 % HS
immediately before use. For chromosomal DNA preparation S. sanguinis was grown in
BHI supplemented with 20 mM DL-threonine (BHIT). When required for selective growth
of S. sanguinis, erythromycin (Em), chloramphenicol (Cm), spectinomycin (Sc),
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Table 1. Bacterial strains and plasmids used
S. sanguinis
SK36
6-26
3-24
VT1614
JFP27
JFP36
JFP56
JFP76
CWA STM
SRT18
SRT21
SRT24
JFP42
JFP44
JFP47
JFP42 (pJFP50)
JFP52
JFP62
Plasmid
pVA2606
pJFP27
pVA838
pJFP29
pJFP30
pJFP34
pJFP36
pJFP46
pJFP56
pJFP76
pJFP16
pCM18
pJFP50
pJFP52
pJFP62

Genotype or description
Human plaque isolate
Cmr; nrdD::magellan2, derived from SK36
Cmr; SSA_0707-SSA_0708 intergenic region::magellan2,
derived from SK36
Knr; ΔsrpA::aphA-3, derived from SK36
ΔnrdD, derived from SK36
Emr; Δ0169::pSerm, derived from SK36
Spr; Δ0169::aad9, derived from SK36
Tetr; Δ0169::tetM, derived from SK36
Cmr; SSA_#::Himar1 derived magellan2
Cmr; srtC::magellan2
Cmr; srtA::magellan2
Cmr; srtB::magellan2
Scr; ΔsrtA::aad9
Knr; ΔsrtB::kan
Scr, Knr; ΔsrtA::aad9, 0169::srtAkan
Scr, Emr; ΔsrtA::aad9 (pJFP50)
Scr, Emr; ΔsrtA::aad9 (pJFP52)
Spr, Emr; ΔsrtA::aad9 (pJFP62)
Genotype or description
Knr; suicide vector derived from pUC19 by replacement
of bla with aphA-3
Knr; pVA2606 containing ΔnrdD
Emr, Cmr; E. coli-Streptococcus shuttle plasmid
Emr; pVA838 containing the 2.7-kb nrdD locus
Emr; pVA838 containing the 2.4-kb nrdD locus
Knr; derivative of pVA2606 with 0169
Knr, Emr; derivative of pJFP34 with pSerm
Knr; derivative of pJFP34 with AscI, NotI in 0169
Scr; derivative of pJFP46 with aad9
Tetr; derivative of pJFP46 with tetM
Knr; derivative of pVA2606 containing 3.3 kb nrdD::cat
Emr; pTRKL2-PCP25-RBSII-gfpmut3-T0-T1
Emr, Cmr; pVA838 containing the 1.112 kb srtA locus
Emr; pCM18 containing the 0.8 kb srtA locus
Emr, Cmr; pVA838-PCP25-srtA

Source
(124)
(198)
(198)
(204)
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
Source
(198)
This study
(154)
This study
This study
This study
This study
This study
This study
This study
(196)
(90)
This study
This study
This study
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kanamycin (Kn) and tetracycline (Tet) were used at 10, 5, 200, 500, and 5 μg ml-1,
respectively.
Electromax E. coli DH10B (Invitrogen) was used as a bacterial host for plasmid
construction. All E. coli strains were cultured in Luria-Bertani (LB) medium, or on LB
containing 1.5 % agarose (LA). When required for E. coli X-gal was added at 40 or 60 µg
ml-1. For selective culture of E. coli, Kn, Em, Cm, Tet, and Sc were used at 50, 300, 5, 2.5,
and 100 µg ml-1, respectively.

DNA Manipulations
Chromosomal DNA was isolated from S. sanguinis SK36 as described previously
(126). Labeling and detection in Southern dot-blotting was performed by the Genius
digoxigenin system (Roche Molecular Biochemicals). PCR was routinely performed in a
GeneAmp 960 thermal cycler (PE Biosystems), MyCycler (Bio-Rad), or an MJ Research
PCT-200 thermal cycler (Bio-Rad). Real-time quantitative PCR was preformed with a
7500 Fast Real Time PCR System (Applied Biosystems). PCR amplification was
performed using Platinum® PCR Supermix (Supermix) or High Fidelity Platinum® PCR
Supermix (HIFI Supermix) (Invitrogen). PCR reaction mixtures typically included 0.2
pmol µl-1 primers, and S. sanguinis SK36 chromosomal DNA or PCR amplicon as template
at 0.2 ng µl-1. Plasmid DNA as PCR template was used at 0.01 ng µl-1. Oligonucleotide
primers were synthesized by the Nucleic Acids Research Facility of Virginia
Commonwealth University or Integrated DNA Technologies. Restriction enzymes were
purchased from New England Biolabs Inc. and used according to the manufacturer’s
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instructions. DNA purification from agarose was routinely performed using Quantum Prep
Freeze ’N Squeeze columns (Bio-Rad). For plasmid DNA extraction form E. coli the
Quantum Prep Plasmid Mini-Prep Kit (Bio-Rad) or the QiaPrep Spin Miniprep Kit
(Qiagen) was used. Purification of PCR products was performed using the MinElute PCR
Purification kit (Qiagen). T4 DNA ligase (Invitrogen) was routinely used for cloning
purposes, as directed by the manufacturer.

Development and screening of S. sanguinis SK36 mutant strains
The sequences of most primers described in this section are given in Appendix A.
Construction of JFP27 (ΔnrdD): Gene Splicing by Overlap Extension (Gene SOEing
(105) was used to construct an internal, in-frame deletion of the nrdD gene with the fusion
of the first 12 codons and last 14 codons. Oligonucleotide pairs ARTR-SalI-24495-up and
ARTR-23327-dn, and ARTR-21212-up and ARTR-SalI-20031-dn were used in the first
PCR with S. sanguinis SK36 chromosomal DNA (gDNA) template and Supermix. The
cycling conditions were as follows: One cycle at 94 ºC for five min; followed by 30 cycles
at 94 ºC for five min, 55 ºC for 30 sec, and 72 ºC for one min; and a final extension step at
72 ºC for 7 min. The resulting PCR products were gel extracted, purified (Bio-Rad), and
concentrated by precipitation with 3 M NaOAc and 95 % EtOH. The purified products
were adjusted to 4 ng µl-1 and combined at a 1:1 ratio for amplification in a second PCR
reaction with primers ARTR-SalI-24495-up and ARTR-SalI-20031-dn. The cycling
conditions used were as follows: one cycle at 94 ºC for 40 sec; followed by 30 cycles of
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94 ºC for 40 sec, 58 ºC for 30 sec, and 72 ºC for 6 min; and a final extension step at 72 ºC
for 7 min.
The band of the anticipated size was gel extracted, purified and concentrated as
described above. The ARTR-24495/20031 product was then cloned into suicide plasmid
pVA2606 (Fig. 2A) via a SalI restriction site for creation of the pJFP27 (Fig. 2B). E. coli
DH10B was electrotransformed with pJFP27 and plated on LA containing Kn and X-gal.
Blue-white screening of resulting colonies identified pJFP27 transformants. Plasmid DNA
was prepared (Bio-Rad) and screened by PCR with ARTR-SalI-24495-up and ARTR-SalI20031-dn primers. DNA sequence analysis confirmed proper insertion and in-frame
deletion of nrdD.
S. sanguinis SK36 was transformed with 500 ng SspI-linearized pJFP27 and plated
on TSA. Colonies were inoculated into overnight broth cultures for rapid PCR analysis by
the boiled cell extraction technique. Briefly, 1 ml of each overnight culture was centrifuged
(18,000 x g for 2 min) and the cell pellet was washed in 1 ml 10 mM Tris-HCl (pH 8.0),
and suspended in 100 µl 10 mM Tris-HCl. Tubes were then boiled for 5 min, cooled and
centrifuged again, and 100 µl of supernatant was transferred to a new tube. Two µl of the
supernatant served as template for PCR screening reactions with primers ARTR-SalI24495-up and ARTR-SalI-20031-dn. A clone that produced a PCR amplicon consistent
with nrdD deletion was selected for further study and named JFP27.
Construction of plasmids for nrdD complementation: Two nrdD gene region constructs
were designed for complementation studies. Primers specific for the two constructs,
ARTR-EcoI-up1, ARTR-EcoRI-up2 and ARTR-EcoRI-dn were used in PCR reactions

27
Figure 2. Plasmid maps of pVA2606 and pJFP27
A) The pVA2606 vector was derived from the E. coli plasmid pUC19 by replacement of
the bla ampicillin resistance determinant with the aphA-3 kanamycin resistance (KnR)
cassette (198). The plasmid contains the pMB1 origin of replication (ori) from pBR322,
but includes additional modifications for temperature-determined copy number, roughly 75
plasmid copies per cell at 37 ºC (and >200 copies per cell at 42ºC). The multiple cloning
site (MCS), in red, is in frame with the lacZα gene (lacZ-alpha) for screening of MCS
insertion by α-complementation (289).
B) The Gene splicing by overlap extension (Gene SOEing) PCR technique was used to
create an in-frame deletion of the nrdD gene. Flanking primers were designed for
amplification and cloning of the mutation site, and neighboring ORFs, including a putative
membrane protein gene (mem) upstream of nrdD, a hypothetical protein gene overlapping
the 3’ end of nrdD (hypo), as well as two putative downstream acetyltransferase genes (ac1
and ac2). The SalI restriction sites incorporated into flanking primers permitted cloning of
the construct into pVA2606 to create pJFP27. The plasmid was made linear by SspI
digestion prior to transformation of SK36.
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with S. sanguinis SK36 gDNA template, and Supermix (Invitrogen). Cycling conditions
for amplification with the up1/dn primer pair were: one cycle at 94 ºC for five min; five
cycles of 94 ºC for 40 sec, 41 ºC for 30 sec, and 68 ºC for 3 min; then 25 cycles of 94 ºC
for 40 sec, 52 ºC for 30 sec, and 68 ºC for 3 min; followed by a final extension at 68 ºC for
7 min. Cycling conditions for amplification with the up2/dn primer pair were: one cycle at
94 ºC for five min; five cycles of 94 ºC for 40 sec, 41 ºC for 30 sec, and 68 ºC for 3 min;
then 25 cycles of 90 ºC for 40 sec, 54 ºC for 30 sec, and 68 ºC for 3 min; followed by a
final extension at 68 ºC for 7 min.
PCR products were gel extracted and purified (BioRad) as described above and
cloned into the pVA838 shuttle vector (Fig. 3A) via EcoRI restriction sites, creating
plasmids pJFP29 and pJFP30 (shown in Fig. 3B and 3C, respectively). E. coli DH10B was
electrotransformed with pJFP29 and pJFP30, and transformants were selected on LA
containing Em. Plasmid DNA was extracted (BioRad), and then screened for the insert by
EcoRI digestion. Sequencing with pVA838 specific primers, pVA838-2939 and pVA8385331, confirmed correct construct insertion at splicing junctions. The plasmids were
introduced into S. sanguinis strains by transformation with 250 ng of DNA. Transformants
were selected by plating on TSA containing Em. PCR with pVA838-specific primers was
used to confirm the presence of appropriate plasmids.
PCR analysis of 6-26 (pJFP29) and 6-26 (pJFP30): Lenticular colonies of 6-26 were
isolated from TSB-LMP agarose tubes by a sterile pipette tip and cultured in 5 ml BHI
with Em overnight, under a reduced O2 condition. An aliquot of the overnight culture was
used to prepare a -70 ºC, 30 % glycerol freezer stock, for later analysis by the soft-agar
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Figure 3. Plasmid maps of pVA838, pJFP29 and pJFP30
A) The pVA838 cloning vector is capable of replication in S. sanguinis and E. coli. It
confers Emr to both E. coli and streptococci. The Cmr cat marker is expressed only in E.
coli, and may be inactivated by insertion at the internal EcoRI site. This is a low copy
number plasmid in E. coli with ~8 plasmid copies/chromosomal equivalent in E. coli V854
(154). In the described studies this vector was employed for cloning S. sanguinis SK36
genes for complementation studies.
B) The nrdD gene of S. sanguinis SK36 was PCR amplified and cloned into the pVA838
EcoRI restriction site to interrupt expression of cat, the chloramphenicol resistance
determinant gene to create pJFP29. In the insert nrdD was preceded by its predicted native
upstream terminator, promoter, and ribosome binding site.
C) The nrdD gene of S. sanguinis SK36 was PCR amplified and cloned into the pVA838
EcoRI restriction site to interrupt expression of cat, the chloramphenicol resistance
determinant gene, to create pJFP30. In the insert nrdD was preceded by its predicted
ribosome binding site only.
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assay as described above. The same overnight culture was prepared for PCR amplification
by boiled cell extraction (as described above), or washed for use as template: 1 ml of cells
were centrifuged at 18,000 x g for 1 min; then washed twice in 1 ml of 10 mM Tris-HCl
(pH 8.0), and subsequently suspended in 100 µl of 10 mM Tris-HCl. Boiled cell and whole
cell preparations were PCR amplified in reactions containing ARTR-SalI-24495-up and
ARTR-SalI-20031-dn primers, 3 µl of template, and 45 µl Supermix in a 50 µl reaction.
Cycling conditions were as follows: one cycle of 94 ºC for 5 min; 30 cycles of 94 ºC for 40
sec, 58 ºC for 30 sec, and 72 ºC for 6 min; and a final extension cycle at 72 ºC for 7 min.
Development of JFP36: The S. sanguinis suicide plasmid pVA2606 (Fig. 2A) was used as
a vector for cloning of the SSA_0169 (0169) locus to generate pJFP34 (Fig. 4A). Primers
specific for 0169 flanking DNA, 0169-SalI-up and 0169-SalI-dn were used for PCR
amplification with S. sanguinis SK36 gDNA as template. Cycling conditions were as
follows: 1 cycle at 95 ºC for 5 min; 5 cycles of 94 ºC for 45 sec, 45 ºC for 45 sec, and 72
ºC for 1 min and 40 sec; followed by 25 cycles of 94 ºC for 1 min, 59 ºC for 1 min, and 72
ºC for 1 min and 40 sec; and a final extension step at 72 ºC for 7 min.
The resulting PCR products were combined and purified (Qiagen) and digested by
SalI (NEB) for cloning into the SalI digested, shrimp alkaline phosphatase (SAP) (Roche)
treated pVA2606 vector. Fifty ng of the digested insert and vector were then combined for
ligation (Invitrogen). E. coli DH10B was electroporated with the resulting plasmid,
pJFP34, and transformants were selected on LA containing Kn and X-gal. Plasmid DNA
was extracted as described above (Bio-Rad) and integration of the insert determined by
SalI digest.
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Figure 4. Plasmid maps of pJFP34 and pJFP36
A) SalI restriction sites were incorporated into an amplicon of S. sanguinis SK36 by PCR
amplification. The PCR product included the 0169 ORF flanked by ~700 bp of upstream
and downstream genomic DNA sequence. The amplicon was cloned into the SalI
restriction site of pVA2606 to create pJFP34. Blue/white screening identified E. coli
transformants with the 0169 insert (as a result of insertional inactivation of lacZα).
B) A unique NcoI site central to 0169 in pJFP34 was adopted for cloning of the
erythromycin resistance cassette pSerm. The resulting plasmid, pJFP36 was transformed
into S. sanguinis SK36 for creation of the erythromycin resistant strain, JFP36.
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To develop pJFP36 (Fig. 4B), we adopted the erythromycin resistance cassette,
pSerm, as a selective marked based on the knowledge that this gene could be expressed in
both streptococci and E. coli. The pSerm construct was kindly provided by Dr. Don
Morrison, University of Illinois at Chicago. Primers specific for pSerm, pSerm-NcoI-up
and pSerm-NcoI-dn were used in PCR with Supermix (Invitrogen) for integration of NcoI
RE sites at the 5’ and 3’ ends of the pSerm construct, with a pSerm PCR amplicon as
template. PCR cycling conditions were as follows: 1 cycle at 94 ºC for 5 min; 5 cycles at
94 ºC for 30 sec, 40 ºC for 30 sec, and 72 ºC for 1 min; 25 cycles of 94 ºC for 30 sec, 52 ºC
for 30 sec, and 72 ºC for 1 min; followed by a final extension step at 72 ºC for 1 min.
The PCR product was purified and digested by NcoI for cloning into the pJFP34encoded 0169 via an NcoI restriction site (the NcoI site is 39 bp within 0169). The digested
insert and vector were combined at a 1.5 to 1 molar ratio for ligation (Invitrogen). The
resulting ligated product was transformed into E. coli DH10B, and Emr, Knr clones were
selected for further evaluation. Orientation of 0169 and pSerm in pJFP36 was determined
by BssHII and XcmI digest, respectively. S. sanguinis SK36 was transformed with 45 ng
pJFP36 and transformants were selected on TSA containing Em. Sequencing with primers
0169-SalI-up, 0169-SalI-dn, Jxn-up, and Jxn-dn confirmed correct construct integration
into S. sanguinis genomic DNA for creation of JFP36.
Development of JFP56: A linker with AscI and NotI sites was integrated into the NcoI site
of pJFP34 for development of pJFP46 (Fig. 5A). The 0169RE-up and 0169RE-dn
oligonucleotides include complementary sequences with, at the 5’ end of 0169RE-up an
NcoI sticky end, followed by a NotI site and AscI site. The 0169RE-dn sequence also
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includes NotI and AscI sites. Complementary base pairing between the two
oligonucleotides results in a 5’ NcoI sticky end overhang for ligation into the NcoI site of
pJFP34. A base pair change at one end of the oligonucleotide (in bold in Appendix A)
abolishes the second NcoI site for a series of unique cloning sites including AscI, NotI and
NcoI.
The 0169RE-up and 0169RE-dn oligonucleotides, at 0.5 pmol µl-1 were 5’
phosphorylated with 0.25 U µl-1 T4 DNA Kinase (Invitrogen) in the presence of 0.1 M
ATP for 30 min at 37 ºC. The reaction mixtures were then combined and heated at 94 ºC
for two min, then put at room temperature for gradual cooling to facilitate annealing
between the complementary base pairs of 0169RE-up and 0169RE-dn. The linker was
combined in a 6:1 ratio (linker:vector) with NcoI digested, SAP treated pJFP34 in the
presence of T4 DNA ligase (Invitrogen) for ligation. E. coli DH10B was transformed with
the ligation product with cells containing the plasmid selected by Knr. Clones containing
the RE-linker were identified by NotI digestion of plasmid DNA. To eliminate the
possibility of linker multimerization at the cloning site, plasmids identified as containing
the linker were digested with NotI, gel electrophoresed, and the correct size linear band
extracted from the gel. The band was purified and concentrated as described above (BioRad). Fifteen fmol of the plasmid was then re-ligated in a 20 µl reaction volume. The
ligation product was transformed into E. coli DH10B cells, and plasmid transformants
selected on LA with Kn. Plasmid DNA was extracted from E. coli (Bio-Rad), and plasmids
containing the linker identified by AscI digestion. Sequence fidelity was confirmed by
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sequencing with Jxn-up and Jxn-dn primers. The resulting plasmid, pJFP46 was used for
cloning of tetM and aad9 in development of S. sanguinis JFP76 and JFP56.
For construction of pJFP56, the aad9 cassette from pR412 (161) was cloned into
the NotI and NcoI RE sites of pJFP46 (Fig. 5B). The spectinomycin resistance cassette was
PCR amplified with Sc-NotI-up and Sc-NcoI-dn primers, with as pR412 template in a
reaction containing HIFI Supermix. The PCR cycling conditions used were as follows: one
cycle at 95 ºC for 4 min; followed by 30 cycles at 94 ºC for 30 sec, 56 ºC for 30 sec, and 68
ºC for 1.5 min; and a final extension step at 68 ºC for 7 min. The resulting PCR product
was purified (Qiagen), and subsequently digested by NotI and NcoI. The digested PCR
product was combined in a 3:1 ratio with the NotI and NcoI double digested and SAP
treated pJFP46 vector for ligation (Invitrogen). E. coli DH10B was transformed with the
ligation product, and resulting transformants were selected on LA containing Sc. Plasmid
DNA was extracted from E. coli clones (Qiagen) and digested by NotI and NcoI for
confirmation of the presence of the aad9 insert in pJFP56. S. sanguinis SK36 was
transformed with 200 ng pJFP56, and transformants were selected on TSA containing Sc.
Sequencing with primers 0169-SalI-F, 0169-SalI-up, Spc638, Spc246, Jxn-up and Jxn-dn
validated integration of the correct construct into S. sanguinis gDNA.
Development of JFP76: For construction of pJFP76, the tetM cassette from pJM133 (88)
was cloned into the NotI and NcoI RE sites of PJFP46 (Fig. 5C). The tetracycline
resistance cassette was PCR amplified from pJM133 template by Tet-NotI-up and TetNcoI-dn primers, in a reaction containing HIFI Supermix (Invitrogen).
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Figure 5. Plasmid maps of pJFP46, pJFP56 and pJFP76
A) The pJFP46 vector was derived from the E. coli plasmid pJFP34 by insertion of an
AscI, NotI, linker in the 0169 insert to create a small, multiple cloning site region for
insertion of antibiotic resistance markers.
B) The cloning site linker of pJFP46 was adopted for development of JFP56. The aad9
gene of pR412 (161) was cloned into the NotI and NcoI restriction sites, and the resulting
plasmid was propagated in E. coli prior to transformation into SK36. The aad9 resistance
determinant confers spectinomycin resistance; the resulting SK36 derivative was named
JFP56.
C) The cloning site linker of pJFP46 was also used for development of pJFP76. The tetM
gene of pJM133 (88) was cloned into the NotI and NcoI restriction sites, and the resulting
plasmid was propagated in E. coli DH10B before transformation of SK36 to create a
tetracycline resistant derivative of SK36, designated JFP76.
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The PCR cycling conditions used were as follows: 1 cycle of 94 ºC for 5 min;
followed by 30 cycles of 94 ºC for 40 sec, 45, 49.3 and 50 ºC for 30 sec, and 68 ºC for 2
min and 10 sec; and a final extension step at 68 ºC for 7 min. The resulting PCR product
was purified (Qiagen), and subsequently digested by NcoI and NotI. The digested PCR
product was combined in a 3:1 ratio with the NcoI and NotI double digested and SAP
treated pJFP46 vector for ligation (Invitrogen). E. coli DH10B was transformed with the
ligation product, and resulting transformants were selected on LA containing Tet. Plasmid
DNA was extracted from E. coli clones (Qiagen) and digested for confirmation of the
presence and orientation of the tetM insert by AscI and HindIII digest, respectively. S.
sanguinis SK36 was transformed with 200 ng pJFP76 and transformants were selected on
TSA containing Tet. Sequencing with primers Jxn-up, Jxn-dn, Tet-NcoI-dn, TetMF1 and
TetMF2 validated the correct construct integration into S. sanguinis genomic DNA for
creation of JFP76.
Development of pJFP16: Plasmid pJFP16 was used for genetic competence comparison of
JFP36 and SK36. To construct pJFP16, the mini-transposon containing cat and
approximately 1.4 kb of flanking DNA was amplified from the STM strain 6-26 using 626-BamHI-up and 6-26-BamHI-dn primers, and Supermix (Invitrogen) (198). The PCR
product was gel-purified (Bio-Rad) and ligated (Invitrogen) into pVA2606 via BamHI
restriction sites. Ligation products were electroporated into E. coli DH10B and
transformants selected on LA with Kn, Cm and X-gal. Plasmid DNA was extracted as
above and orientation of the insert determined by EcoRI and NdeI digest.
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PCR amplification of ORFs for in vitro transposition: PCR was performed in 50 μl
reaction volumes with 45 µl of HIFI Supermix (Invitrogen), or 100 µl reaction volumes
with 90 µl of HIFI Supermix (Invitrogen), with S. sanguinis SK36 gDNA template, and the
ORF-specific primer set (Appendix B). The cycling conditions used were as follows: 1
cycle at 94 ºC for five min, followed by 30 cycles of 94 ºC for 40 sec, 53 to 56.5 ºC for 30
sec, and extension at 68 ºC for 3 min. This was followed by a final extension at 68º for 7
min.
In vitro transposition of PCR amplicons: The signature-tagged plasmid library used for in
vitro transposition was previously described (198). The plasmids were pre-screened by Dr.
Todd Kitten to select 40 with signature-tags producing high-signal intensity, and minimal
cross-reactivity in dot-blot DNA hybridization. The in vitro transposition reaction included
1.2 µg of PCR product template (above), 0.5 µg µl-1 of pJFP1-encoded magellan2
containing a unique sequence tag (referred to numerically, 1-40), 2 µl of 10 x NEB4
buffer, 100 µg ml-1 BSA (New England Biolabs Inc.), and 1µl of 2 mg ml-1 MarC9 Tnp in
a total volume of 20 µl. Transposition was performed at 30 ºC for 1 h. Immediately
following transposition 380 µl 1 x Tris-EDTA (TE) was added, and an the sample
extracted with an equal volume of phenol/CHCl3, followed by a second extraction with
CHCl3. Organic phase separation was performed in 2 ml Phase-Lock Gel Heavy tubes (5
Prime).
DNA was precipitated from the aqueous phase with the addition of 2 µl oyster
glycogen or 1 μl Ethachinmate (Wako), 0.1 volumes of 3 M NaOAc, and 1 ml of EtOH,
and suspended in 14 µl of 0.1 x TE. Gaps in the DNA sequence following transposition
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were filled by T4 DNA polymerase (Invitrogen). The reaction mixture contained 2 µl of 10
x T4 DNA polymerase buffer, 2 µl of 1 mM dNTPs, 50 µg µl-1 of BSA (New England
Biolabs), 1 µl of T4 DNA polymerase (1-3 units µl-1), and 14 µl of transposition product.
The entire reaction was incubated at 12 ºC for 15 min, and was terminated with the
addition of EDTA to 10 mM. The enzyme was then heat inactivated by incubation of the
mixture at 75 ºC for 20 min. To remove residual dNTPs and enzyme the transposition
products were purified on a column from the MinElute PCR Purification Kit (Qiagen),
with DNA eluted from the column in 16 µl 0.1 x TE. Nicks in the DNA phosphate
backbone were the sealed by a ligation reaction. For this, 15 µL of eluate was combined
with 10 x T4 DNA ligase buffer and 1 µl of T4 DNA ligase (Invitrogen) in a total reaction
volume of 20 µl. Ligation was performed at room temperature for 1 h. T4 DNA ligase was
subsequently inactivated by incubation of the mixture at 75 ºC for 10 min. Ten µl of the
transposition product was then used for transformation of S. sanguinis SK36.
Diagnostic PCR for estimation of transposon location: Chloramphenicol resistant clones
were selected and inoculated into 2 ml BHI containing Cm, in a 48 well block. The block
was covered with an air-pore tape strip and incubated overnight at 6 % O2, 37 ºC. Once
cultures reached turbidity indicative of stationary phase 1 ml was removed and centrifuged
in a bench top microcentrifuge at 14k rpm for 1 min. The cells were washed with Tris-HCl
(pH 8.0) for use as template in PCR, as described above. For diagnostic PCR primers
flanking the ORF were used in conjunction with the magellan2 inverted repeat primer
Mout. For each clone two PCR reactions were performed, one primed by the ORF-up
primer and Mout, and a second PCR primed by the ORF-dn primer and Mout. PCR
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reactions included 18 µl Platinum Supermix (Invitrogen), 1.2 µl of the washed cells as
template, and primer pairs at 0.2 pmol µl-1. The cycling conditions used were: 1 cycle at 94
ºC for 1 min, followed by 30 cycles of 94 ºC for 30 sec, 56 ºC for 30 sec, and 72 ºC for 2
min 30 sec; amplification terminated with a final single extension step at 72 ºC for 7 min.
Gene SOEing for creation of JFP42 and JFP44: Mutagenesis of srtA or srtB was
conducted in a three-step approach. The gene SOEing (105) strategy used is shown in
Figure 6. The templates for PCR included S. sanguinis SK36 gDNA; pR412 (161); or the
kanamycin resistance cassette, kan, expressed from a synthetic promoter designed for S.
pneumoniae (243).
In the first step, antibiotic resistance markers and 5’ and 3’ regions of the S.
sanguinis gene were amplified in three separate PCR reactions. pR412 (primer set spcUP
(+) and spcDO (-)), or kan (primer set DAM303 (+) and DAM347 (-)) was used as
template. Cycling conditions for amplification of aad9 were: 1 cycle of 94 ºC for 5 min, 30
cycles of 94 ºC for 45 sec, 50 ºC for 45 sec, and 68 ºC for 1.5 min, and a final extension
cycle at 68 ºC for 7 min. Cycling conditions for amplification of kan were 1 cycle of 94 ºC
for 5 min, 30 cycles of 94 ºC for 45 sec, 55 ºC for 45 sec, and 68 ºC for 1.3, and a final
extension at 68 ºC for 7 min.
For srtA and srtB constructs the 5’ portion of the gene and upstream sequence was
amplified with consensus primer 1 (+), and primer 2 (-) designed to include a 5’ tail
complementary to the antibiotic resistance primer (+). For both constructs the 3’ portion of
the gene and downstream sequence was amplified with primer 3 (+) which includes a 5’
tail complementary to the antibiotic resistance primer (-), and consensus primer 4 (-). The
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cycling conditions for srtA1 and srtA2, srtA3 and srtA4 reactions were: 1 cycle at 94 ºC
for 5 min, followed by 30 cycles of 94 ºC for 45 sec, 60 ºC for 45 sec, and 68 ºC for 1.75
min, followed by a final extension cycle at 68 ºC for 7 min. The cycling conditions for
srtB1 and srtB2, srtB3 and srtB4 reactions were: 1 cycle at 94 ºC for 5 min, followed by 30
cycles of 94 ºC for 45 sec, a gradient between 55 - 65 ºC for 45 sec, and 68 ºC for 1.3 min,
followed by a final extension cycle at 68 ºC for 7 min. PCR products from the three
reactions were purified from remaining primers and reaction buffer (Qiagen).
In the second step, 5’ or 3’ portions of each gene were fused to antibiotic resistance
markers in two separate PCR reactions. The cassette aad9 was fused to the 5’ (primer pair
srtA1 (+) and spcDO (-)) or 3’ (primer pair spcUP (+) and srtA4 (-)) portion of srtA. The
cassette kan was fused to the 5’ (primer pair srtB1 (+) and DAM347 (-)) or 3’ portion of
srtB (primer pair DAM303 (+) and srtB4 (-)). The 5’ or 3’ PCR product and antibiotic
cassette PCR product were combined as the PCR template. Amplification conditions for
aad9 fusion were: 1cycle 94 ºC for 45 sec, 30 cycles of 94 ºC for 45 sec, 58 ºC for 45 sec
(5’:aad9) or 54 ºC for 45 sec (aad9:3’), and 68 ºC for 2.75 min; followed by a final
extension cycle at 68 ºC for 7 min. Amplification conditions for kan fusion were: 1 cycle
94 ºC for 45 sec, 30 cycles of 94 ºC for 45 sec, a gradient of 55 to 60 ºC for 45 sec, and 68
ºC for 2.25 min; followed by a final extension at 68 ºC for 7 min. The resulting fusion
products were purified as described above.
The third step created a fusion of the entire construct: the 5’ portion of each gene,
antibiotic resistance cassette, and the 3’ portion of each gene. For this the 5’:ab cassette
and 3’:abr cassette products for each gene were combined as template for PCR. Flanking

45
Figure 6. Gene SOEing strategy for sortase mutation
The three-step approach used for mutagenesis of S. sanguinis (Ss) srtA and srtB is
depicted. Through gene SOEing (105), deletion of the majority of the ORF was coupled
with insertion of an antibiotic resistance cassette. SOEing was enabled by 5’ tails
incorporated into primer 2 and primer 3 that were complementary to the (+) and (-)
antibiotic resistance (Abr) cassette primers, respectively. In the first step the 5’ portion and
3’ portion of the ORF were amplified, as well as the antibiotic resistance cassette.
Amplification of the 5’ upstream region of the ORF was primed by pair 1 and 2.
Amplification of the 3’ downstream region of the ORF was primed by pair 3 and 4. The
resistance marker was amplified by the (+) and (-) pair. In the second step the antibiotic
resistance cassette was fused to the 5’ fragment, or 3’ fragment of the gene in a PCR
reaction primed by 1 and (-), or (+) and 4, respectively. The resulting products were
combined as template in the third, and final amplification reaction primed by the ORF
flanking primers 1 and 4.
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consensus primers were used to amplify the entire construct. For srtA amplification the
primers srtA1 and srtA4 were used, whereas srtB1 and srtB4 were paired for srtB. Cycling
conditions for srtA:aad9 fusion were: 1 cycle of 94 ºC for 5 min, followed by 30 cycles of
94 ºC for 40 sec, a gradient of 54, 58, and 63 ºC for 30 sec, and 68 ºC for 3.75 min,
followed by a final extension cycle at 68 ºC for 7 min. Cycling conditions for srtB:kan
fusion were: 1 cycle of 94 ºC for 5 min, followed by 30 cycles of 94 ºC for 40 sec, a
gradient of 60, and 65 ºC for 30 sec, and 68 ºC for 3.5 min, followed by a final extension
cycle at 68 ºC for 7 min. The complete mutagenic constructs were purified as described
above and transformed into S. sanguinis SK36. Transformants were selected by antibiotic
resistance conferred by the cassette used. DNA sequencing of the srtA mutant with primers
srtA1, srtA2, srtA3, srtA4, spcDO, spcUP, spc246 and spc638 confirmed sequence fidelity
of regions flanking srtA in strain JFP42. DNA sequencing of the srtB mutant was
performed with primers srtB1, srtB2, srtB3, srtB4, DAM303, DAM347, kan306R and
kan637F confirmed sequence fidelity in regions flanking srtB in strain JFP44.
Development of JFP47: In this complementation strategy, srtA downstream of its putative
native promoter and RBS, was recombined into the genomic locus used for creation of
JFP36, JFP56 and JFP76, SSA_0169 (Fig. 7B). An extensive gene SOEing (105) strategy
was developed for fusion of srtA with its predicted native promoter upstream of gyrA (Fig.
7A) to the kanamycin resistance cassette kan. The fusion construct was flanked by
consensus sequences upstream and downstream of SSA_0169 that would permit
homologous recombination with the intended insertion locus. A schematic depicting
progressive amplifications is shown in Figure 7C.
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Templates for PCR amplification were SK36 gDNA and a kan PCR product (243).
Successive rounds of amplification resulted in SOEing of the entire construct. Each
template was purified (Qiagen) before inclusion in the next PCR reaction. A
complementary 5’ end to the 0169-2 primer was incorporated in the 0169srtAP fusion
primer for SOEing of the upstream SSA_0169 region to the srtA promoter and coding
region. A complementary 5’ end to the DAM303 primer was incorporated in the kansrtA
fusion primer for SOEing of the kan resistance marker 3’ to srtA. A complementary 5’ end
to the DAM347 primer was incorporated in the kan0169 primer for SOEing of kan to the
SSA_0169 downstream region.
Amplification of the SSA_0169 upstream and downstream regions was performed
with the SK36 gDNA template, the 0169-SalI-up [0169-1 in Fig. 7B and 7C, and below]
and 0169-2 primer pair, or the kan0169 and 0169-SalI-dn [0169-4 in Fig. 7B and 7C, and
below] primer pair, and HIFI Supermix (Invitrogen). The cycling conditions were as
follows: 1 cycle of 95 ºC for 5 min; five cycles of 94 ºC for 45 sec, 45 ºC for 45 sec, and
68 ºC for 45 sec; 25 cycles of 94 ºC for 1 min, 56 and 59 ºC for 1 min, and 68 ºC for 45
sec; followed by a final extension cycle of 68 ºC for 7 min. The kan cassette was fused to
the downstream SSA_0169 region by combining a previously amplified kan PCR product
(see construction of JFP44 above) and the kan0169/0169-SalI-dn PCR product as template
for amplification with the DAM303 and 0169-SalI-dn primer pair. Cycling conditions
were: 1 cycle of 94 ºC for 40 sec; 30 cycles of 94 ºC for 40 sec, 50, 55 and 60 ºC for 30
sec, and 68 ºC for 1.5 min; followed by a final extension cycle at 68 ºC for 7 min.
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Figure 7. Construction of JFP47

A) The predicted srtA RBS, and srtA coding region were fused to the predicted promoter
of srtA transcription, 5’ of gyrA. Spacing between the promoter, RBS and start ATG of
gyrA were conserved, though nucleotides external to the promoter were changed for
fidelity to the 24 nucleotides preceding srtA.
B) The final PCR amplified fusion construct is shown, along with primer pairs used for
sequential PCR amplification in synthesis of the larger amplicon. 5’ primer tails enabling
gene SOEing are indicated by color coding.
C) The overall PCR strategy for creation of the srtA:kan:SSA_0169 fusion is shown. In the
first step kan and the SSA_0169 downstream region were PCR amplified in separate
reactions primed by the primers shown. The products were combined as template in a
SOEing PCR for fusion of the kan cassette with the 3’ region of SSA_0169. A long primer
incorporating a 5’ tail complementary to SSA_0169, the native gyrA promoter, and srtA
sequence was for amplification of srtA from SK36 gDNA. The srtA amplicon was
combined with the kan:SSA_0169 PCR product as template in a reaction for amplification
with the primer pairs shown. In a final PCR reaction, the fusion construct was combined
with a PCR amplicon of the 5’ SSA_0169 region as template amplified by flanking 0169
primers. The flanking SSA_0169 ends of the amplicon permitted recombination of the PCR
products into the SSA_0169 locus of JFP42. A Knr clone, JFP47 was used in
complementation studies.
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Figure 7.
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Fusion of srtA to the gyrA promoter was performed using the long fusion primer
0169srtAP and the kansrtA fusion primer with SK36 gDNA as template. The reaction
mixture was as described above. Cycling conditions were: 1 cycle at 94 ºC for 5 min; 5
cycles of 94 ºC for 45 sec, 45 ºC for 45 sec, and 68 ºC for 1 min; 25 cycles of 94 ºC for 45
sec, 55 or 60 ºC for 45 sec, and 68 ºC for 7 min; a final extension cycle was performed at
68 ºC for 7 min. The resulting PCR product was fused to the kan:0169 amplicon in a
subsequent PCR reaction. The two templates were combined in a reaction as described
above, with amplification primed by the 0169srtAP and 0169-SalI-dn primer pair. Cycling
conditions were: 1 cycle of 94 ºC for 5 min; 30 cycles of 94 ºC for 45 sec, 55 ºC for 45 sec,
and 68 ºC for 2.5 min; followed by a final extension cycle of 68 ºC for 7 min. In a final
PCR reaction the entire fusion construct was created by combining the PsrtA/kan:0169
amplicon and the upstream 0169 amplicon as template in a reaction primed by the 0169SalI-up and 0169-SalI-dn primer pair. The templates were combined in reaction as
described above. Cycling conditions were: 1 cycle of 94 ºC for 5 min; 30 cycles of 94 ºC
for 45 sec, 52, 56.8 or 60 ºC for 45 sec, and 68 ºC for 3.25 min; followed by a final
extension at 68 ºC for 7 min.
Ten µl of the PCR product was transformed into competent JFP42 cells (SK36
served as a control for transformation), and transformants were selected on TSA containing
Kn. Clones were selected for sequencing of the SSA_0169 insertion site by primers Jxn-up,
Jxn-dn, kan306. Clone JFP47 was selected for further analyses.
Development of JFP42 (pJFP50): An alternative native promoter of srtA was predicted in
the 3’ sequence of gyrA. The 320 bp upstream of srtA and the srtA coding region were

52
cloned into the pVA838 shuttle vector. EcoRI sites were incorporated into the primer set,
srtA-EcoRI-up and srtA-EcoRI-dn, used for PCR amplification of srtA from SK36 gDNA.
Cycling conditions were as follows: 1 cycle of 94 ºC for 5 min; 30 cycles of 94 ºC for 46
sec, 55 ºC for 45 sec, and 68 ºC for 1.25 min; followed by a final extension cycle at 68 ºC
for 7 min. The resulting PCR product was purified (Qiagen), and digested by EcoRI for
ligation into the EcoRI digested, SAP treated pVA838 vector. The digested insert and
vector were then combined at a 3 to 1 molar ratio for ligation (Invitrogen). Two µl of the
ligation reaction were electroporated into E. coli DH10B (Invitrogen). E. coli
transformants were selected by Emr on LA plates.
The pVA838 vector encodes both Cm, and Em resistance (Fig. 3A). The EcoRI
cloning site is within the Cmr cassette, and therefore clones containing the insert would be
rendered Cms. Fifty Emr resistant DH10B clones were replicate plated on LA, followed by
LA with Cm at 20 µg µl-1 to screen for and recover Cms clones. Twelve of the 50 clones
were Cms. These clones were cultured from the LA plate in LB containing Em, and
plasmid DNA prepared (BioRad). The resulting plasmid, termed pJFP50 (Fig. 8) was sent
for DNA sequencing with primers srtA-EcoRI-up, pVA838-2939, and pVA838-5331 to
confirm srtA sequence fidelity. Competent JFP42 was transformed with 200 ng pJFP50,
and transformants were selected on TSA containing Em.
Development of JFP52: In an alternative strategy for complementation of JFP42, srtA was
cloned into the pCM18 E. coli-streptococcal shuttle vector (Fig. 9A). SphI RE sites were
engineered in the primers, srtA-SphI-up and srtA-SphI-dn, used for PCR amplification of
srtA from SK36 gDNA. Cycling conditions were: 1 cycle at 94 ºC for 5 min; 30 cycles at
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Figure 8. Plasmid map of pJFP50

The 320 bp preceding srtA (3’ gyrA), and the srtA coding sequence were cloned into the
EcoRI restriction site of pVA838. E. coli electrotransformants were selected by Emr, and
screened for Cms resulting from insertion inactivation of the Cmr cassette. The plasmid
with sequence fidelity designated pJFP50 was transformed into competent JFP42 cells.
Emr transformants were then screened for complementation of srtA mutant phenotypes.
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Figure 9. Construction of pJFP52

A) The region of pCM18 used for cloning of srtA is shown. The synthetic lactococcal
promoter, CP25, and the synthetic ribosomal binding site (RBSII) from pQE70 (Qiagen)
drive expression of the gfpmut3 green fluorescent protein gene in E. coli, as well as S.
gordonii. Plasmid selection is through an Emr cassette not shown. This low copy number
plasmid (6-9 copies per chromosomal equivalent) exerts a broad host range, owing to its
small size (8.2 kb) and the presence of both gram-positive (pAMβ1) and gram-negative
(P15A) replicons (90).
B) The srtA gene of S. sanguinis was cloned into pCM18 via the SphI restriction site
occurring in the first codon of gfpmut3, thus placing srtA under the control of the CP25
promoter. The resulting plasmid, pJFP52 was transformed into S. sanguinis JFP42, with
Emr confirming maintenance of the plasmid. Transcription through srtA to gfpmut3 was
evidenced by green fluorescence of JFP42 and SK36 (not shown).
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94 ºC for 45 sec, 44 ºC for 45 sec, and 68 ºC for 1 min; followed by a final extension cycle
at 68 ºC for 7 min. The PCR product was purified (Qiagen), and then digested with SphI.
The digested insert was cloned into SphI linearized, and SAP treated pCM18 (Invitrogen).
The resulting ligation product was electroporated into E. coli DH10B and transformants
were selected by Emr conferred by pCM18. Plates were viewed on a Dark Reader
transilluminator (Clare Chemical Research) for identification of non-fluorescing colonies,
which would indicate insertion of srtA 5’ of gfpmut3. Plasmid DNA extracted from E. coli
(Bio-Rad) was digested by SphI and PvuI to confirm the presence of srtA in pCM18; the
plasmid containing the insert was termed pJFP52 (Fig. 9B). Plasmid DNA was sequenced
with primers CP25, srtA-SphI-up, and gfpmut. Following confirmation of srtA sequence
fidelity and proper orientation of srtA, 150 ng of plasmid DNA was used for
transformation of JFP42. Transformants were selected on TSA containing Em.
Development of JFP62: pCM18 instability in JFP42 resulted in the development of a final
complementation construct incorporating features of previous constructs. The srtA gene
was cloned with the CP25 promoter from pCM18 into the stabile pVA838 shuttle vector
(Fig. 3A). The primer set pJFP52srtA-up and pJFP52EcoRI-dn was used for amplification
of pJFP52 encoded srtA. Cycling conditions were: 1 cycle of 94 ºC for 5 min; 30 cycles of
94 ºC for 40 sec, 50, 56.1 or 60 ºC for 30 sec, and 68 ºC for 1.25 min; followed by a final
extension at 68 ºC for 7 min. The PCR product was cloned into the EcoRI site of pVA838,
and ligation products were electroporated into Electromax DH10B cells as described
above. Resulting Emr clones were screened for Cms, as described above. DNA sequencing
of the resulting plasmid, pJFP62 (Fig. 10), was completed using primers pVA838-2245,
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Figure 10. Plasmid map of pJFP62
The L. lactis synthetic promoter CP25, ribosomal binding site (RBSII) and srtA gene were
cloned from the unstable pCM18 background into the stable pVA838 vector by preexisting
or engineered EcoRI restriction sites. Integration of the insert at EcoRI inactivated the Cmr
marker. This was the basis of screening for the insert in E. coli. Plasmid prepared from
Emr, Cms E. coli was transformed into JFP42. Emr transformants were further evaluated
for complementation of srtA mutant phenotypes.
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pVA838-2939, pVA838-5331, and 1219-F. Competent JFP42 cells were transformed with
200 ng pJFP62, and transformants were selected by Emr. The resulting strain was
designated JFP62.

Transformation of S. sanguinis.
In vitro transformations of S. sanguinis strains were performed as previously described
(198). Briefly, strains were cultured in TH-HS to an OD at 660 nm of 0.06 to 0.08.
Transforming DNA, 330 µl of cells, and 70 ng synthetic CSP—with the amino acid
sequence DLRGVPNPWGWIFGR (79)—were transferred to 0.7-ml microcentrifuge tubes
and incubated at 37 °C for 1 h. Cells were plated on TSA with or without selective
antibiotics and grown at 37 °C for 48 h under 6 % O2. The frequency of transformation
was defined as the ratio of transformants to total colony-forming units (CFUs). The
efficiency of DNA uptake was defined as the number of transformants per µg of
transforming DNA.

In vitro growth comparisons
Soft-agar evaluation of anaerobic growth sensitivity: For soft-agar studies (Kurtz 2002)
LMP agarose was dissolved in TSB by autoclaving, and then aliquoted in 10 ml volumes
into glass Hungate tubes or polystyrene (PS) Falcon tubes (BD). Em, 5 µg µl-1 of the
oxygen dye indicator resazurin sodium salt (Acros), or 20 µg µl-1 of the oxygen indicator,
methylene blue were added to select tubes. All tubes were then placed in a 37 ºC incubator
inside an anaerobe chamber for 48 h. Tubes were then inoculated with 100 µl of
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streptococcal overnight cultures, mixed by inversion, and incubated at ambient temperature
in the anaerobe chamber for 30 minutes to permit solidification of the agar. Tubes were
then removed from the anaerobe chamber and incubated aerobically with the caps loosened
at 37 ºC for 24 h. The depth of growth in cm was measured in each tube with a standard
ruler and documented using a digital camera. Values were compared using ANOVA with
the Tukey-Kramer multiple-comparisons post-test with α=0.05.
Overnight growth comparisons in a microplate format: Stationary phase S. sanguinis
cultures were diluted 100-fold in BHI, and 200 µl aliquots added to the wells of a 96-well
microplate (Greiner). Growth at 37 ºC, at ambient atmosphere was monitored every 10 min
over 20 h by measuring the OD at 450 nm. The cells were mixed by orbital shaking (140
rounds/min) with a shaking width of 4 mm for 10 sec before every recording. The
experiment was performed in a FLUOstar microplate reader (BMG Technologies).
When noted in the results section a modified procedure was used. Colonies of S.
sanguinis strains taken from TSA plates containing selective antibiotics were cultured
overnight in BHI to stationary phase. Cells were diluted 10-fold in pre-incubated BHI for
three additional h of subculture at 37 ºC. Cells were harvested by centrifugation at 3,743 x
g for 10 min at 4 ºC, and washed once in ice-cold sterile PBS (pH 7.2 – 7.4) before
suspension in 7 ml of PBS. The optical density at 660 nm of each strain was adjusted to
~0.8. Cells at this concentration were diluted 200-fold in BHI and 200 µl aliquots
monitored in a 96-well plate, as described above.
In vitro competitive index assays: The effect of co-culturing strains in vitro was studied by
replicating incubation times described above for in vivo competitive index (CI) assays
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(below). Stationary phase cultures of S. sanguinis strains in BHI (sans antibiotics) were
diluted 10-fold in fresh BHI and grown for an additional three h at 37 ºC. Cells were
washed in PBS as described above, and the optical density of each strain was adjusted to
0.8 at 660 nm. Equal volumes of strains at the same optical density were combined for the
“mock” inoculum. From this mixed strain culture, 10 µl was diluted into 10 ml of preincubated BHI for growth at 37 ºC, 6 % O2 overnight. The inoculum was also serially
diluted and plated on TSA containing selective antibiotics for enumeration of CFUs for
each strain. Following 20.5 – 23 h of co-culture in BHI, cells were serially diluted and
plated on TSA containing selective antibiotics. Plates were incubated at 37 ºC, 6 % O2 for
2 days. The competitive index value was determined by dividing the CFU ratio of the
mutant to control after 20 h of co-culture by the CFU ratio of mutant to control inoculated.
Significance was determined by a paired t-test of log transformed CI values, with P < 0.05
indicating a significant difference in co-culture growth in vitro.

Strain evaluation in the rabbit model of IE
A previously described rabbit model of infective endocarditis was adapted for use
in this study, with specific-pathogen free New Zealand White rabbits weighing 3 to 3.9 kg
as subjects (65, 198). The protocol used was approved by the Institutional Animal Care
and Use Committee, and is in compliance with all federal guidelines and institutional
policies. To impose pre-disposing valve damage for infective endocarditis, a catheter was
inserted along the right carotid artery and past the aortic valve of anesthetized rabbits. The
catheter was sutured and remained in place for the duration of the experiment. Two days
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post-surgery, streptococci were inoculated into the right lateral ear vein of the rabbits. At
pre-determined times rabbits were sacrificed by intravenous injection of euthasol (Virbac
AH, Inc.). During necropsy accurate placement of the catheter was confirmed and the heart
excised. Apparent vegetations were recovered from the aortic valve and surface of the left
ventricle and homogenized in sterile PBS. Multiple vegetation homogenate dilutions were
spread on the surface of TSA plates for recovery of bacterial strains.

STM analyses in the rabbit model of IE
Inoculum preparation: Signature-tagged mutants were cultured overnight in a 48-well
block in 1.25 ml BHI containing Cm. Cells were mixed by vortexing and pooled into a 50
ml conical tube. From the conical tube, an aliquot was diluted 1:10 into 12.6 ml preincubated BHI, and 1.5 ml pooled cells were transferred to 10.5 ml pre-incubated BHIT.
The tube containing BHIT was sub-cultured for 2.25 h at 37 ºC, with addition of 0.6 g
glycine at 1.5 h post-dilution. Cells in BHIT were then harvested by centrifugation at
3.743k x g, 10 min, 4 ºC and the resulting pellet washed in 1 ml cold, sterile dH2O, and
then stored at -20 ºC until DNA extraction was performed (126).
Cells in BHI were subcultured for 3 h at 37 ºC and then harvested by centrifugation
at 3.743k x g, for 10 min at 4 ºC. The resulting cell pellet was washed in 7 ml cold, sterile
PBS (pH 7.2-7.4). The cells were then diluted in PBS to achieve an OD at 660 nm
equivalent to ~ 1 x 108 cells ml-1. Cells at this concentration were used as the inoculum,
with 0.5 ml loaded into 1 ml Leur-lock syringes, fitted with 26 gauge, ½ in. needles. Pre-
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catheterized rabbits were injected with the inoculum and infection permitted to proceed to
20 h.
Amplification of signature tags: For each rabbit tested TSA plates containing recovered
colonies with 4,500 – 10,000 colonies per plate were suspended in 1 ml BHIT. The
suspended colonies were then diluted 60 – 100 fold in fresh BHIT containing Cm for
overnight growth. Cells were then diluted 10 fold and sub-cultured for 3 additional hours
prior to preparation of chromosomal DNA as previously described (126).
DNA extracted from input pooled strains and output pooled strains was then used
as template in PCR with signature tag invariant end primers, PB1 and PB2. PCR
components included 1 µg extracted DNA, 90 µl Supermix, and 0.5 pmol µl-1 PB1 and
PB2 primers in 100 µl total reaction volume. PCR cycling conditions used were: 1 cycle at
95 ºC for 1 min, followed by 25 cycles of 94 ºC for 30 sec, 45 ºC for 1 min, and 72 ºC for
10 sec. PCR terminated in a final extension cycle at 72 ºC for 2 min. PCR products were
electrophoresed on 3 % NuSieve agarose gels, purified on Freeze ’N Squeeze columns
(BioRad), and ethanol precipitated with a final resuspension of the pellet in 20 µl 0.1x TE.
The PCR digoxigenin probe synthesis kit (Roche) was used to DIG-label amplified
signature tags in a second round of PCR. The nested primer pair PB11 and PB12, at 0.25
pmol µl-1 was combined with 10 x buffer, DIG-labeled dNTPs, unlabeled dNTPs,
polymerase and 2 µl of PCR template in a 100 µl reaction volume, as specified by the
manufacturer. The PCR cycling protocol was as follows: 1 cycle at 95 ºC for 1 min,
followed by 20 cycles of 94 ºC for 30 sec, 37 ºC for 1 min, 72 ºC for 10 sec, and a single
final extension at 72 ºC for 2 min. DIG-labeled products were purified (Qiagen), and DNA
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eluted in 15 µl 1 x TE was gel electrophoresed on a 3 % NuSieve agarose gel (Cambrex).
DNA bands of the input and output amplicons were excised from the gel and prepared for
hybridization analysis by the addition of 1 ml of hybridization fluid. The tube was boiled
for 5 min to melt the agarose and denature the probe. Hybridization analysis was
performed as described below.
Dot blot hybridization analysis: Dot blots were created by transferring 1.1 µg of each
STM plasmid (containing tags used) in 22 µM NaOH, and 6X SSC buffer to a
MagnaGraph nylon membrane (Micron Separations) with a vacuum manifold (Schleicher
& Schuell Bioscience). DNA was then cross-linked to the membrane using a UV
Stratalinker (Stratagene). Duplicate membranes were then probed with the input pool and
output DNA probes as directed by the Genius chemiluminescent kit protocol (Roche). The
resulting chemiluminescent signal was detected by a FluorChem Imager with FluorChem
software, V. 3.04A (Alpha Innotech Corporation).

Competitive index analyses in the rabbit model of IE
Inoculum preparation: The S. sanguinis colonies from TSA were grown in BHI (without
antibiotic unless otherwise specified) overnight. Stationary phase cells of the strains were
pooled (unless otherwise indicated) and diluted 1:10 in 14 ml pre-incubated BHI for 3
additional h of sub-culture at 37 ºC. Cells were harvested by centrifugation at 3,743 x g for
10 min at 4 ºC, washed once in ice-cold PBS (pH 7.2 – 7.4) and adjusted to an optical
density of 0.8 at 660 nm, corresponding to ~5 x 107 – 1 x 108 CFUs ml-1 of each strain.
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Five-hundred μl of cells at this optical density were injected into the right lateral ear vein
of pre-catheterized rabbits.
When strains were not pooled for co-culture prior to inoculation, they were
subcultured separately for 3 h and each strain was subsequently adjusted to an optical
density at 660 nm of 0.8, as described above. Equal volumes of strains compared were then
combined, and 0.5 ml of the combined strain inoculum injected into previously
catheterized rabbits.
Determination of the CI value: The actual number of CFUs rabbits received was
determined by plating the inoculum on TSA containing selective antibiotics. Twenty h
after infection, rabbits were sacrificed as described above. Vegetations collected from the
aortic valve during necropsy were homogenized, diluted and plated. Plates containing the
inoculum or vegetation homogenates were grown for 2 days at 37 °C, 6 % O2. Resulting
colonies were enumerated for determination of the competitive index (CI) value, which is
defined as the mutant/wild-type ratio of the homogenate divided by the mutant/wild-type
ratio in the inoculum. Since colony numbers are often highly skewed log transformed
values were used to compute the CI value. Statistical significance was determined by
Student’s paired t-test, with P < 0.05 representing significance.
Previous experiments in our lab revealed that selection via the Cm resistance
cassette of STM strains caused reduced colony formation under the normal growth
atmosphere of 6 % O2. A previously described layer-plating technique that is not inhibitory
for Cmr clones was used when comparing STM mutants to JFP36. Briefly, bacterial cells
suspended in 12.5 ml TSB with 1 % LMP agarose were poured into a petri dish. The dish
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was left at room temperature to allow the agar to harden, and then transferred to a 37 ºC
incubator for 2 h. The top layer of 12.5 ml TSA, containing selective antibiotics was then
added. As the TSB-LMP agarose layer contains no antibiotic, twice the normal selective
antibiotic concentration was added to TSA. The agar was kept at room temperature until
completely hardened, and plates were then incubated at 37 ºC, aerobically for 2 days.
In several experiments S. sanguinis SK36 derivative strains were compared directly
to the parental strain. S. sanguinis SK36 lacks a selective marker; therefore, plating in the
presence and absence of selective antibiotic (specific for the mutant tested) was used to
enumerate mutant CFUs and total CFUs, respectively. SK36 CFUs were determined by
subtracting the mutant CFUs from total CFUs.

Individual inoculum analyses in the rabbit model of IE
Inoculum preparation: Colonies of the mutant strain (from TSA with selective antibiotic)
or SK36 (from TSA) were inoculated in 5 ml BHI for growth at 37 ºC, 6 % O2 overnight.
Cells of each strain were sub-cultured in pre-incubated BHI, and then adjusted to an optical
density at 660 nm of 0.8. Previously catheterized rabbits received 0.5 ml of the single
strain inoculum. The inoculum was then diluted and plated on TSA for estimation of the
number of bacteria in the inoculum received by rabbits.
Determination of bacterial recovery: Rabbits infected with streptococci were sacrificed at
2 or 20 h post-inoculation. During necropsy surgeons were cautious to only remove
material with the characteristic vegetation appearance. Vegetations recovered were
weighed, and then homogenized in 2 ml of ice-cold, sterile PBS (pH 7.2 – 7.4). Serial
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dilutions of the homogenate were spread on TSA (no antibiotics), and plates were
incubated for 2 days at 37 ºC, 6 % O2. The number of colonies recovered from each rabbit
was determined. As colony counts are often skewed the values were log transformed. To
account for differences in the amount of vegetation matter collected, the CFU recovered
was divided by the gram weight of the homogenized vegetations. Significance was
determined by comparing log CFU/g values for each strain in a Welch corrected (equal
variance not assumed), unpaired t-test, with P < 0.5 indicating a significant difference in
bacterial recovery.

qRT-PCR analysis
RNA extraction for analysis of 0169: A stationary phase culture of S. sanguinis SK36 was
diluted 1:20 into BHI pre-incubated aerobically (225 rpm), under 6 % O2, or anaerobic
conditions (0 % O2); and grown 5 additional h at 37 °C. RNA was extracted from cells by
Trizol (Invitrogen).
RNA extraction for analysis of srtA: Early stationary phase cultures of S. sanguinis strains
SK36, JFP36, JFP42, and JFP47 in BHI were used for RNA extraction by Trizol
(Invitrogen).
Treatment of RNA for transcript detection: RNA samples were purified and doubleDNase I treated on RNeasy columns (Qiagen), and RNA quality assessed by the Experion
RNA StdSens Chip (Bio-Rad). Reverse transcription was performed with pre-formulated
beads from the Ready-To-Go You-Prime First-Strand reverse transcriptase kit (Amersham
Biosciences), and primed by the random hexamer primer pd(N)6. For each RNA sample a
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control reaction without reverse-transcriptase was performed to monitor for DNA
contamination. PCR reactions (10 µl) comprised 5 µl RT2 Real-Time SYBR Green/Rox
PCR master mix (SuperArray), 10 pmol of each forward and reverse primer (detectors are
described in Appendix A) and 1 µl template. The cDNA quantity was used for
normalization of samples, with a previously described technique (148). Briefly, an aliquot
of each RNA sample was combined with RNA hydrolysis solution (1 mM EDTA, 100 mM
NaOH) and heated for 20 min at 70 °C before and after reverse transcription. The samples
were then neutralized by addition of 6 µl 0.5 M Tris-HCl, pH 6.4. The neutralized samples
were mixed with 200-fold diluted RiboGreen (Invitrogen) and fluorescence measured at
485/520 nm excitation/emission wavelengths in a FLUOstar microplate reader (BMG
technologies). The correction factor used for normalization was calculated by subtracting
fluorescence of samples before reverse transcription from fluorescence values of samples
following the reverse transcription reaction. Following quantitative PCR, the transcript
abundance value was divided by the correction factor of the corresponding sample.
Transcript abundance of each gene was quantified based on standard curves created by
serially diluting a PCR amplification product of each gene of interest and using it as
template for the real-time reaction. Relative to the standard curve, n-fold differences
among template quantities for a specific gene could be compared among samples.

Static in vitro biofilm formation assay
This assay is based on the ability of streptococci to develop biofilms on solid PS
surfaces, and was modified from previously described protocols (190, 76). Early stationary
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phase S. sanguinis strains were diluted 1:100 in chemically defined biofilm medium (BM)
containing 1 % glucose (BM + Glu), or 1 % sucrose (BM + Suc) (151). Aliquots of 0.1 ml
were transferred to the wells of a 96-well PS plate for incubation at 37 °C for 20 h at 6 %
O2. Wells with media alone served as negative controls. For biofilm quantification, media
and planktonic cells were removed from the wells by decanting and washing twice with
dH2O. Wells were dried and stained with 1 % (wt/vol) crystal violet (CV) for 15 min.
Excess dye was removed with three dH2O washes, and CV staining assessed via release of
biofilm-associated dye into 30 % glacial acetic acid. The OD at 600 nm of soluble CV was
recorded. Significance was determined by one-way ANOVA with a Tukey-Kramer
multiple comparisons post-test, with significance represented by P < 0.05.

Polystyrene adhesion screening
The adhesion assay used was modified from previously described PS binding
analyses for simultaneous screening of multiple clones. Colonies from transformation
plates were inoculated into 1 ml BHI containing the appropriate antibiotics and grown
overnight under 6 % O2, at 37 ºC. Cells were diluted 10-fold into pre-incubated BHI and
sub-cultured at 37 ºC for 3 additional h to achieve early stationary phase growth. Cells
were then diluted 50-fold into pre-incubated BM + Glu, and 200 µl transferred to the wells
of a 96-well microplate (Greiner) in duplicate. Plates were incubated for 4 h at 37 ºC to
permit adhesion of bacteria to the PS surface. Non-adherent cells were removed by
decanting and a single wash with dH2O. Adherent cells were stained with 25 µl of 1 % CV
for 15 min. Excess dye was removed by three washes with dH2O, and bound dye released
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by the addition of 30 % (v/v) glacial acetic acid. One-hundred and twenty-five µl of the
dye was transferred to a new 96-well Greiner plate, and the OD at 660 nm was recorded.

Production of CwFrac antisera
Mutanolysin digestion was used to extract cell wall-associated proteins of SK36 for
generation of antisera reactive to the cell surface peptidoglycan-linked proteins. The cell
wall fraction of SK36 was prepared from 400 ml of early stationary phase SK36. Cells
were harvested by centrifugation at 5k x g for 10 min at 4 ºC, and washed twice in 20 ml
TE + protease inhibitor cocktail (Pi) (Sigma) (1:100). Each pellet was vigorously
suspended in 2.4 ml protoplasting buffer (2 M Tris, 1 mM MgCl2, 0.44 M raffinose) (SEB)
+ Pi (1:100) using a vortex, and then inverted with 120 µl of mutanolysin (Sigma) (10,000
U ml-1). Tubes were incubated at 37 ºC for 30 min and then centrifuged at 5k x g for 20
min at 4 ºC. The supernatant containing mutanolysin released cell wall fragments was
collected. This protein fraction was twice dialyzed against 1 L PBS at 4 ºC in Snakeskin
tubing (22 mm x 35 ft, 7000 Mw) (Pierce). Protein concentration was then determined by
the BCA Protein Assay Kit (Pierce). The cell wall fraction (CwFrac) immunogen was then
sent to Covance for production of rabbit polyclonal antisera.

Whole cell ELISA
The procedure used for cell fixation was previously described (103, 189). S.
sanguinis strains grown overnight in BHI with selective antibiotics were sub-cultured for 3
h in BHI alone. Cells were harvested and adjusted to an optical density at 660 nm of ~0.9
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in TNMC (1 mM Tris-HCl [pH 8.0] containing 0.15 M NaCl, 1 mM MgCl2, and 1 mM
CaCl2) buffer. Fifty µl of the adjusted cells were transferred to the wells of a 96-well
4HBX Immunolon plate (Thermo electron); 1 mg ml-1 BSA (Pierce) was included in
several wells as a control for non-specific reactivity. Plates were centrifuged at 800 rpm,
for 5 min at 20 ºC. To fix the cells, 0.1 ml TNMC with 0.25 % glutaraldehyde was added
to each well, and the plates centrifuged at 800 rpm for 5 min, at 4 ºC. The plates were then
incubated at 20 ºC for 20 min. Excess liquid was aspirated from the wells and the cells
were then washed twice with 100 µl of blocking buffer (TBS containing 0.2 % Tween-20
and 2.5 % BSA), prior incubation with 100 µl blocking buffer overnight at 4 ºC.
Detection of SrpA: A SrpA mAb provided by Dr. Hui Wu (University of Alabama) was
used for detection of SrpA on the surface of whole cells. Following incubation in blocking
buffer overnight, 0.05 ml of 1:50 diluted α-SrpA mAb in a blocking buffer was added to
each well and plates were incubated at room temperature for 2.5 h. Unassociated mAb was
removed by three washes with 0.1 ml TBS-T. The secondary antibody, α-mouse IgG
conjugated to alkaline phosphatase (AP) (1:1,000 in blocking buffer) was added to the
wells in 0.05 ml volumes. Plates were incubated for 2.5 h, and unassociated secondary
antibody removed by three washes in 0.1 ml TBS-T. One-hundred µl of the alkaline
phosphatase substrate, p-NPP (KPL) was added to each well. The reaction proceeded for
three minutes before addition of 0.1 ml 5 % EDTA. Plates were read at 410 nm on a
FLUOStar plate reader. Significance was determined by a Kruskal-Wallis test
(nonparametric ANOVA), with P < 0.05 representing a significant difference.
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Detection of whole cells by CwFrac: Antisera prepared against the cell wall fraction of S.
sanguinis SK36 (referred to as CwFrac below) was used to demonstrate equal amounts of
whole cells following glutaraldehyde fixation. Following incubation with blocking buffer
overnight, 0.05 ml of diluted CwFrac in blocking buffer was added to each well. Plates
were incubated at room temperature for 2.5 h, and unassociated antibody removed by three
washes with 0.1 ml TBS-T. The α-Rabbit IgG AP conjugated secondary antibody, diluted
1:2,000 in blocking buffer was added to the wells in 0.05 ml volumes, and plates were
incubated at room temperature for 2.5 h. Following three washes with TBS-T, CwFrac
association was detected by p-NPP, as described above.
Two separate protocols were used to demonstrate the specificity and sensitivity of
CwFrac for detection of SK36. To determine the antibody dilution permitting specific,
non-saturating reactivity with whole cells, serially diluted antisera (1:5,000, 1:10,000,
1:50,000, 1:100,000, and 1:200,000) was reacted against fixed whole cells of SK36 (as
well as other strains tested). The optimal dilution of 1:25,000 was then used to demonstrate
differential reactivity of the sera reflective of various amounts of cells present in the wells.
The optical density of each strain tested was adjusted to ~0.9 at 660 nm, as described
above. After adjustment, cells at this optical density were serially diluted across a 96-well
plate so that each serial dilution occurred in triplicate. The range of dilutions included
undiluted, 2-fold, 4-fold, 8-fold, 16-fold and 32-fold. BSA at 1 mg ml-1 served as a
negative control for nonspecific reactivity of the immune sera. An identical assay was used
with pre-immune sera collected from rabbits prior to challenge with CwFrac. Reactivity to
sera was determined in a chromophore assay, as described above.
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Fractionation of S. sanguinis
S. sanguinis strains cultured overnight in 20 ml BHI were centrifuged at 5k x g, for
10 min at 4 ºC. The cell pellet and supernatant were then treated to obtain a supernatant
protein fraction, cell wall-associated protein fraction, and a protoplast protein fraction.
To prepare the supernatant fraction, 18 ml of supernatant was collected following
centrifugation and then processed for precipitation of secreted proteins. Supernatants were
filtered across a 0.2 µm membrane, and 10 % (v/v) TCA was added. Tubes were mixed by
vortexing and incubated on ice for 1 h. The mixture was centrifuged at 9.5k x g for 15 min
at 4 ºC for extraction of TCA precipitated proteins. The resulting pellet was washed twice
in 1 ml -20 ºC acetone, and dried in an oven for 5 min to drive off residual acetone. The
pellet was resuspended in 0.2 ml PBS + Pi (10:1 (v/v)).
For preparation of the cell wall fraction the cell pellet was washed twice in 1 ml TE
Buffer + Pi (10:1 (v/v)) before suspension by vortexing in 0.24 ml SEB + Pi (10:1 (v/v)).
The cell suspension was then mixed with 12 µL mutanolysin (Sigma) by inversion and
incubated at 37 ºC for 1 h. The suspension was centrifuged at 5k x g for 15 min at 4 ºC for
collection of the supernatant containing proteins released by mutanolysin.
The remaining protoplast pellet was washed once in 0.5 ml SEB + Pi, and then
resuspended in 1 ml PBS + Pi. Protoplasts were lysed by sonication at 80 % for 10 min,
followed by bead beating in Lysing Matrix B tubes (BIO 101). Following centrifugation at
15k x g for 15 min at 4 ºC, the supernatant containing released proteins was collected to
represent the protoplast fraction.
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SrpA Immunoblot analysis
Bacterial cell fractions were subjected to SDS-PAGE in 5 % precast Tris-HCl gels
(Criterion, Bio-Rad). For immunoblot analysis, proteins were transferred from gels onto a
PVDF membrane (Bio-Rad) by electroblotting. Immunoblots were blocked for 1 h in a
blocking buffer (TBS containing 0.2 % Tween-20 and 1 % BSA). After blocking, the
immunoblot was incubated overnight at 4 ºC with 1:50 diluted α-SrpA primary antibody.
AP-conjugated α-mouse IgG (Pierce), diluted 1:7,500 served as the secondary antibody.
The immunoblot was incubated with the secondary antibody for 1 h at room temperature.
The immunoblot was washed with TBS-T after each incubation step for removal of
unbound antibody. Detection of bound AP antibody was by the Western-blue alkaline
phosphatase substrate (Pierce). General protein staining of duplicate Tris-HCl gels was
performed with SYPRO Ruby (Invitrogen), per the manufacturer’s instructions. Protein
bands were visualized by UV light in a Fluorchem Imager with Fluorchem software,
v.3.04A (Alpha Innotech Corporation).

Hexadecane phase partitioning
Stationary phase overnight cultures were diluted 10-fold into 12.6 ml pre-incubated
BHI and sub-cultured for 3 h art 37 ºC. Cells were harvested and washed in cold, sterile
150 mM NaCl once prior to suspension in 8 ml 150 mM NaCl. Cells were then evenly
divided between 4 snap-top conical tubes. Two tubes served as non-hexadecane controls.
The remaining tubes were supplemented with 333 µl of n-hexadecane, followed by
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immediate vortexing for 1 min. Afterward cells were incubated at room temperature,
undisturbed for 25 min. The optical density at 660 nm was recorded for the aqueous phase
of each strain. Duplicate reads in the presence and absence of hexadecane were averaged
and the percent affinity for hexadecane of each strain determined by the following
equation: % Affinity = 100 x [1- (A/A0)], where A = the absorbance of cells with nhexadecane, and A0 = the absorbance of cells without n-hexadecane.

Bioinformatics
Oligonucleotide primers used were designed using Oligo (Molecular Biology
Insights) and FastPCR (www.biocenter.helsinki.fi/bi/bare-1_html/fastpcr.htm) software.
DNA sequences were viewed and aligned using SeqMan II software (DNASTAR Inc).
Multiple sequence comparisons were made using ClustalW W (202). Transcriptional
terminators were predicted using the Genetics Computer Group program Terminator (29,
30). Plasmid maps were created using Gene Construction Kit® v3.0 (Textco BioSoftware).
Search algorithms for ORFs encoding putative Cwa proteins: Open reading frames
(ORFs) predicted by Glimmer (54) from the compiled and contiguous S. sanguinis SK36
genome sequence (GenBank accession number CP000387) were searched for proteins
containing the characteristic C-terminal LPXTG tripartite motif of Cwa proteins. This cell
wall sorting signal included an LPXTG sortase substrate pattern (in which X may be any
amino acid), followed by a hydrophobic domain, and at least one positively charged amino
acid within 8 residues of the C-terminus. The EMBOSS (http://www.emboss.org) program
fuzzpro uses predictive patterns to search protein sequences. The query pattern for
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identification of putative S. sanguinis Cwa proteins was modified from that published by
Janulczyk and Rasmussen: L-P-[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]- X(0,8)[VIFAGTSML](17)- [RK]-[RK](2), for prediction by fuzzpro of proteins containing the
motif terminating within 5 amino acids of the C-terminus (111). Two query patterns were
used:
(A): L-P-[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]-X(0,8)-[VIFAGTSML](17)-[RK][RK](2)-X(0,5)>
(B): L-P-[SKTAQEHLDN]-[TA]-[GN]-[EDASTV]-X(0,8)-[VIFAGTSML](16,20)-[RK][RK](2)-X(0,5)>
In these patterns mandatory residues are distinguished form alternative residues by the
bracketing of alternative residues. The gap designated by X (0,8) may be from 0 to 8 amino
acids. Parenthetical numbers indicate repetition of the preceding residue. The applied
patterns differ in the allowed number of hydrophobic residue repeats [VIFAGTSML]
following LPXTG. As more repeats are permitted with pattern (B), greater stringency
among hits was enforced by decreasing the number of permitted mismatches from 5 with
pattern (A), to 4 with pattern (B).
The SignalP 3.0 server was then used to scan fuzzpro positive ORFs for the
presence of a gram-positive signal sequence (15) within 70 amino acid residues of the Nterminus, with both the Neural networks (NN) (D-measure cutoff of 0.45) and Hidden
Markov Models (HMM) applied. Proteins positive for both an N-terminal signal peptide by
SignalP and a C-terminal tripartite motif were then scanned visually to confirm the
presence of an LPXTG pattern. Erroneous positive hits trended toward multiple-pass
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integral membrane proteins as suggested by transmembrane helices prediction performed
with the TMHMM 2.0 server (http://www.cbs.dtu.dk/services/TMHMM/). For comparison
identical searches with the described parameters were performed for ORFs predicted from
complete genome sequences of S. gordonii strain Challis substrain CH1 (GenBank
accession CP000725), S. mutans UA159 (GenBank accession AE014133), and the
incomplete genome of S. mitis NCTC 12261, v11.0 (http://www.tigr.org/).
Bioinformatics survey of predicted S. sanguinis Cwa proteins: Putative S. sanguinis Cwa
ORFs were annotated by a protein basic local alignment search tool (BLASTP) query of
the microbial genome database, with an expect-value (positive hits by chance) cutoff of
1.0. To elucidate similarities and differences between oral streptococcal Cwa proteins, the
predicted proteins of S. gordonii CH1, S. mitis NCTC 12261, and S. mutans UA159 were
used as queries to search for homologs in the S. sanguinis SK36 protein database
(http://www.sanguinis.mic.vcu.edu/blast.html).
Cwa proteins unique to S. sanguinis SK36 among related streptococcal species,
unrelated oral bacterial species, and additional agents of infective endocarditis were
identified using the Phylogenetic Profiler application of the Integrated Microbial Genomes
(IMG) resources offered by the DOE Joint Genome Institute (http://www.jgi.doe.gov/),
with an expect-value cutoff of 1e-10. Genomic information available through IMG for
organisms in (Table 2) was used for identification of unique ORFs of S. sanguinis SK36.
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Table 2. Subtractive comparison for identification of unique S. sanguinis ORFs
The phylogenetic profiler application of IMG, offered by DOE was used to eliminate
homologous genes shared by S. sanguinis and 54 streptococcal spp., gram-positive
pathogens, oral microflora, as well as causative agents of infective endocarditis. The evalue cut-off for extraction of proteins with homologs was 1e-10. Of the 2272 genes
predicted for S. sanguinis, 246 did not have significant homologs among genomes
compared. Eight Cwa protein genes were identified as being unique to S. sanguinis.
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Table 2.
Order Species for comparison
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32

S. sanguinis genes prior to comparison
Clostridium perfringens 13
Corynebacterium diphtheriae NCTC 13129
Corynebacterium efficiens YS-314
Corynebacterium jeikeium K411
Enterococcus faecalis V583
Fusobacterium nucleatum ssp. nucleatum ATCC 25586
Lactococcus lactis ssp. lactis Il1403
Porphyromonas gingivalis W83
Staphylococcus aureus RF122
Staphylococcus aureus ssp. aureus COL
Staphylococcus aureus ssp. aureus MRSA252
Staphylococcus aureus ssp. aureus MSSA476
Staphylococcus aureus ssp. aureus MW2
Staphylococcus aureus ssp. aureus Mu50
Staphylococcus aureus ssp. aureus N315
Staphylococcus aureus ssp. aureus NCTC 8325
Staphylococcus aureus ssp. aureus USA300
Staphylococcus epidermidis ATCC 12228
Staphylococcus epidermidis RP62A
Staphylococcus haemolyticus JCSC1435
Staphylococcus saprophyticus ssp. saprophyticus ATCC
15305
Streptococcus agalactiae NEM316
Streptococcus mutans UA159
Streptococcus pneumoniae R6
Streptococcus pneumoniae TIGR4
Streptococcus pyogenes M1 GAS
Streptococcus thermophilus CNRZ1066
Streptococcus thermophilus LMG 18311
Treponema denticola ATCC 35405
Treponema pallidum ssp. pallidum Nichols
Enterococcus faecium DO
Fusobacterium nucleatum ssp. vincentii ATCC 49256

Genes
remaining
2272
1399
1295
1258
1246
945
900
803
800
760
756
752
752
752
752
752
752
751
748
744
739
733
603
514
453
444
432
412
407
399
399
397
395
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Order
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54

Species for comparison
Streptococcus suis 89/1591
Corynebacterium glutamicum ATCC 13032 (Bielefeld)
Corynebacterium glutamicum ATCC 13032 (Kitasato)
Lactococcus lactis ssp. cremoris SK11
Streptococcus thermophilus LMD-9
Lactococcus lactis ssp. cremoris MG1363
Streptococcus pyogenes Manfredo
Corynebacterium glutamicum R
Staphylococcus aureus ssp. aureus JH9
Streptococcus suis 05ZYH33
Streptococcus suis 98HAH33
Campylobacter concisus 13826
Campylobacter curvus 525.92
Staphylococcus aureus ssp. aureus JH1
Staphylococcus aureus ssp. aureus Mu3
Staphylococcus aureus ssp. aureus Newman
Streptococcus gordonii Challis CH1
Eubacterium ventriosum ATCC 27560
Actinomyces odontolyticus ATCC 17982
Staphylococcus aureus ssp. aureus USA300_TCH1516
Peptostreptococcus micros ATCC 33270
Eubacterium dolichum DSM 3991

Putatively unique S. sanguinis SK36 Cwa proteins
SSA_1663
SSA_1632
SSA_1633
SSA_1634
SSA_0146
SSA_0167
SSA_0273
SSA_1023

Genes
remaining
384
382
382
382
379
378
378
378
378
376
376
374
373
373
373
373
249
247
246
246
246
246
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Identification of S. sanguinis SK36 sortase homologs: S. sanguinis SK36 sortase-like
ORFs with homology to published sortase sequences were found by BLASTP analysis of
predicted proteins of the v.15 contig of S. sanguinis SK36. The following forty-five
publicly available sortase sequences (www.ncbi.nlm.gov) were queried against predicted
ORFs of the nearly complete SK36 genome sequence: GI: 1169933 (Shewanella
oneidensis MR-1); GI: 3238307 (S. aureus ssp. aureus COL); GI: 2859503 (S. aureus ssp.
aureus MRSA252); GI: 936904 and GI: 939748 (Bacillus subtilis ssp. subtilis str. 168);
GI: 1201902 and GI: 1201386 (Enterococcus faecalis V58); GI: 1199996 (E. faecalis
V583); GI: 1028429 (S. mutans UA159); GI: 2650068, GI: 2650116; GI: 2650498, GI:
2650495, GI: 2650024, and GI: 2650023 (Corynebacterium diphtheriae NCTC 13129);
GI: 1088124 and GI: 1083901 (Bacillus anthracis str. Ames); GI: 2851511 (B. anthracis
str. Sterne); GI: 1116387 (Clostridium acetobutylicum ATCC 824); GI: 111657852, GI:
930404, GI: 930406, and GI: 930405 (S. pneumoniae TIGR4); GID: 4962816
(Streptococcus. pyogenes str. Manfredo); GI: 901269, GI: 900461, and GI: 900465 (S.
pyogenes M1 GAS); GI: 891152, GI: 890596, GI: 893453, GI: 893835, GI: 892492, and
GI: 892801 (Bacillus halodurans C-125); GI: 4916727 (Clostridium difficile 630); GI:
3036999 (Actinomyces naeslundii T14V); GI: 1099286, GI: 1099285, GI: 1099173, GI:
1102888, GI: 1097914, GI: 1098275, and GI: 1096358 (Streptomyces coelicolor A3(2));
GI: 1470914, GI: 1471438 (Methanothermobacter thermautotrophicus str. Delta H). S.
sanguinis SK36 ORFs homologous to query protein sequences were recorded, and identity
to one of three sortases classes (A, B, or C) was used for annotation of S. sanguinis
sortase-like proteins (59). Tmap (EMBOSS) analysis of S. sanguinis sortase-like proteins
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indicated hydrophobic transmembrane domains directing both extra-cytoplasmic export of
the precursor protein, and transmembrane topology of the mature protein
(http://www.emboss.org).
MudPIT detection of Cwa proteins: S. sanguinis cell wall-associated protein and
protoplast fractions were prepared as described above. The protein fractions were subjected
to LC/LC/MS–referred to below as MudPIT–with the assistance of Dr. Patricio Manque
(Virginia Commonwealth University). Protein samples were suspended in solubilization
buffer (7 M urea, 2 M thiourea, 1 % DTT, 2 % Triton X-100, with protease inhibitors; 100
μM PMSF, 100 μM TLCK, 1 μM pepstatin A, 100 μM leupeptine, 5mM EDTA, 50 μM
TPCK) and precipitated with a 2D clean-up kit (GE Healthcare). Samples were then
reduced by the addition of dithiothreitol, alkylated with iodoacetamide, and digested by
trypsin overnight. Resulting peptides were desalted using C8 cartridges (Michrom
BioResources) and then subjected to two-dimensional liquid chromatography-MS/MS
analyses with a Michrom BioResources Paradigm MS4 multidimensional separation
module, a Michrom NanoTrap platform, and an LCQ DecA XP Plus ion trap mass
spectrometer. The mass spectrometer was operated in the data dependent mode with the
four most abundant peptides selected and fragmented to create tandem mass spectra.
Resulting MS/MS spectra were recorded in the profile mode and proteins identified by
searching the MS/MS spectra against the S. sanguinis SK36 database using Bioworks v3.2.
The probability based scoring algorithm of Bioworks v3.2 was used for scoring of peptide
and protein hits. Cutoffs for protein identification included only peptides with fully tryptic
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termini and cross correlation scores exceeding 1.9 for singly charged peptides, 2.3 for
doubly charged peptides, and 3.75 for triply charged peptides.

CHARACTERIZATION OF S. SANGUINIS ANAEROBIC
GROWTH DEPENDENCY ON THE ANAEROBIC
RIBONUCLEOTIDE REDUCTASE
Introduction
Identification of NrdD
In a previously published screen for S. sanguinis endocarditis virulence
determinants by random STM an apparent avirulent mutant was identified in which the
open reading frame SSA_2230 was interrupted. A competitive index assay was also
used to establish a quantitative value for competitiveness of the mutant, 6-26 relative to
the parental strain, SK36 in the rabbit model of IE. The mean CI value derived for 6-26,
0.31, confirmed that insertion mutagenesis of SSA_2230 resulted in a significant
decrease in competitiveness in vivo (P < 0.05) (198). SSA_2230 shares 84 % amino
acid sequence similarity to the characterized anaerobic ribonucleotide triphosphate
reductase (ARNR), NrdD of Lactococcus lactis ssp. cremoris MG1363 (accession
number: Y_001031637) (260, 261). The sequence similarity between these two proteins
and with E. coli NrdD sequences resulted in annotation of SSA_2230 as NrdD.
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Prokaryotic ribonucleotide reductases
The ribonucleotide reductase (RNR) catalyzes the conversion of the four
ribonucleotides, 5’ -di (or tri)-phospho -adenosine, -cytidine, -guanosine, and -uridine,
to their respective 2’ deoxyribonucleotide (dNTP) species to provide substrates for
synthesis and repair of DNA. RNR maintenance of cellular deoxyribonucleotide pools
is regulated allosterically by both precursors and products of the reaction. Three classes
of RNRs have been identified among microorganisms: class I, class II and class III
(reviewed in 128). Class I RNRs are further separated into class Ia and class Ib based on
sequence differences, and dissimilar allosteric regulation (117). Many bacterial species
encode more than one RNR class to permit adaptation of the species to diverse
environments. Class I RNRs require oxygen for catalytic activity (203), class II RNRs
are active irrespective of the presence of O2, and the class III RNRs are inactivated in
the presence of O2 and therefore only catalyze the synthesis of dNTPs under
anaerobiosis (125).
The classes of RNRs are also distinguished by structural differences, allosteric
regulation mechanisms, and by cofactors required for deoxyribonucleotide synthesis;
however the general chemistry governing catalysis is conserved. RNRs act by radical
chemistry for reduction of the 2’ hydroxyl of ribose. For all RNR classes a one of two
conserved Cys in the active site of the enzyme is proposed to form a thiyl radical for
reaction initiation by substrate oxidation (68). The complete enzymatic turnover in
synthesis of dNTPs is reliant upon additional Cys residues, with the number of
conserved Cys residues differing between the classes. Class I and II enzymes both
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encode five essential Cys residues (128), whereas Class III enzymes encode only the
two conserved Cys at the active site (6). While all RNRs act through a free radical
mechanism, the generation of the free radical is distinct between the classes.
The class I enzymes, encoded by genes commonly annotated nrdAB (class Ia),
or nrdEF (class Ib) form a α2β2 structure, with the α protein (NrdA/NrdE) conferring
both catalytic and allosteric properties, and the β protein (NrdB/NrdF) providing the
mechanism for radical generation (116, 128). In the active form the β protein of both
class Ia and class Ib enzymes contains a stable tyrosyl radical in proximity to a diiron
oxygen cluster (142, 203). Through long-range transfer the tyrosyl radical is passed to
the conserved Cys of the active site to generate the requisite thiyl radical. The
requirement of oxygen for class I RNR function permits catalysis of dNTPs under both
aerobic and microaerophilic conditions, however the reductase is not active in strictly
anaerobic atmospheres.
Class II enzymes may consist of a monomeric polypeptide (as is the case in
Lactobacillus leichmannii; 235), but more commonly exist as homodimeric proteins.
Regardless of the protein structure all class II RNRs require adenosylcobalamin, a
cobalt containing derivative of vitamin B12 for development of the Cys radical in the
active site. The thiyl radical of the active site is proposed to be generated directly by the
cleavage of 5’ deoxyadenosylcobalamin bond to form cobalt and a deoxyadenosyl
radical, and therefore a second class I β-like protein is not required (149). This system is
independent of O2, and therefore catalytically active in both aerobic and anaerobic
environments.

88
Class III RNRs, the anaerobic RNRs (ARNR) are destabilized by O2 with
activity restricted to anaerobic conditions. Characterization of the L. lactis ssp.
cremoris, S. aureus, and E. coli ARNR was complicated by residual activity of class I
RNRs of these organisms in standard anaerobic laboratory growth conditions (77, 116,
162). To determine ARNR properties in organisms encoding both class I and III
enzymes, inhibition of the class I enzyme is often performed by growth of strains in the
presence of hydroxyurea. Class III ARNRs belong to the “Radical Sadenosylmethionine (SAM)” superfamily of proteins that share a common mechanism
of free radical generation by the cleavage of SAM (239). ARNRs consist of two
proteins, commonly annotated as NrdD and NrdG that form a α2β2 structure (118), with
the catalytic and allosteric sites on the nrdD encoded, α protein (193), and the smaller
nrdG encoded β protein conferring radical generation. In contrast to class I RNRs, in
which a tyrosyl radical is formed on the activase β protein and then transferred to the α
protein active site Cys residue, the free radical of ARNR is generated at a conserved
Gly of NrdD (the class III α protein) in a mechanism dependent on an iron-sulfur cluster
bound by NrdG. In this process the [4Fe-4S]2+ cluster is reduced to a [4Fe-4S]+ state by
reduced flavodoxin (21), which is generated in the bacterial cell by flavodoxin
reductase and NADPH. The reduced NrdG forms a tight complex with NrdD, and then
associates with SAM (Fig. 11). SAM bound by the reduced NrdG Fe-S is subsequently
reductively cleaved to form methionine and a 5’-deoxyadenosyl radical. The
deoxyadenosyl radical then transfers its spin to the conserved Gly of NrdD in a step
requiring the transfer of one proton and one electron (from Gly) to deoxyadenosyl,
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Figure 11. The proposed mechanism for ARNR radical generation
In the first step [1] of ARNR radical generation the [4Fe-4S]2+ cluster of NrdG is
reduced to a [4Fe-4S]+ state by reduced flavodoxin, which is generated in the bacterial
cell by flavodoxin reductase (FR) and NADPH. In the second step [2] NrdG in this state
forms a tight complex with NrdD, and then associates with S-adenosylmethionine (SAdoMet). S-AdoMet bound by the reduced NrdG Fe-S is subsequently reductively
cleaved to form methionine and a 5’-deoxyadenosyl radical. In the third step [3] the
deoxyadenosyl radical then transfers its spin to the conserved Gly of NrdD and is then
released as 5’deoxadenosine. The figure shown was adapted from (261).
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Figure 11.
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this is then released as 5’deoxadenosine. Formation of the glycyl radical of NrdD
primes the enzyme for ribonucleoside triphosphate reduction with formate acting as an
electron donor (reviewed in 128). The NrdD proteins of both L. lactis and E. coli harbor
the conserved Gly stable free radical at their C-termini. In L. lactis the sequence
adjacent to the conserved Gly is KRTCGYL (260). The O2 sensitivity of ARNRs is a
result of cleavage of NrdD at the Gly radical by O2 for inactivation of the ARNR (125).
Additional conserved features of NrdD include the two active site Cys (6) essential for
reduction of ribonucleotide substrates to deoxyribonucleotides, and a region sandwiched
between the NrdD homodimers that governs the binding of allosteric effectors for
regulation of protein activity (143).

Allosteric regulation of RNR activity
RNRs are allosterically regulated by dNTPs and ATP for synthesis of balanced
DNA precursor pools in the cell. These allosteric enzymes contain prototypical distinct
sites for substrate binding (the active/catalytic site), and association of the regulatory
effector. Binding of the effector subsequently causes conformational changes in the
enzyme that affect the substrate binding site and catalytic activity of the protein.
Regulation of ARNRs by this mechanism has been studied in E. coli, the Escherichia
bacteriophage T4, and L. lactis (5, 70, 260). The specificity of the four RNR substrates
is determined by binding of the allosteric effector to the specificity site (S-site), which
induces necessary structural changes for substrate binding. The effectors that associate
with the S-site in all RNR classes are deoxyribonucleoside 5’triphosphate products
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dATP (and in the case of T4 ARNR, ATP), dTTP and dGTP. The general scheme for
allosteric regulation, determined for the class Ia RNR for E. coli includes the following
progressive reduction of ribonucleoside 5’ diphosphate (NDP) precursors: binding of
dATP at the S-site promotes the binding and reduction of the pyrimidines CDP and
UDP; binding of dTTP at the S-site both inhibits the reduction of CDP and UDP and
initiates the reduction of GDP; and binding of dGTP inhibits the reduction of GDP and
promotes the reduction of ADP (reviewed in 128). In the case of Class I RNRs the
substrates reduced are NDPs, and products are deoxyribonucleoside 5’diphosphates
(dNDPs). For class II and III RNRs the substrates are 5’triphosphates (NTPs), for
production of dNTPs. Class Ia RNRs contain a general activity site (the A site) in
addition to the specificity site, which is competitively bound by ATP or dATP to turn
on or off the enzyme, respectively (Fig. 12). Two allosteric sites have been identified
for E. coli and L. lactis ARNRs; however only one site was found in the T4 ARNR (5).
In both E. coli and L. lactis experimental evidence indicates that two effector binding
sites are exclusively associated with ATP (and dATP); or dATP, dGTP and dTTP (Fig.
12). The site bound exclusively by the ATP effector is referred to as the pyrimidine site,
as the association with ATP results in reduction of UTP and CTP substrates. The other
effector binding site- bound by dGTP and dTTP is termed the purine site, in that ADP
and GDP substrates are reduced. Association with dATP at a threshold concentration at
either site results in enzymatic inactivation (70, 260). Through these regulatory
mechanisms a balanced supply of dNTPs is created for the replication of DNA.
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Figure 12. Effector binding for allosteric regulation of Class Ia and ClassIII RNRs
The schematic shown includes the proposed mechanisms for allosteric regulation of
class Ia and III RNRs. The association of effector molecules with specificity site of the
class Ia RNR and the pyrimidine and purine sites of the class III ARNR are indicated.
The enzymatic activity is induced by association of the class Ia active site with ATP,
whereas association with dATP turns the enzyme off. Regulation is different with the
class III ARNR, in that a single activity site does not exist. Instead pyrimidine and
purine sites have been identified. These are named to indicate the substrate resulting
from association with a specific allosteric effector. As for class Ia RNRs, binding of
dATP at a certain threshold concentration is thought to result in enzymatic inactivation.
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Figure 12.
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Transcriptional regulation of RNRs in E. coli
Expression analysis of regulation of E. coli RNRs indicates they are
differentially transcribed in response to O2 tension, and exposure to agents of oxidative
stress. E. coli encodes class Ia, class Ib and class III RNRs. Transcription of both
aerobic RNRs is induced under aerobic growth conditions; however the capacity for
aerobic growth is conferred for the most past by the class Ia RNR (115). In contrast,
under oxidative stress expression of the class Ib RNR is enhanced, and it has been
proposed that this RNR in E. coli responds to DNA damage resulting from oxidative
stress (174, 208).The expression of the ARNR operon in E. coli is upregulated under
anaerobic conditions by the major aerobic/anaerobic shift regulatory protein FNR. FNR
directly associates with FNR binding sites of the nrdDG promoter to activate
transcription of ARNR operon. Deletion of FNR resulted in increased anaerobic
expression of nrdA, thus indicating that under anaerobiosis FNR inhibits expression of
the class Ia RNR. The mechanism of FNR nrdAB regulation is thought to be indirect as
no putative FNR binding sites appear in the promoter region of the nrdAB operon (27).
Negative regulation of E. coli RNRs is through the NrdR regulatory protein that
associates directly with promoters for class Ia, Ib and III RNR genes via NrdR binding
sites (262). With E. coli as an example it is assumed that in all prokaryotes encoding for
RNRs expression is regulated at the level of transcription by both positive and negative
regulatory proteins.
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Rationale

NrdD is the essential α-component of the ARNR complex formed by the
association of an NrdD homodimer with the β-component, NrdG, therefore the
anticipated outcome of nrdD mutation is sensitivity to entirely reduced atmospheres
(125). It was hypothesized that 6-26 would grow only in aerobic atmospheres. Dr.
Sehmi Paik demonstrated in a time-course growth experiment that 6-26 grew
indistinguishably from SK36 under aerobic conditions (Fig. 13). When the same
experiment was conducted under supposed anaerobic conditions 6-26 exhibited a slower
growth rate than SK36, but did reach stationary phase within 8 h of subculture (Fig. 13)
(196). The observation that anaerobic growth was not entirely attenuated in 6-26 caused
Dr. Paik to speculate that 6-26 may have acquired an extragenic suppressor mutation
permitting anaerobic growth. Dr. Paik attempted to reconstruct the nrdD mutation by
PCR amplification of the nrdD::magellan2 region of 6-26 and cloning of the amplicon
in the suicide vector pVA2606, to create pJFP16. SK36 transformed with pJFP16
yielded three Cmr clones, JFP20, JFP21 and JFP22. These strains were compared to
SK36 and 6-26 by surface plating on TSA with or without Cm, and growth under
reduced oxygen in the anaerobe jar or in the anaerobe chamber. Dr. Paik found that S.
sanguinis strains JFP20, JFP21, and JFP22 all exhibited similar growth to SK36 and 626 when incubated in the anaerobe jar and in the anaerobe chamber (Fig. 14).
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Figure 13. Growth study of SK36 and 6-26
Growth studies were performed for SK36 and the STM mutant, 6-26 in 200 μl volumes,
with the optical density at 450 nm recorded at ten minute intervals. In independent
experiments SK36 and 6-26 were cultured aerobically (filled symbols), or under an
ostensibly anaerobic (reduced oxygen) atmosphere (empty symbols) to compare the
growth trends of the two strains as a function of O2 availability (196).
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Figure 14. Growth of S. sanguinis ARNR mutants under different O2 tensions
The growth of S. sanguinis SK36 was compared with that of ARNR mutant strains on
agar plates. Cells were plated on either TSA plates or on TSA containing
chloramphenicol (‘+ Cm’), and grown under reduced O2 in an anaerobe jar or in an
anaerobe chamber for 2 days. SK36, the parental, WT strain; 6-26, the original STM
mutant; 1, JFP20; 2, JFP21; 3, JFP22; the JFP20, JFP21, and JFP22 strains were recreated ARNR transposon insertion mutants (196).
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One unexpected outcome of this experiment was that anaerobe chamber growth of 6-26,
JFP20, JFP21 and JFP22 was attenuated on TSA with Cm, suggesting that expression of
Cm acetyltransferase (CAT) in these strains had an additional negative effect on growth
(Fig. 14) (196). As these studies failed to demonstrate a growth defect on TSA under
our standard laboratory procedure for imposing anaerobiosis we sought to develop an
in-frame deletion of nrdD for further analysis of this locus. This strategy was intended
to test the possibility of an extragenic suppressor mutation in 6-26, as well as avoidance
of polar effects owing to transposon insertion, and to negate apparent growth
suppression owing to CAT expression.
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Results

Development of JFP27
The nrdD locus of S. sanguinis SK36 includes nrdD preceded upstream by a
putative membrane protein gene (SSA_2231), downstream by a hypothetical protein
gene (SSA_2229) overlapping with the 3’ end of nrdD, two acetyltransferase genes
(SSA_2228 and SSA_2227), and the ARNR β protein encoding gene nrdG (SSA_2226)
(Fig. 15). The strategy for mutagenesis of nrdD included deletion of conserved Cterminal residues (KRTCGYL) that encompass the site of glycyl radical formation, and
maintenance of the 3’ end of the gene to avoid mutagenesis of the downstream
hypothetical protein gene (SSA_2229). Gene SOEing was used to create an in-frame
deletion construct with removal of the central 705 aa of the 731 aa sequence, for fusion
of the first 12 codons with the last 14 codons of nrdD. The plasmid containing this
construct was used as transforming DNA with competent SK36 cells. As no selective
marker is conferred by the mutagenic construct, S. sanguinis colonies on TSA agar were
replica plated and grown under a reduced oxygen condition (anaerobe jar) or in an
anaerobe chamber for identification of clones incapable of anaerobic growth. All 100
clones screened grew under both conditions, and therefore this screening strategy was
unsuccessful. Twenty replica plated clones were selected, and cultured in BHI
overnight. A boiled cell preparation of each clone was PCR amplified for size
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Figure 15. The nrdD locus of S. sanguinis
The structure of the nrdD locus is indicated for the strains and plasmids listed on the
left. Potential terminators are indicated as a circle above a vertical line. The position and
orientation of the transposon in strain 6-26 are indicated by the flag. Gene designations
are as follows: Mem, putative membrane protein; nrdD, anaerobic ribonucleotide
reductase gene; hypo, a hypothetical protein gene; Ac1, putative acetyltransferase gene;
Ac2, second putative acetyltransferase gene; nrdG, anaerobic ribonucleotide reductase
small subunit gene; wzg, ortholog of putative transcriptional regulator wzg of S.
gordonii.
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determination by gel electrophoresis for differentiation between strains with an intact
vs. deleted nrdD. Three of the twenty clones screened exhibited a product size
indicating the mutation of nrdD (data not shown). The clone chosen for further
characterization, designated JFP27, exhibited normal growth on agar in anaerobe jars
under reduced O2. Therefore JFP27, 6-26 and SK36 were grown under the same
reduced O2 condition prior to analysis of anaerobic sensitivity.

Optimization of the soft-agar growth assay
The conundrum presented by persistent growth S. sanguinis nrdD mutants on
agar under assumed anaerobic conditions, meant that an alternative technique was
needed for characterization of these strains. In the soft-agar assay chosen, oxygenreactive dye indicators were mixed into the culture tube for estimation of oxygen
gradients in the agar. Preliminary soft-agar assays were conducted in snap-top 14-ml PS
round-bottom tubes with TSB-LMP agarose supplemented with resazurin, methylene
blue, or no dye indicator at all. Following anaerobe chamber pre-incubation of tubes for
48 h, stationary phase SK36 was added. Incubation at room temperature for 30 minutes
following inoculation with SK36 was sufficient for solidification of the agar. Tubes
were then removed from the anaerobe chamber; the tops loosened to establish an
oxygen gradient within the agar, and grown at 37 ºC for 24 hours. Visual inspection of
TSB-LMP agarose tubes containing dye indicated that Falcon tubes were not an ideal
choice for this assay, as pink (resazurin) or blue (methylene blue) color was observed
throughout the length of the tube (data not shown). The PS tubes used may have been
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porous to oxygen during aerobic incubation. In support of this, dissection of the agar
confirmed that dye reactivity was exclusively at the walls of the tube.
Glass Hungate tubes were then used for comparison of the oxygen dye
indicators, resazurin and methylene blue for soft-agar growth of SK36. As described
above, TSB-agarose was driven to anaerobiosis by pre-incubation in the anaerobe
chamber. Following inoculation of SK36, and agar solidification, the tubes were
incubated aerobically. An image taken 2 minutes after removal of tubes from the
anaerobe chamber demonstrates the initial reactivity to oxygen at the agar surface (Fig.
16). These tubes lacked any coloration when in the anaerobe chamber. The zones of
reactivity increased after aerobic incubation overnight; however they were restricted to
the very top of the tubes, suggesting that an anaerobic state was achieved at greater
agarose depths (Fig. 16). As shown in Figure 16, the depth of oxygen reactivity was
greater in the control tube without SK36, than in the presence of streptococci, thus
indicating consumption of oxygen for growth of this facultative anaerobe. In the studies
performed comparing resazurin and methylene blue it became apparent that methylene
blue was restrictive for SK36 growth under the conditions used. While growth of SK36
was observed in aerobic zones of TSB-LMP agar, no growth occurred in the region of
methylene blue reactivity (data not shown). This was not an issue when resazurin was
used as a dye indicator. This observation, in addition to the greater reduction potential
of resazurin made the magenta indicator a logical choice for further analysis of S.
sanguinis strains.
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Figure 16. Optimization of the soft-agar assay
Two different dye indicators were investigated for oxygen detection in the soft-agar
assay, resazurin (+R) and methylene blue (+M). The molten soft-agar was driven to
anaerobiosis in an anaerobe chamber. Stationary phase cells of S. sanguinis SK36 were
inoculated into half the soft-agar tubes (SK36) and images were taken of the tubes 2
minutes after removal from the anaerobe chamber (2 min.) for evidence of dye
reactivity. The tubes were then incubated aerobically at 37 ºC for 21 hours to permit
growth of SK36. Growth and oxygen densities were documented photographically.
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Comparison of S. sanguinis strains by the soft-agar growth assay
Growth comparisons of SK36, JFP27 and 6-26 were performed in glass Hungate
tubes in the presence or absence of resazurin, as described above. The parental strain
SK36 consistently grew throughout the tube, in aerobic (dye indicated) and anaerobic
zones (Fig. 17). In contrast the growth of JFP27 and 6-26 was restricted to oxidized
agar, indicated by the pink hue of the oxidized resazurin. This suggests that sensitivity
of 6-26 and JFP27 to anaerobic conditions is attributed to the loss of NrdD expression.
To confirm this, we attempted to complement NrdD strains with the nrdD gene
expressed from its native promoter. Sequence analysis predicted a possible terminator
149 bp upstream of nrdD (29, 30). The regions preceding nrdD from S. sanguinis, two
strains each of S. pyogenes and S. pneumoniae, S. mutans, and S. agalactiae were
compared for conservation of promoter elements among streptococci. With the
exception of SK36, all other species shared potential -35, -16, and -10 promoter
sequence elements (274) and other potential promoter elements in the 59 bp upstream of
nrdD (Fig. 18). As a homologous region was not identified for S. sanguinis SK36, it
appears that an evolutionarily divergent promoter may regulate the expression of nrdD
in S. sanguinis.
The plasmids pJFP29 and pJFP30 contain nrdD preceded by 337 or 36
nucleotides, respectively, cloned into the E. coli-Streptococcus shuttle vector pVA838.
Plasmid pJFP29 was designed to include the possible terminator and the postulated
subsequent native promoter of nrdD (Fig. 15).
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Figure 17. Soft-agar growth of S. sanguinis nrdD mutants
S. sanguinis strains SK36, 6-26, and JFP27 were compared by a reduced soft-agar
growth assay. Tryptic soy broth soft-agar with or without resazurin (TSA+R, or TSA,
respectively) was driven to anaerobiosis in an anaerobe chamber. Stationary phase cell
of SK36, 6-26 or JFP27 were then added to the soft-agar and the tubes incubated
aerobically to create an oxygen gradient within the soft-agar. The negative control
lacking streptococci is shown for indication of the gradient of oxygenated (pink) and
reduced (yellow) agar. S. sanguinis SK36 exhibited the wild-type phenotype of growth
in both oxygenated and reduced zones, whereas the nrdD mutants, 6-26 and JFP27
displayed growth restricted to agar containing oxygen.
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Figure 18. Identification of putative nrdD promoter elements
Regions upstream from the nrdD gene in the species indicated were aligned using the GCG program PILEUP, with default
parameters. Gray highlighting indicates conserved promoter elements. Potential transcriptional start sites are indicated by a
single underline. Start codons for nrdD and potential ribosome binding sites are indicated in bold. Sources and accession
numbers for the sequences are: Pn R6, S. pneumoniae R6 (AE008401); Pn TIGR4, S. pneumoniae TIGR4 (AE007335); Py, S.
pyogenes M1 (AE006630, AE006631); Py 8232, S. pyogenes MGAS8232 (AE010118); Sag, S. agalactiae 2603V/R
(AE014286); Sm UA159: S. mutans UA159 (AE015029, AE015030); Ss SK36: S. sanguinis SK36 (4806195).
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Figure 18.
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TGTATTTTTAAAATTTTAGATTTTTAACACAAGATATTGATTTTTCTTTTTAGAGTGGTATAATACTTTTTAGAAAGAACATTTTAGAAAAGAGCATG
TGTATTTTTAAAATTTTAGATTTTTAACACAAGATATTGATTTTTCTTTTTAGAGTGGTATAATACTTTTTAGAAAGAACATTTTAGAAAAGAGCATG
AATATATTGTTTCGAGCAAAAACTTGACACAATATATTGATTTTTTTAGTTGTCGTGATATAATAGTTCCGTAAGGAGATTTGATATG~~~~~~~~~~
AATATATTGTTTCGAGCAAAAACTTGACACAATATATTGATTTTTTTAGTTGTCGTGATATAATAGTTCCGTAAGGAGATTTGATATG~~~~~~~~~~
AATATATTGTTCTGAGCAAAAACTTGACACAATATATTGATTTTTTTTCTTTGCATGCTATAATTGTCACTGGAGGATATTTCACATG~~~~~~~~~~
AATATATTGTTCT.AAATTTTTTTTACCACAATATATTGATTTTTTTCTTTCTTGTGTTATAATAGCTTCTGTAAGGAGAAAGACGTATG~~~~~~~~
CTGTCGGAGATTCTTGGAATTTCTTAGCAAGCGATAGGTTTAAAGAGACTTGATTTGTCCTAAGGGCAGAGAAAAGGATGTGTTCGTGATG~~~~~~~
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To exclude the possibility of nrdD being expressed from a plasmid-borne
promoter, pJFP30 was created, in which the nrdD gene was preceded by 36 bp-enough
to contain a ribosome binding site but not a complete promoter (Fig. 15).
S. sanguinis SK36, 6-26 and JFP27 were each transformed with pVA838,
pJFP29, and pJFP30. Erythromycin-resistant transformants were screened for the nrdD
insert by PCR amplification of boiled cell preps of isolated clones with primers
pVA838-2939 and pVA838-5331 that flank the insertion site in pVA838. PCR products
analyzed by gel electrophoresis confirmed the presence of the plasmid-borne nrdD
insert in strains transformed with pJFP29 and pJFP30 (data not shown).
Complementation of the NrdD mutant phenotype in 6-26 and JFP27 was then evaluated
by soft-agar studies. For the control strain, SK36 growth was unaffected by
transformation with pVA838, pJFP29 or pJFP30, as all strains grew throughout the tube
(typically 7.0 cm in depth) (Fig. 19A and 19B). The nrdD mutant strain JFP27
containing pJFP29 exhibited growth that was indistinguishable from that of parent
strain, SK36. In contrast pJFP30 failed to complement the growth of JFP27, suggesting
that complementation of JFP27 by pJFP29 was due to expression of nrdD from its
native promoter (Fig. 19A and19B). The complementation observed for JFP27 (pJFP29)
additionally confirms that NrdD is essential for growth in an entirely reduced, anaerobic
condition.
With STM mutant 6-26, typical dense growth in the reduced agar was not
restored by either pJFP29 or pJFP30. The soft-agar growth of 6-26 (pJFP29) and 6-26
(pJFP30) was distinctive, however, in that isolated colonies were observed growing in
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Figure 19. Soft-agar comparison of S. sanguinis plasmid transformants
A) S. sanguinis strains were inoculated into anaerobic soft-agar tubes and then
incubated overnight with exposure to ambient air to create an oxygen gradient.
Photographs were taken of the tubes after overnight growth. The strains indicated on the
left, containing vector alone (pVA838) or vector plus nrdD constructs (pJFP29 and
pJFP30) were inoculated into tubes with or without the oxygen indicator dye resazurin
(right and left tubes in each pair, respectively).
B) Depth of growth in tubes without resazurin was measured in cm with a standard ruler
and the percent growth determined by dividing the zone of growth by total agar depth
and multiplying by 100. Values are averages ± standard deviations for three samples
obtained on at least two separate occasions. Asterisks indicate results significantly
different from those for SK36 (P < 0.001).
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the reduced agar (Fig. 19A). (Smaller spots apparent in some of the other tubes are
bubbles in the agar rather than colonies. These were easily distinguished by the
lenticular disk morphology of the colonies.) This phenotype was not observed for 6-26
(pVA838), suggesting that plasmid-borne nrdD caused this aberrant growth. As wildtype turbid growth was not restored in 6-26 containing pJFP29 or pJFP30 we speculated
that a specific event occurring in a sub-set of cells resulted in the formation of
individual colonies. A plausible explanation of this observation is low-frequency
recombination between nrdD of pJFP29 or pJFP30 and the corresponding sequence of
nrdD flanking the transposon at the chromosomal locus of this gene. To further
investigate this possibility colonies of 6-26 (pJFP29) and 6-26 (pJFP30) were isolated
from the reduced agar by removal of turbid agar at the top of the tube and extraction of
colonies from deep in the reduced agar with a sterile pipette tip. The collected colony
was cultured in liquid broth overnight, and cells prepared for amplification with
chromosome specific primers flanking nrdD (ARTR-SalI-22495-F and ARTR-SalI20031-R) for assessment of the genomic nrdD region. Analysis of the PCR products by
gel electrophoresis indicated that the transposon had been lost from the genomic nrdD
in the 6-26 (pJFP30) cells, in that the same size amplicon was observed for SK36 cells
(Fig. 20A). In contrast, the size of the 6-26 (pJFP29) PCR product indicated that the
transposon was still present in the nrdD gene in these cells (Fig. 20A).
Overnight cultures of isolated 6-26 (pJFP29) and 6-26 (pJFP30) colonies were
also regrown in soft-agar. Dense growth was observed for both strain variants
throughout the tube, a phenotype similar to the wild-type (Fig. 20B). Agar with turbid
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growth was extracted from these tubes and grown in liquid culture overnight for
preparation of cells for amplification of genomic nrdD, as described above. The gel
electrophoresis pattern of these PCR products was similar to the isolated colonies in that
genomic nrdD appeared to be restored in 6-26 (pJFP30), whereas the transposon
interrupting nrdD was maintained in 6-26 (pJFP29) (Fig. 20A). Therefore the
mechanism accounting for restored growth in reduced agar was distinct between these
strain variants.

CAT expression does not affect growth in soft-agar
Dr. Sehmi Paik Lee observed that strains 6-26, JFP20, JFP21 and JFP22,
expressing CAT from the magellan2 mini-transposon were hyper-sensitive to growth in
an anaerobic atmosphere (196). To determine whether this CAT sensitive phenotype
persisted in the soft-agar assay, the growth of a hypervirulent STM mutant, 3-24 was
compared to SK36 by both surface plating in the presence and absence of
chloramphenicol, and soft-agar culturing in the presence and absence of
chloramphenicol. For surface plating the strains were grown in an anaerobe chamber 37
ºC incubator for two days. Soft-agar growth experiments were performed as described
above.
Reduced growth on plates containing chloramphenicol was observed for the
transposon insertion mutant, 3-24 when compared to lawn formation on plates without
the selective antibiotic (Fig. 21A). However, 3-24 exhibited soft-agar growth through
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Figure 20. PCR detection of transposon insertion in 6-26
A) Primers flanking nrdD at the genomic locus were used for PCR amplification of the
nrdD gene, with washed cell preparations as template. SK36 was used as a control for
reversion at the nrdD locus (lane 1), and compared to isolated 6-26 (pJFP30) (lane 2) or
6-26 (pJFP29) (lane 4) colonies. PCR amplification was also performed on washed 6-26
(pJFP30) (lane 3) or 6-26 (pJFP29) (lane 5) cells isolated from turbid agarose. The
expected amplicon for SK36 was 4.4 kb, whereas the presence of the transposon within
nrdD would result in a 5.8 kb product.
B) Isolated 6-26 (pJFP29) and 6-26 (pJFP30) colonies were regrown in reduced softagar (+). Control soft-agar tubes for each strain that lack cells, yet containing resazurin
are also shown (—).
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Figure 21. Soft-agar evaluation of 3-24
S. sanguinis 3-24 and SK36 were compared for growth on the surface of TSA plates
with (TSA+Cm) or without (TSA) chloramphenicol. Plates were incubated at 37 ºC in
an anaerobe chamber. 3-24 exhibited decreased growth on a plate containing
chloramphenicol, despite the cat gene expressed by this strain (A). SK36 grew well on
TSA, but did not grow in the presence of chloramphenicol, as anticipated (B). The
reduced soft-agar assay was then used for anaerobic culture of 3-24 and SK36 in the
presence (TSA+Cm) or absence (TSA) of chloramphenicol. The oxygen dye indicator,
resazurin was included in duplicate tubes for visualization of the oxygenated zone of
soft-agar (+R). 3-24 grew well in the presence and absence of chloramphenicol when
cultured in anaerobic soft-agar (C), with turbidity similar to wild-type SK36 in TSA
alone (D). Spots visible in soft-agar tubes are bubbles introduced during inversion to
mix cells with the media.
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the entire tube in the presence and absence of chloramphenicol, which was
indistinguishable from SK36 (Fig. 21C and 21D). These observations suggest that the
defect in growth on an agar surface imposed by chloramphenicol selection does not
occur when a strain is embedded in agar.
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Discussion

S. sanguinis, a facultative anaerobe, possess both class Ib and class III RNRs to
permit de novo deoxyribonucleotide synthesis in the diverse atmospheres encountered
by this organism. The extreme O2 sensitivity of class III RNRs mandates
deoxyribonucleotide synthesis by class Ib RNRs under growth atmospheres ranging
from aerobic to microaerophilic (125). Growth observed for S. sanguinis mutants 6-26,
JFP20, JFP21, JFP22 and JFP27 under our standard anaerobic conditions suggested that
under trace amounts of O2 the class Ib RNR remains catalytically active. Growth studies
of E. coli and S. aureus ARNR mutants provide additional evidence of residual activity
of class I RNRs at low levels of oxygen, with growth defects owing to nrdDG mutation
most apparent when mutants were cultured in the presence of hydroxyurea, an inhibitor
of class I RNRs (77, 162). A soft-agar assay previously used for evaluation of the P.
gingivalis oxidative stress response was employed for evaluation of anaerobic growth of
S. sanguinis mutants (246). The oxygen reactive dye resazurin was incorporated into
soft-agar to establish the extent of oxygen permeability in the growth medium. Turbid
growth of JFP27 and 6-26 was reproducibly restricted to oxygenated zones (as indicated
by resazurin), and therefore putatively reliant on the class Ib RNR for dNTP synthesis.
The restricted growth observed for 6-26 and JFP27 suggests that transposon insertion
mutagenesis or deletion of nrdD both result in anaerobic growth inhibition.
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Our efforts to complement the mutant phenotypes of these strains suggest a
model for the transcriptional organization of the nrdD locus in S. sanguinis. The
genomic locus of nrdD in S. sanguinis includes nrdD preceded upstream by a putative
membrane protein gene and downstream by a 3’ overlapping hypothetical protein gene,
two acetyltransferase genes and nrdG, which encodes the β-subunit of the ARNR
holoenzyme. Complementation of the in-frame nrdD deletion mutant JFP27 by pJFP29
but not pJFP30 suggests that the nrdD promoter is contained within the pJFP29
construct. Through nucleotide sequence comparison of the upstream, intergenic region
of S. sanguinis nrdD to other streptococci it was determined that putative promoter
elements conserved for other species do not occur in S. sanguinis. Therefore a unique,
unidentified promoter may regulate the expression of nrdD in S. sanguinis.
The failure of pJFP29 to complement the nrdD mutation in 6-26 suggests that
the transposon mutation was polar on the expression of downstream genes. In 6-26
(pJFP30) occasional recombination between the chromosomal and plasmid borne nrdD
gene resulted in restoration of the genomic nrdD gene and transcription of the
remainder of the operon, yielding colony formation in reduced soft-agar. This was
likely not observed for JFP27 bearing pJFP29 or pJFP30 because of the limited
sequence shared by the genomic and plasmid nrdD loci (72 and 260 bp at the 3’ and 5’
ends, respectively of genomic nrdD). Yet isolated colonies in reduced soft-agar were
also observed for 6-26 (pJFP29) despite the maintenance of the transposon insertion at
the genomic locus. Thus it appears that restoration of growth in 6-26 (pJFP29) results
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from an uncharacterized mutation restoring expression of chromosomal genes
downstream of nrdD.
Analysis of the reduced soft-agar growth of an unrelated STM mutant, 3-24
demonstrated that anaerobic growth sensitivities of STM mutants on chloramphenicol
plates are circumvented by this culturing strategy. A layer plating technique was used
for competitive index studies of STM mutants, with bacteria in soft-agar overlaid with
1.5 % agarose with antibiotic, which negated the problem of chloramphenicol selection
by surface plating (198). The apparent sensitivity of streptococci to chloramphenicol
selection under anaerobic conditions has not been previously described, and the
mechanism of this growth inhibition is unknown. The observation that S. sanguinis
selection in chloramphenicol under reduced O2 is possible when strains are embedded in
agar allows for reliable characterization of STM mutants.
The objective of the experiments described here was to characterize whether the
S. sanguinis nrdD gene was required for growth under anaerobiosis, as previously
demonstrated for other bacterial species. Anaerobic growth attenuation of JFP27 and 626 in reduced soft-agar indicated that nrdD expression was essential. Aside from
confirming this in vitro phenotype attributed to nrdD, isolation of 6-26 as an avirulent
strain by STM suggests that regions of the vegetation in IE are anaerobic. Analysis of
IE by STM potentially would identify different classes of virulence determinants in
strains associated with the vegetation depending on the vegetation microenvironment
encountered. At the surface of the vegetation bacteria must be able to colonize the
platelet-fibrin matrix and contend with host defenses at the blood interface. Within the
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vegetation bacteria potentially encounter reduced levels of nutrients and oxygen as a
result of bacterial accruing and progressive fibrin stratification (64). To our knowledge
oxygen levels within the vegetation have not been measured. A survey of S. aureus
STM strains in an endocarditis model identified 5 anaerobic mutants that were
attenuated in vivo (50). Theses studies indicate that the interior of the vegetation is low
in oxygen despite the circulating oxygenated blood at the surface of the vegetation, and
that expression of anaerobic specific genes (in the case of S. sanguinis, nrdD) is
required for persistence in vivo.

DEVELOPMENT OF GENETIC TOOLS FOR ANALYSIS
OF S. SANGUINIS
Rationale
Among the viridans group streptococci, Streptococcus sanguinis is the most
common streptococcal agent of IE (181). An in vivo screening for S. sanguinis SK36 IE
virulence determinants by random signature-tagged mutagenesis identified 5 avirulent
mutants with transposon insertions in ORFs encoding housekeeping genes or genes
necessary for survival under anaerobic conditions (198). The lack of identification of
classical virulence factors, e.g., those facilitating adhesion in colonization, was
surprising given the abundance of putative virulence factors predicted from the
complete SK36 genome sequence (285). Therefore a need exists for development of
genetic tools to facilitate further screening of streptococcal factors required for
development of disease.
To screen mutants for defects in the rabbit model of infective endocarditis it is
best to inoculate a test strain along with a virulent control strain. In this way factors
contributing to inter-rabbit variation including pre-infection vegetation size,
physiological differences and immune competency can be accounted for, as both strains
encounter the same conditions. The co-administration of strains in this experimental
design requires selective markers for distinguishing between strains recovered in a
128
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complex pool comprising both the experimental strain of unknown virulence, and the
control. It is commonplace to create marked genomic mutations using antibiotic
resistance cassettes; however a conundrum exists as to the best method for selection of a
control strain. Using a subtractive approach to estimate the recovery of an unmarked
control strain may be misleading due to the assumption that both strains have equal
plating efficiency. Therefore an attractive alternative would include exclusive selection
of the control strain from a multiple strain pool. A control strain with a selectable
marker would also be useful for evaluation of unmarked mutant strains, for example an
in-frame deletion mutant. This type of comparison is not feasible with SK36 as a
control. In addition, the development of a collection of selective marker constructs
would permit us to add a selectable marker to an in-frame deletion mutant, at the same
locus as the competitive control. This scenario would permit the detection of
phenotypes entirely determined by in-frame deletion of a gene of interest.
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Results

Identification of SSA_0169
The S. sanguinis SK36 genome is more compact than published genomes for
other streptococcal species, with an average intergenic region of 115 bp (vs. average
intergenic region lengths of 130 to 177 bp) (285). Given the proximity among predicted
ORFs we sought to identify an insertion site with minimal risk of affecting important
genes or operons. A 2.225 kb SK36 chromosomal region including a putative 644 bp
stretch of non-coding DNA (shown in brackets in Fig. 22) was cloned into the suicide
vector pVA2606 to create pJFP34. A unique NcoI site within the predicted non-coding
region of the insert was employed for cloning of pSerm, an erythromycin resistance
cassette that is expressed in E. coli and streptococci (47). The cassette used is optimal
for our strategy as expression of pSerm is not reliant on an external promoter. This
cassette was engineered by PCR to fuse the -35 region from the native ami operon S.
pneumoniae promoter, pA, proximal to the -10 region and 16 bp upstream of pAMβ1
encoded erm (47).
The resulting plasmid containing pSerm, pJFP36 was transformed into S.
sanguinis SK36 to generate JFP36. In the initial annotation of the SK36 genome
sequence, no open reading frame (ORF) was predicted for the 644 bp region between
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SSA_0168 (0168) and SSA_0170 (0170) (Fig. 22). However, after creation of strain
JFP36, a subsequent GLIMMER analysis predicted the SSA_0169 (0169) ORF. This
ORF encodes a 65 amino acid hypothetical protein that lacks homology to any proteins
of known function. The predicted ORF is 303 bp downstream from the 0168 gene, and
if co-transcribed, 0169 would be the last gene of the operon. The flanking open reading
frames, 1068 and 0170, are also hypothetical.

Transcriptional analysis of 0169
As 0169 was predicted to encode a small, non-conserved hypothetical protein
we wanted to determine whether expression of this ORF occurs. Quantitative (real-time)
reverse transcriptase PCR was used to determine whether 0169 transcript was detectible
during in vitro culture under various oxygen tensions, including aerobic culture, 6 % O2,
and anaerobic culture. We determined that transcription of 0169 is variable under the
conditions tested, with the least expression occurring under reduced oxygen or
anaerobic conditions that are typical in laboratory culture (Fig. 23). In contrast, ~80-fold
more 0169 transcript was detected in S. sanguinis SK36 cultured aerobically relative to
anaerobic and 6 % O2 conditions, indicating that expression of 0169 is enhanced during
aerobic growth.
An in vitro growth comparison of S. sanguinis SK36 and JFP36 was then
performed to determine whether interruption of 0169 by pSerm affected growth under
aerobic conditions. As shown in Figure 24, JFP36 and SK36 grew similarly, suggesting
that mutation of 0169 did not influence growth of JFP36.

132

Figure 22. The 0169 locus of S. sanguinis SK36
The 0169 locus is shown. The 0169 gene putatively encodes a 65 aa protein. This ORF
was mutated for development of S. sanguinis SK36 derivatives selectable by antibiotic
resistance determinants. In the initial annotation of the S. sanguinis SK36 genome
sequence 0169 was not identified, and this cloning region was selected based on an
apparent 644 bp non-coding region. However, a subsequent GLIMMER analysis did
identify the ORF 0169, which is flanked on by two hypothetical ORFs, 0168 (upstream)
and 1070 (downstream). The region shown in brackets (2.225 kb) was cloned into the E.
coli vector pVA2606 for creation of pJFP34.
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Figure 23. qRT-PCR detection of an 0169 transcript
S. sanguinis SK36 was cultured aerobically (O2+), in an anaerobic atmosphere (O2-), or
in 6 % O2 for five hours. The amount of RNA transcript of 0169 and 16S rRNA was
then determined from RNA extracted from cells grown under the different O2 tensions.
The fold change in transcript abundance relative to the 6 % O2 condition is shown.
RiboGreen fluorescence of nucleic acid was used to normalize samples for differences
in the efficiency of reverse transcription. Values depicted represent the mean and SEM
16S rRNA and 0169 transcript levels from three independent samples.

135

Figure 23.

Fold change
relative to 6% O2

200

100

0
+
O2

,1

6S

+
O2

,0

169

- , 16
O2

S

- , 01
O2

69

Oxygen tension, detector

136

Figure 24. Aerobic growth comparison of JFP36 and SK36
S. sanguinis SK36 and JFP36 stationary phase cells were diluted 200 fold in BHI, and
the growth of the subcultured cells monitored over a 20 hour period by recording the
optical density at 450 nm every 10 minutes. The growth study was performed in a PS
96-well plate, with cells incubated aerobically at 37 ºC. Growth to 13 hours is shown to
emphasize the similarity between SK36 and JFP36 in the log growth phase.
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Figure 24. Aerobic growth comparison of JFP36 and SK36
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Characterization of JFP36 biofilm formation
To investigate the impact of pSerm insertion in JFP36 on biofilm development, a
previously described semi-quantitative assay was used (76). S. sanguinis SK36 served
as a positive control in this assay, and its isogenic mutant, VT1614, served as a negative
control. In VT1614, srpA is interrupted by the kanamycin resistance gene, aphA-3
(204). The S. parasanguinis SrpA homolog, Fap1 was required for wild-type biofilm
formation in the presence of 1 % glucose (76). JFP36 biofilm formation was
indistinguishable from SK36 (Fig. 25) in the presence of glucose (P= 0.25) and sucrose
(P= 0.11), and for both JFP36 and SK36, biofilm formation in 1 % glucose was
significantly greater than that of VT1614 (P < 0.001). Therefore, mutation of 0169 did
not alter biofilm development under the conditions tested.

Genetic Competence of JFP36
The capacity for genetic manipulation is invaluable for studying microbial
pathogenesis. S. sanguinis is naturally competent and readily transformable when
provided extracellular DNA in the presence of CSP and animal serum. One potential
future use of JFP36 is the employment of this strain as a genetic background for inframe deletions in genes of interest. Therefore we sought to compare transformation
frequency and efficiency between SK36 and JFP36, to determine whether this
application of JFP36 is feasible. The plasmid used as transforming DNA, pJFP16 gives
reproducibly high transformation frequencies and efficiencies, and integrates the cat
gene into the chromosome in single copy. As shown in Table 3, JFP36 was competent
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Figure 25. Biofilm comparison of S. sanguinis SK36 and JFP36
S. sanguinis SK36, JFP36 (Δ0169), and VT1614 (ΔsrpA) were grown to early stationary
phase in BHI, and then subcultured (1:100) in biofilm medium with 1 % glucose
(BM+Glu), or 1 % sucrose (BM+Suc). Strains were grown under static conditions in PS
microplates at 37 ºC, 6 % O2 for 20 hours. Biofilm formation as determined by CV
staining was quantified at 600 nm. Assays were performed in triplicate, in three
independent experiments, means and SD are shown. ***= P < 0.0001
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Table 3. Genetic competence comparison of SK36 and JFP36
S. sanguinis strain
SK36
JFP36

Transformation frequency‡
27.38 %
27.13 %

Transformation efficiency¥
8.6 x 107 CFU µg-1 DNA
8.25 x 107 CFU µg-1 DNA

r

‡: The ratio of transformants (Cm conferred by homologous recombination of the

pJFP16 encoded nrdD::cat) to total colony forming units
r
¥: The number of transformants (Cm ) per µg of pJFP16 transforming DNA
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for uptake and recombination of pJFP16 transforming DNA with transformation
frequencies and efficiencies similar to wild-type.

Analysis of JFP36 competitiveness in vivo.
S. sanguinis JFP36 was then tested for competitiveness in the rabbit model of IE
by a competitive index (CI) assay. In this experiment early stationary phase SK36 and
JFP36 were co-inoculated into four catheterized rabbits and infection monitored 20
hours post-inoculation. The CI (competitiveness value of JFP36) value was determined
by dividing the ratio of JFP36 to SK36 recovered from the rabbit by the ratio of JFP36
to SK36 in the inoculum. A mean CI value of 1.22 (range 0.4 to 1.7) was obtained from
the four rabbits. Because a CI value of 1 indicates equal competitiveness between the
two strains, this CI value confirms that competitiveness of JFP36 is not significantly
different from SK36 (P= 0.52). Therefore JFP36 would serve as a valid control strain in
future in vivo competitive index assays, and would permit direct discrimination between
wild-type and one or more mutant strains on plates containing different antibiotics.

Development of JFP56 and JFP76
Maintenance of competitiveness in JFP36 confirms that manipulation of 0169 is
not detrimental in vivo. We chose to develop additional novel S. sanguinis strains with
different antibiotic resistance markers at the 0169 locus to increase the applicability of
this tool. In the design of a spectinomycin resistant derivative of SK36, the aad9
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resistance cassette from pR412 (161) was cloned into a linker central to the 0169
segment of pJFP46 for creation of pJFP56.
Expression of the plasmid pR412 encoded aad9 is controlled by a strong,
synthetic promoter which includes the 5’ region of the native ami operon pneumococcal
promoter, pA fused to the 3’ region of the aad9 promoter to permit optimal expression
of spectinomycin resistance in S. pneumoniae (56) (similar to the promoter of pSerm,
described above). The pJFP56 insert maintained the synthetic aad9 promoter adjacent
the aad9 gene. S. sanguinis SK36 was subsequently transformed with pJFP56 for
identification of the spectinomycin resistant strain, JFP56. Expression of aad9 at the
0169 locus of S. sanguinis was evidenced by successful selection of the JFP56 strain.
A tetracycline resistant S. sanguinis strain was also developed by cloning of the
tetM gene from pJM133 (88) into the linker transecting 0169 in pJFP46 for creation of
pJFP76. The class M tetracycline resistance determinant, tetM originates from the
Tn916 composite conjugative transposon of E. faecalis (231). In pJM133 tetM
transcription was controlled by a native aad9 promoter of the E. faecalis plasmid,
pD255, aad9 resistance determinant (205). The promoter controlling expression of tetM
is constitutively expressed in both E. coli and streptococci and therefore ideal for our
purposes in this study. S. sanguinis SK36 was transformed with the tetM containing
plasmid, pJFP76, for isolation of the tetracycline resistant strain JFP76. DNA
sequencing of tetM in the 0169 locus of JFP76 indicated that the actual cassette used
shared greater identity with tetM of the S. pneumoniae Tn1545 determinant (GI:48189)
than the tetM gene of Tn916. The mosaic nature of tetM alleles has been previously
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investigated by sequence alignment for identification of sequence polymorphisms. It is
of interest that allelic variation observed in nature was attributed to differing
homologous recombination between two distinct tetM alleles of Tn916 S. aureus and
Tn1545 of S. pneumoniae. The evolution of mosaic tetM alleles would have been
facilitated by the conveyance of these determinants on mobile conjugative transposon
elements (192).

Analysis of JFP56 and JFP76 competitiveness in vivo and in vitro
An in vitro growth study of JFP36, JFP56 and JFP76 was conducted for
verification that growth of these strains was similar under our typical laboratory culture
conditions. The growth study results shown in Figure 26 confirmed that insertion of
different resistance determinants in 0169 had no effect on the growth phenotype of
these strains, in that all strains exhibited identical growth patterns in the period studied.
Competitiveness of JFP56 and JFP76 was determined by comparison to the
competitive erythromycin resistant strain, JFP36 by the competitive index assay. In past
CI analyses our lab has directly compared two strains in vivo by co-inoculation into a
previously catheterized rabbit (198). In this study we chose to co-inoculate the three
strains with different selective makers, JFP36, JFP56 and JFP76 for a direct comparison
of strains encountering shared selective pressures in vivo. For this purpose the three
strains were adjusted to an equal optical density corresponding to ~ 5 x 107 to 1 x 108
CFUs for co-administration intravenously. The inoculum received by the rabbits was
determined to be 6.11 x 108 CFUs, with JFP36, JFP56 or JFP76 accounting for 16.9 %,
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75.3 % or 7.9 % of the inoculum, respectively. Bacteria were recovered from aorticvalve associated vegetations 20 hours later and plated on TSA containing the
appropriate antibiotic for selection of the erythromycin, spectinomycin, or tetracycline
resistant strain. The CI values were then determined for JFP56 or JFP76 relative to the
control, JFP36 by dividing the ratio of the unknown (JFP56 or JFP76) to JFP36
recovered from the rabbit, by the unknown to JFP36 ratio in the inoculum. The mean CI
values determined for JFP56 and JFP76 are depicted and described in Figure 27. JFP76
was determined to be equally competitive to JFP36 with a mean CI value of 0.83 (P=
0.2735), which suggests that JFP76 is also applicable as a competitive control for future
studies. The mean CI value for JFP56 of 0.38, suggested that competitiveness of JFP56
was significantly reduced as a result of aad9 expression at the 0169 locus (P= 0.0470).
However, the percentage of JFP56 in the inoculum was much higher than expected and
thus indicated that an error in plating may have occurred.
We chose to repeat the direct CI comparison of JFP56 and JFP36 by intravenous
co-inoculation of the two strains into catheterized rabbits. In this experiment the rabbits
received a total inoculum of 1.28 x 109 CFUs of which 52.3 % was JFP56, and 47.7 %
JFP36. The competitiveness of JFP56 was determined by recovery of bacteria
associated with aortic valve vegetations at 20 hours post-administration of strains, as
described above. The mean CI value for JFP56 relative to JFP36, 0.96, indicated that
JFP56 was as competitive as the wild-type strain (P= 0.6932) (Fig. 27).
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Figure 26. In vitro growth comparison of JFP36, JFP56 and JFP76
Early-stationary phase cultured cells of S. sanguinis JFP36, JFP56 and JFP76 were
adjusted to an equal optical density at 660 nm, and then subcultured (1:100) in BHI for
an overnight growth assay. The growth study was performed in a 96-well PS plate, at 37
ºC, with the optical density at 450 nm recorded every 10 minutes. Growth to 12 hours is
shown to emphasize the similarity between the log growth curves of JFP36, JFP56 and
JFP76.
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Figure 27. CI comparison of JFP56 and JFP76 to JFP36
S. sanguinis strains expressing different resistance determinants at the 0169 locus were
compared for competitiveness in the rabbit model of IE to determine whether the strains
could serve as virulent controls in future experiments. In two separate experiments
JFP56, JFP76 and JFP36 were compared by co-inoculation of the three strains (Ф), or
co-inoculation of JFP56 and JFP36 only (ζ) into previously catheterized rabbits. Rabbits
were sacrificed 20 hours later for recovery of bacterial strains by plating on selective
antibiotics. The CI value for the two strains of unknown competitiveness, JFP56 and
JFP76 was determined by comparison to the control competitive strain, JFP36 for each
rabbit. In the graphical representation the dotted line at 1 indicates the value for equal
competitiveness. Each symbol represents a CI value from one rabbit, and the bar
indicates the mean CI value. In the triple strain comparison JFP56 was significantly less
competitive than JFP36 (*= P < 0.05), whereas JFP76 was equally competitive to
JFP36. Reevaluation of JFP56 resulted in a CI value indicative of equal
competitiveness. The actual mean CI and range of value observed for each strain are
shown in the table.
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Figure 27.
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The evenly divided inoculum ratio in the JFP56 and JFP36 CI experiment
provided these strains an equal opportunity for colonization and growth, and would
therefore result in a more reliable CI score. Even combining the CI values from the two
experiments evaluating JFP56 does not result in a mean CI value (0.6) significantly
different from an equal competitiveness value of 1 (P= 0.0810).
From these experiments we concluded that competitiveness of JFP56 and JFP76
in vivo was unaffected by the resistance determinant used, and these strains, in addition
to JFP36 could act as controls for screening and identification of mutants attenuated in
the rabbit model of IE.
In a final set of experiments an in vitro competitiveness assay was used to
compare the growth of JFP56 or JFP76 to JFP36 during co-culture. This type of
experiment indicates whether in vivo findings may be construed by phenotypes
unrelated to in vivo conditions, instead owing to effects of co-culturing of strains or
general differences in the growth rates of strains. For this experiment strains were
adjusted to an equal optical density and then co-cultured in vitro for the typical infection
duration (~20 hours). The in vitro CI value was derived by comparing CFUs of strains
following co-culture, to CFUs before co-culture (“the inoculum”); with a CI value of 1
suggesting strains grow equally well during co-culture in vitro. The mean in vitro CI
value for JFP56 or JFP76 relative to JFP36 was determined by two independent
experiments performed in triplicate. The CI values obtained for JFP56 and JFP76, 1.31
and 1.51, respectively suggest that co-culturing of these strains with JFP36 in vitro
results in growth significantly greater than JFP36 (P= 0.0086, P= 0.0005, for JFP56,
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and JFP76). The observed in vitro phenotype was attributed to a greater number of
JFP56 or JFP76 CFUs recovered following co-culture, as the ratio of JFP56 or JFP76 to
JFP36 in the inoculum was similar to that observed during in vivo analysis. The shared
core genome of these strains suggests that difference in growth in vitro, as determined
by CFU formation is an artifact of the selective marker used. The similar in vivo CI
values for JFP36, JFP56 and JFP76 (discussed above) indicate that additional selective
pressures encountered in vivo result in comparable growth of these strains in the animal
model for a recovery to inoculum ratio closer to 1.
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Discussion

We intended to develop a system for integration of selective markers into the
chromosome of S. sanguinis SK36, while maintaining WT phenotypes of this species. A
scan for non-coding sections of the S. sanguinis genome sequence prompted the use of a
predicted intergenic region separating two opposing, hypothetical ORFs, 0168 and
0170. Following the development and preliminary characterization of JFP36 an ORF
was identified for this intergenic region, 0169, that was inactivated by insertion of the
erythromycin resistance gene. The 0169 ORF putatively encodes a 65 amino acid
protein with no homology to previously characterized proteins. In addition, the 0169
locus is non-conserved among closely related streptococcal species (Integrated
microbial genomes resource (http://img.jgi.doe.gov/cgi-bin/pub/main.cgi)). Despite the
novelty of this ORF, and indications that 0169 was a pseudogene, a 0169 transcript was
detectible by qRT-PCR. The transcriptional analysis of 0169 confirmed expression of
the ORF was greatly increased during aerobic culture, which is an atypical condition for
typical laboratory growth of S. sanguinis. The unintended manipulation of 0169 did not
have any consequence on relevant in vitro phenotypes of S. sanguinis, including
doubling time during in vitro growth, biofilm formation, and competence for DNA
transformation. Most important for the objective of this work, JFP36 was equally
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competitive to SK36 in vivo, and therefore appropriate for use in future competitive
index assays.
The proven maintenance of virulence in JFP36 resulted in the development of
two additional derivatives of SK36 with unique resistance markers, JFP56 and JFP76.
Competitive index comparisons of JFP56 and JFP76 in the rabbit model of IE
confirmed both exhibited the virulent phenotype. The in vitro growth comparison of
JFP36, JFP56 and JFP76 suggested that doubling times of these strains were similar.
Contrary to our expectation in vitro co-culture of JFP36, JFP56 and JFP76 resulted in
different recovery ratios of the three strains, with growth of JFP36 apparently attenuated
during co-culture. This phenomenon is most likely caused by the antibiotic determinant
gene, as this is the only substantial difference between the strains. However, the effect
is independent of selective expression of the resistance marker since no selective
antibiotics were present in the liquid growth medium at the time of co-culture. One
possible explanation is that expression of the resistance determinant may affect cell
viability at greater cell densities indicative of stationary growth phase cells. In the
infective vegetation streptococci may reach a cell density of 108 to 1010 within 20 hours,
which is similar to the streptococcal density per ml following overnight culture.
However, selective pressures encountered in vivo may result in slower growth rates than
in vitro, so that cells spend less time at stationary phase prior to plating for enumeration
of surviving streptococci. If viability for a strain is decreased in stationary phase, then
less of that strain would be recovered by plating. Unfortunately the distinguishing host
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pressures that might influence growth of these strains can not be replicated in the
laboratory.
The genomic tools developed in this chapter will enhance the screening and
identification of novel determinants for IE. Since it is often desirable to insert antibiotic
resistance markers and other exogenous genes into the chromosome, potential future
applications include exploitation of the 0169 chromosomal site for ectopic expression of
native genes to allow for complementation of mutations elsewhere in the genome.

A COMPREHENSIVE ANALYSIS OF S. SANGUINIS CELL
WALL-ASSOCIATED PROTEINS IN EARLY IE
Introduction
Cwa proteins as mediators of pathogenesis
The Cwa protein class of surface exposed proteins was first identified by
detection of a common C-terminal LPXTG (aa abbreviations are described in Appendix
C) sorting motif among 6 cloned gram-positive surface proteins (72). The prevalence of
this protein class in gram-positive species is evidenced by the identification of proteins
containing this motif in nearly all published genome sequences (25, 49). Cwa proteins
are considered particularly important in pathogenesis as many have been grouped as
MSCRAMMs mediating adhesion to adhesive matrix molecules of host tissue and host
cells. Previously described streptococcal MSCRAMM adhesins include the S. pyogenes
M family proteins Emm, Mrp and Enn (reviewed by 185), and viridans streptococcal
antigen I/II, and Csh homologs (152, 169). Enzymatic functions have also been ascribed
to multiple streptococcal Cwa proteins. Streptococcus pyogenes C5a peptidase and the
S. pneumoniae neuraminidase modulate host immune components and sialylated
proteins, respectively to putatively enhance pathogenesis (191, 279). Cwa proteins of S.
mutans, β-d-fructosidase and dextranase are considered important for nutrient storage
and acquisition (24, 48).
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Cell surface localization of Cwa proteins
Cwa proteins are typified by two signal sequences that direct, first the
extracytoplasmic export of the precursor protein, and second the covalent linkage of the
protein to the cell wall. Extracytoplasmic trafficking and export of the precursor Cwa
protein is specified by a gram-positive type I N-terminal signal (leader) peptide
sequence. The leader peptide includes an N-terminal region with positively charged
amino acids, followed by a central hydrophobic region, and then a C-terminal region
containing hydrophilic residues (reviewed in 266). The presence of the leader peptide
drives Sec-dependent secretion of the precursor protein through a translocase channel.
The mediators of Sec secretion have been determined for E. coli, and partly
characterized in B. subtilis. S. sanguinis homologs to proteins described below are
indicated parenthetically.
In the putative system for translocation in Bacillus subtilis, based on E. coli,
export is considered co-translational. This mode of transport in E. coli initiates with the
signal recognition particle (SRP: Ffh (SSA_1167) + 4.5S RNA) binding to the leader
peptide of the nascent polypeptide as it emerges from the ribosome. Binding of SRP to
the polypeptide arrests protein translation until association with FtsY (SSA_1557), and
subsequent targeting of the complex to the Sec translocase at the cytoplasmic
membrane. Following association with the translocase, translation resumes as the
protein is transported across the membrane through a SecYEG heterotrimer (SSA_0127,
SSA_2208, and SSA_1604 respectively) translocase channel. The SecA ATPase
(SSA_0543) associates with the channel to couple the energy from ATP binding and
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hydrolysis to the stepwise translocation of the Cwa protein precursor (reviewed in 288).
In E. coli, SecD and SecF are large integral membrane proteins that form a
heterotrimeric complex with YajC and associate loosely SecYEG in a supramolecular
translocase complex (62). In B. subtilis, SecD and SecF are fused into a single
membrane protein that potentially contributes to the efficiency of protein secretion (26).
As described for S. mutans, S. sanguinis SK36 lacks a SecDF homolog, yet does encode
a YajC-like protein (SSA_1792) (91).
As the precursor protein emerges from the translocase, the type I leader peptide
is recognized and cleaved by a membrane spanning type I signal peptidase (SSA_0351,
SSA_0849). The mature N-terminus of the Cwa protein is then exposed, and the
remaining signal peptide degraded. Recent studies in S. pyogenes have revealed that the
leader peptide also directs the cell wall location of the Cwa protein. For example, the
leader peptide of the M protein directs localization at the cell division septum, whereas
the protein F leader peptide results in emergence of the protein at the old division pole
(39).
Studies concerning the cellular location of the Sec machinery in S. pyogenes
resulted in the coining of the term “ExPortal” to describe the translocase localization to
a single site at the extreme pole of the cell (220). This is distinct from the reported
helical pattern assumed by Sec machinery on the cell surface of B. subtilis (37).
Immunogold labeling suggests that in S. mutans SecA and the transpeptidase enzyme,
sortase A, required for Cwa protein surface anchoring, are co-localized at a single
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position on the cell surface. Therefore the site of protein translocation may also be the
site of protein anchoring by sortase A (107).
An accessory sec locus with sec homologs, secA2 (SSA_0836) and secY2
(SSA_0832) was identified in S. gordonii. These proteins mediate the selective
transport of a single serine-rich Cwa protein, GspB. In concert with specialized
transport, GspB contains an unusually long leader peptide (17). The accessory sec locus
of S. gordonii is conserved in S. sanguinis, and is adjacent to a serine rich protein in this
species as well. Therefore the specialized export of this protein is likely shared between
these species.
Following Sec-dependent export, the C-terminal sorting signal of the Cwa
protein drives sortase transpeptidase-dependent anchoring of the protein to the cell wall.
The sorting signal is ~40 amino acids in length and consists of a tripartite motif with an
N-terminal LPXTG-related pattern, followed by a hydrophobic domain, and a positively
charged tail at the extreme C-terminus of the protein (reviewed in 255). It is thought
that the hydrophobic region and positively charged terminus retain the Cwa protein in
the membrane until association with sortase occurs. Evidence of intermediate
membrane association is in the observation that mutation of LPXTG abolishes cell wall
linkage; however the protein is not secreted from the cell, as has been observed with
complete loss of the tripartite motif (227).
Genomic sequence scanning of gram-positive organisms has revealed that
almost all encode sortase-like proteins, and many encode multiple sortase paralogs (49,
199). All sortase homologs contain a signature active site motif, LXTC, with Leu, Thr
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and Cys residues conserved (109). A comprehensive analysis of 241 bacterial genomes
(96 species of bacteria) resulted in the grouping of similar sortase-like proteins
(determined by BLAST scores, and confirmed by Hidden Markov Modeling (HMM)).
Six sub-family groups were proposed in all, including five occurring in gram-positive
organisms: subfamily A sortases (referred to here as the class A sortases, and sortase
A), subfamily B sortases (referred to as class B sortases, and sortase B), subfamily 3
sortases (referred to below as sortase C, SrtC), subfamily 4 sortases, and subfamily 5
sortases; as well as a sixth subfamily unique to gram-negative organisms (49). Putative
substrates of the sortase subfamilies could be delineated based on proximity to a
putative requisite sortase and the observation of distinct cell wall sorting motifs within
these groups. The majority of putative cell wall-associated protein substrates rely on a
“housekeeping” sortase of the sortase A (SrtA) class for cell wall anchoring. Genes
encoding SrtA are ubiquitous among low G+C content gram-positive bacteria (59).
The most well characterized sortase family protein, SrtA of S. aureus, catalyzes
the covalent linkage of the Cwa protein to the lipid II precursor of peptidoglycan (PG)
in a reaction sensitive to the cell wall synthesis inhibitory antibiotics vancomycin and
moenomycin (258).
The specific structure of PG differs between species, but several elements are
conserved, including the PG glycan strands composed of repetitive disaccharide units,
N-acetylglucosamine-(β1-4)-N-acetylmuramic acid (GlcNAc-MurNAc) (80). In mature
PG the glycan polymers are adjoined to peptide chains (in S. sanguinis the peptide
moieties include L-Ala-D-iGln-L-Lys-D-Ala; 19), which are cross-linked by short cell
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wall peptide cross-bridges. Biosynthesis of PG initiates in the cytoplasm of the cell with
MurNAc and the L-D-peptide chain associating to form Park’s nucleotide. This Park’s
nucleotide precursor is then linked by a phosphodiester linkage to the membrane bound
carrier, undecaprenol phosphate to create the membrane bound lipid I form. Addition of
GlcNAc and cross-bridge modification at the ε-amino of L-Lys (the crossbridge in S.
sanguinis is dialanine, Ala2; 19) generates the lipid II precursor. Lipid II is then
translocated across the cytoplasmic membrane.
In the transpeptidation reaction catalyzed by SrtA a covalent linkage occurs
between the Cwa protein and the lipid II precursor of PG. The sortase enzyme cleaves
the LPXTG pattern between the Thr and Gly residues. The conserved SrtA active site
Cys residue captures the cleaved polypeptide as a thioester-acyl enzyme intermediate.
Catalysis is completed by the nucleophilic attack of the amino group of (in the case of
S. sanguinis, Ala2) the crossbridge of lipid II. Penicillin binding proteins then perform
transglycosylation reactions to extend the glycan chain, and transpeptidation reactions
that increase crossbridge crosslinking (between the peptide D-Ala at position 4 and the
amino group of Ala2) to strengthen the PG (258). These final reactions yield the mature
gram-positive cell wall.

Sortase A structure and function
Sortase A is a type II transmembrane protein with an N-terminus rich in
hydrophobic residues, which serves as a signal peptide directing extra-cytoplasmic
export of the precursor protein; and as a stop-transfer signal for anchoring to the
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cytoplasmic membrane. Certain features of the sortase protein sequence are not
conserved among other class A sortases, including the signal peptide, membrane anchor
and a short linker domain extending from amino acid 26-59 (109). Functional studies of
N-terminally truncated S. aureus SrtA, SrtAΔN59 revealed that the first 59 residues were
not required for cleavage of a d-LPETG-e fluorophore (e) substrate and, therefore are
unlikely to contribute to SrtA function in vitro. In contrast residues 60-206 compose the
catalytic core of sortase A and are conserved among gram-positive species. A
recombinant SrtA protein excluding the non-conserved N-terminal residues (1-59) was
used to elucidate the structure of this enzyme by nuclear magnetic resonance (NMR).
SrtA forms an 8-stranded β-barrel fold with 2 short helices and several loops (109). The
active site of the protein is arranged around the catalytically essential thiol containing
side-chain of Cys-184, and includes the conserved residues LXTC. Strands β6 and β 7
of SrtA form the floor of a hydrophobic depression, with walls formed by loops
connecting sequential β strands (109). This hydrophobic pocket encompasses the
protein catalytic site, and accommodates the hydrophobicity of the sorting signal
(LPXTG) substrate (257).
The in vitro hydrolytic and transpeptidation activities of sortase are stimulated
by Ca2+, and are partially activated by alternative divalent cations Mn2+ and Mg2+ (182).
This dependence on extracellular Ca2+ is functionally relevant as S. aureus would
encounter extracellular calcium concentrations of 1.5 mM or greater during entry into
human tissues and roughly 2.5 mM Ca2+ in human serum, suggesting that the rate of
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sortase catalyzed anchoring of surface proteins would increase during the onset of
infection (109, 182).
Seminal studies assessing the contribution of sortase to virulence in an animal
model were all performed using S. aureus SrtA (163, 254, 257). Expression of SrtA has
also been linked with virulence and colonization phenotypes in multiple gram-positive
pathogens through in vivo and in vitro analyses (42, 200, 287). As the defect in
previously characterized srtA mutants is in cleavage and anchoring of surface proteins,
and not protein-secretion preceding the sortase step, protein-lipid II precursors
accumulate. A sub-cellular localization experiment detecting SrtA protein substrates
revealed that precursor Cwa proteins accumulated in cytoplasmic, membrane and cell
wall fractions of an S. aureus srtA mutant, whereas Cwa proteins were only detected in
the cell wall fraction of wild-type staphylococci (163). In a similar comparison with S.
pyogenes studying M protein localization, M protein was detected in the cell wall and
supernatant fraction of the wild-type strain, and exclusively in the supernatant of a srtA
mutant derivative strain (12). Though cytoplasmic membrane secretion of SrtA
substrates may be intact, without a functional SrtA transpeptidase, SrtA-dependent
adhesins exhibit a loss of function in vitro (163). SrtA has recently emerged as a
protective vaccine candidate in a study evaluating an S. aureus polyprotein DNA-vector
vaccine combining the extra-membrane portion of SrtA with the fibronectin and
fibrinogen binding portions of FnbB and ClfA. The polyprotein vaccine caused a
polarized Th1 effect and significantly increased survival of mice challenged
intravenously with S. aureus (78).
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Sortase B attributes
In S. aureus and Bacillus anthracis, SrtB is required for anchoring a heme-iron
scavenging protein, IsdC (157, 165). In both species SrtB and IsdC are encoded in an
operon with additional genes composing a putative iron acquisition system. The operon
is under the control of the ferric uptake repressor, Fur. Under iron replete conditions Fur
inhibits transcription of these genes. In S. aureus the SrtB substrate, IsdC contains the
sequence NPQTN in place of the typical LPXTG sorting signal (the isdC homolog in B.
anthracis contains NPKTG) (165). Two additional iron surface determinants in the S.
aureus operon, isdA and isdB encode proteins contain the SrtA LPXTG sorting signal,
and are anchored by SrtA. The susceptibility of these different surface determinants to
extracellular proteases revealed that sortase substrates of the isd locus are differentially
surface exposed (164). Both IsdA and IsdB are susceptible to proteolytic cleavage;
whereas IsdC is susceptible to proteinase K degradation only after lysostaphin treatment
of the cell wall (159, 164). The model of Isd mediated heme-iron uptake includes IsdA,
IsdB and another SrtA substrate IsdH acting as receptors for hemoprotein ligands,
followed by passage of heme through the cell wall via IsdC (reviewed in 158).
Biochemical analysis of the anchor structure of IsdC of S. aureus revealed that
the NPQTN sorting signal is also cleaved between the Thr and Gly residues, and then
covalently linked to the Gly5 crossbridge, as has been described for SrtA substrates.
However IsdC was linked to PG fragments with less crosslinking than typically
observed for SrtA candidates. Marraffini and Schneewind proposed that this
observation, coupled with non-uniform cell surface distribution of the IsdC is attributed
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to linking of IsdC to an assembled cell wall fragment, rather than the lipid II precursor
of PG (160).
The structures of S. aureus and B. anthracis SrtB proteins have been
determined, and are very similar. Like SrtA, the core of the S. aureus SrtB enzyme is
formed by an eight stranded β-barrel. The β6/β7 loop, discussed above imparts the
substrate specificity of S. aureus SrtA and SrtB (18). Evaluation of L. monocytogenes
and S. aureus SrtB in pathogenesis suggests that this protein is not required for
establishing infection, but does contribute to persistence in infected tissues (165, 187).

Sortase C attributes
Like SrtB, SrtC is encoded by a subset of gram-positive species, and has been
characterized as the mediator of gram-positive surface pilus formation in important
gram-positive pathogens including Actinomyces naeslundii, Corynebacterium
diphtheriae, S. pyogenes, Streptococcus agalactiae, S. pneumoniae, and Enterococcus
faecalis (13, 58, 155, 173, 183, 256). Gram-positive pili are encoded by cwa genes
typically clustered in an operon with a class C sortase, which is responsible for
polymerizing the pilin subunits on the gram-positive cell surface (175, 229). Alignment
of the pilus locus Cwa protein substrate sequences led to the identification of a two
conserved motifs additional to the N-terminal signal peptide, and C-terminal sorting
signal. Pilin protein conserved motifs include a central “pilin motif” that contains a
conserved Lys residue in the consensus sequence WxxxVxVYPK (259), and an “E box”
with the amino acid residues YxLxETxAPxGY (256). Analysis of the C. diphtheriae
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SpaA precursor demonstrated that the Lys of the pilin motif was essential for pilin
polymerization. In the suggested model for polymerization a C. diphtheriae SrtC
homolog cleaves between the Thr and Gly residues of the LPXTG pattern to create an
acyl enzyme intermediate, as described above. The ε-NH2 of the conserved Lys then
performs nucleophilic attack at the sortase acyl enzyme for crosslinking of two adjacent
SpaA subunits by a transpeptide bond (158); repetition of this process would yield the
elongated pilus structure.
In species examined thus far Cwa proteins clustered with the cognate SrtC are
differentially assembled into the pilus structure. A major pilin subunit constitutes the
backbone of the pilin shaft, and contains the pilin motif. The E box mediates association
of the pilus backbone with decorative, accessory Cwa subunits also encoded in the pilus
locus (256, 259). These accessory pilin proteins may associate with the pilus structure at
the pinnacle of the pilus, or along the length of the pilus (229).
In C. diphtheriae analysis of sortases mediating Cwa pilus assembly and cell
surface anchoring of pilus structures revealed that the major housekeeping sortase (class
A sortase) SrtF can catalyze the cell wall anchoring of both pilin monomers and pili, but
cannot polymerize pilin subunits. Modulation of SpaA pilin subunit expression revealed
that SrtF is critical for pilus anchoring when SpaA is abundant (244). These findings
suggest that multiple sortases are involved in gram-positive pilus assembly, and the
transpeptidases may be hierarchal in establishing the functional, surface-exposed pilus.
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Predictive patterns of Cwa proteins
Essential residues for specific activity of S. aureus SrtA were determined using
Dnp chromophore-linked A-L-P-X-T-G sorting pattern pentapeptides, with all naturally
occurring amino acids (excluding C and W) tested at each underlined position (133).
The authors concluded that alternative residues at positions 1, 2, and 4 were minimally
tolerated; and G at position 5 essential for catalysis. Therefore the kinetically preferred
substrate for S. aureus SrtA contains the L-P-X-T-G pattern (133). This specific pattern
with few alternative residues permitted has been adapted for identification of novel SrtA
substrates within translation products of sequenced genomes of S. epidermidis RP62A,
and S. aureus strains by in silico methods (28, 219).
A survey of 65 published cell wall-associated proteins from multiple grampositive species confirmed the essentiality of L-P at positions 1 and 2, as these were
conserved in all identified sequences; however, a variety of amino acids were observed
in positions 3 to 6. That sequences analyzed were derived from diverse genetic origins
suggests flexibility in positions 5 and 6 that may be species dependent (111). Janulczyk
and Rasmussen adapted their observations of conserved residues within the L-P-X-T-G
pattern, spacing and relative frequency of residues in the hydrophobic domain, and the
percent occurrence and positioning of C-terminal positively charged residues for
development of a predictive tripartite pattern less stringent than classical patterns. This
recognition of variability within the tripartite pattern resulted in a pattern search tool
applicable for prediction of previously uncharacterized proteins in numerous grampositive species (111).
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Transposable elements
Transposons are genetic elements capable of mobilizing between DNA sequences.
Transposon elements have been identified in the genomes comprising Eubacteria,
Archaea and Eukarya (93). In addition to contributing to natural genomic diversity,
transposons also have vast applications in molecular biology. In bacterial species
transposons have been adapted for insertion mutagenesis techniques on the genomic
scale, as well as for specific analysis of individual genes.
In general, transposons are composed of discrete DNA segments, and the
complexity of these regions determines the transposon type. The most simple
transposable elements, referred to as insertion sequence elements include gene(s)
mediating transposition (mobilization of the transposon) flanked by inverted repeat (IR)
sequences- which are recognized by the transposase (Tnp) enzyme during transposition
(Fig. 28). In contrast, composite transposons encode additional genes, like antibiotic
resistance cassettes. An example composite transposon is Tn5 (Fig. 28). Tn5 contains
two inversely oriented copies of the IS50 element separated by genes encoding
resistance to Kn, bleomycin, and streptomycin. Conjugative transposons display hybrid
properties of transposons, plasmids, and bacteriophages. These transposons can mediate
their own transfer from a donor DNA molecule in one bacterial cell to a target molecule
in another cell. For example, the conjugative transposon Tn916 excises from donor
chromosomal DNA to form a covalently closed circular molecule that is passed to a
recipient cell via conjugal transfer (38). Modified transposons, like the mariner-based
mini-transposon, magellan2, which does not encode Tnp, have also been developed for
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Figure 28. Genetic organization of transposons

Insertion sequence element: IS1

Composite transposon: Tn5

Mini-transposon: magellan2

Repeat sequence
Transposition gene
Antibiotic resistance gene
Inactive gene
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researcher-controlled transposon mobilization (Fig. 28) (139).

In vitro transposition and mariner-Himar1 transposons
In the most simplistic format in vitro transposition requires only the transposon
terminal inverted repeats, purified Tnp, target DNA, and a simple reaction buffer
providing essential cations. The efficiency of this technique depends on the insertion
site preference of the Tnp, and the catalytic activity of the Tnp used. Native Tnps have
evolved for inefficient transposition as a mechanism for maintenance in their resident
genome. For example, the wild-type Tnp of Tn5 does not perform transposition in vitro,
and is extremely inefficient in vivo (213). To circumvent the inactivity of this Tnp,
researchers have identified multiple classes of hypermutations that increase catalysis by
orders of magnitude. The sites of mutagenesis enhancing transposition have indicated
that in part Tnp efficiency is a result of greater protein flexibility for forming DNA
contacts, and stabilization of the DNA Tnp complex, once formed (275, 280, 293, 294).
Factors affecting in vitro transposition of the Himar1-type mariner transposon have
been well characterized. Himar1 can execute transposition in vitro using only its
purified Tnp, in the presence of Mg2+ or Mn2+ (138). The Tnp encoded by these mariner
elements belong to an extended superfamily of transposases (including Tn5) and
retroviral integrases characterized by conserved positively charged residues, D,D35E or
D,D34D in the catalytic domain of the protein (Fig. 29). As discussed for Tn5, the
mariner Tnps have evolved to be less deleterious in their host via decreased activity.
For in vitro application Lampe et al. identified hyperactive forms of Himar1 Tnp by
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error-prone PCR of the transposase gene (137). A derivative of Himar1, termed MarC9
with ~50 fold greater transposase activity was identified with two mutations governing
enhanced catalysis (reproduction from reference 137, shown in Fig. 29). The mutations,
Q131R and E137K in MarC9 were mapped to the domain of Tnp supposed to mediate
nonspecific DNA binding, prompting the authors to speculate that enhanced MarC9
activity may be attributed to a general increase in affinity for DNA(137).
The mariner transposon elements are of the short-inverted terminal repeat
(ITR)-type. These elements make up a large family of related transposons widely
distributed among metazoans (218). More than 13 subfamilies of mariner elements have
been described; within subfamilies elements have highly conserved sequences with 25100 % protein sequence identity (217). Despite this sequence similarity, Tnp of the
different mariner elements almost exclusively act on the ITR of their transposon, in a
mechanism that is thought to be entirely sequence specific. For example, the two known
active mariner elements, Mos1 and Himar1 ITRs share 33 % identity, yet their
respective Tnps can not transpose the other (140). Himar1 Tnp has been shown to
preferentially transpose shorter transposons bearing the consensus ITR, with
transposition frequency decreasing by ~38 % for every 1kb increase in size. The
Himar1 Tnp specifically targets TA dinucleotides for transposon insertion in a manner
almost entirely independent of nucleotides flanking the target site. However, in vitro
studies have revealed that Himar1 does preferentially transpose into certain sites within
a DNA target, suggesting that there is a preference for flanking sequences that are more
malleable to the Tnp (139). It is thought that greater malleability of the nucleotide
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Figure 29. Schematic of the Himar1 Tnp derivative MarC9
Functional domains of Himar1 including the putative DNA binding domains, and
catalytic domain, and amino acids separating these regions are shown. D* denotes the
putative catalytic residues of the D,D34D catalytic domain. Amino acids changes
Q131R and E137K conferring hyperactivity to MarC9 are indicated. NLS indicates
nuclear localization signals pertinent to transposition in vivo in eukaryotic hosts.
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sequence adjacent to the target site enhances recognition of TA nucleotides by Tnp. The
TA preference exhibited by Himar1 Tnp is cation dependent. In the presence of Mg2+
the Tnp targets TA sites; however when Mn2+ is supplied, insertion site specificity is
more lenient and includes G and C nucleotides as well (138).
The Himar1 element has been advanced as a genetic tool for several reasons
alluded to above. The Tnp of Himar1 displays minimal target site requirements for
ensured mutagenesis of the target DNA template. This reaction is made all the more
efficient by the application of a hyperactive form of the Himar1 Tnp resulting in a high
frequency of transposition. Also, seminal studies by Robertson and colleagues
analyzing Himar1 transposition in vitro confirm the reaction can be entirely researcher
controlled with the use of purified Tnp and a mariner derived mini-transposable
element (not encoding its own Tnp) (138, 139).

Signature-tagged mutagenesis (STM)
The technique of STM was conceived and developed by David Holden for
analysis of Salmonella typhimurium (95). STM is a transposon mutagenesis system that
employs a library of transposons containing unique DNA sequences i.e. “tags”.
Traditionally the transposon library has been used for random insertion mutagenesis of
bacterial species. The resulting pool of insertion mutants can then be tested in a speciesrelevant model with recovery/persistence of a specific mutant detected via the unique
DNA tag. When applied to in vivo studies of bacterial pathogenesis STM permits the
high throughput screening of a mixed population of mutants. This type of negative
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selection screening identifies factors required for virulence and has the advantage of
identifying of previously uncharacterized virulence determinants.
The signature-tags are synthetic oligonucleotides designed with a 40 bp variable
central region bordered by invariant ends. The tags were designed to exclude
recognition sites of restriction endonucleases used for subsequent cloning of tags into
the transposon element, while maintaining enough sequence variability that an identical
sequence would occur once in 2 x1017 molecules (95).
The initial STM screening studies employed the gram-negative species S.
typhimurium and a mini-Tn5 tagged transposon library (95). This mini-Tn5
transposition system has been subsequently applied to various γ-proteobacteria
pathogens, as the transposon is most active in this genetic background (93). STM has
additionally been applied to gram-positive pathogens, albeit with alternative transposon
delivery systems (Tn917, Tn1545, IS1096) originating from these bacteria (8, 36, 112).
The indiscriminate mariner-Himar1 mini-transposon magellan2 has also been
successfully employed for STM in gram-positive streptococcal species (92, 198).
In the traditional application of STM a suicide plasmid encoded mini-Tn5
transposon library with unique signature-tags was electroporated into E. coli and then
transferred into the strain under scrutiny via conjugation. The resulting transconjugants
were selected by acquired resistance markers conferred by genomic insertion of the
transposon (73, 94, 209, 296). As some organisms are refractory to transposon
mutagenesis, and in particular to the Tn5 system, the versatility of this method was
expanded with the application of in vitro mutagenesis of target DNA, followed by
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homologous recombination of transposition products for compilation of a mutant library
(242). Regardless of the mechanism of transposition, after mutagenesis mutants bearing
unique signature-tags are assigned to pools in which each tag is represented only once.
During assembly of the mutant libraries bacteria are cultured in liquid media and/or
agar plates. In this way, mutants with transposon insertion in genes essential for growth
in vitro are automatically excluded as they are rendered uncultivable. Following
creation of mutant library pools each pool is screened in vivo, where high selective
pressures are encountered. The model of disease used is dictated by the pathogen under
study; however infection must be monitored to find a relevant disease interval
permitting colonization, and onset of disease prior to death. After a predetermined time,
animals are sacrificed and bacteria recovered. The unique tags of the transposon are
then used for detection of distinct strains received by the animal (the “input”), and
strains recovered from the animal (the “output”).
The tag DNA hybridization detection method depicted in Figure 30 is that
originally detailed by David Holden and colleagues (95). For this detection method the
mutant library is first used to create hybridization membranes. Colonies may be blotted
onto the membrane (colony blots), or dot blots created with PCR amplicons of
signature-tag sequences used, or plasmid DNA containing signature-tags used spotted
onto the membrane. Differently tagged mutants are pooled into groups prior to
inoculation into the animal; a portion of the inoculum is later used to create the input
pool probe. After in vivo selection viable mutants are recovered and used for
preparation of the output pool probe. Probes are developed by PCR amplification and
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labeling of signature-tags present in the input and output strain populations. These
labeled probes are then hybridized on the dot blot membranes for comparison of the
presence and absence of strains in the input and output pool. Mutants not recovered by
negative selection yield a signal on the input pool dot blot, lacking in the output pool
dot blot.
A few considerations are necessary to derive reliable results from negative
selection analysis by STM. To ensure accurate identification of clones, signature-tags
are often prescreened for consistent and reproducible detection and lack of crosshybridization (95). The pool size and complexity of the pools administered should also
be considered, as these factors are inversely related to the accuracy of results obtained.
As the complexity of the pool tested increases the likelihood that virulent mutants will
not de detected also increases (in the instance that they are not present in sufficient
numbers), resulting in virulent strains categorized as avirulent. Detection by DNA
hybridization is particularly sensitive to the complexity of the pool tested, as pool
complexity is inversely related to the quantity of labeled tag for each transposon.
Therefore, for accurate detection pool sizes should not exceed the detectable threshold.
Another phenomenon to consider is the possibility of a bottleneck occurring during
colonization (92). In principle signature-tagged mutagenesis depends on all strains
having equal access to colonization for onset of infection. The population of bacteria
that survive during colonization must overcome selective pressures encountered in vivo.
Initial design and optimization of signature-tagged mutagenesis screens typically
include experiments evaluating whether a bottleneck is occurring.
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Figure 30. STM screening schematic

1. In vitro transposition of genomic DNA
Tag

2. Generation of mutant library
1

2

3

4

5

6

7

8

9

AbR

10 11 12

+

1 2 3 4
5 6 7 8
9 10 11 12

Tag
6. PCR amplify and
label tags

3. Mutants pooled in vitro:
Input pool

7. Probe input pool
membrane

8. Compare hybridizations and
identity missing mutants

1

2

5

6

4. Negative selection
screening in vivo

4
7

8

9 10 11 12
7. Probe output pool
membrane

Tag
6. PCR amplify and
label tags

5. Recover mutants

178
Achieving consistently reproducible results from the recovery pool confirms that this is
not the case. A general requirement for meaningful screening is a large output pool,
exceeding 104 bacteria to recover the maximal number of tags (73, 95). The parameters
described here directly affect the outcome of STM screening.
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Rationale

An in vivo screening for S. sanguinis SK36 IE virulence determinants by
random signature-tagged mutagenesis identified 5 avirulent mutants with transposon
insertions in ORFs encoding housekeeping genes or genes necessary for survival under
anaerobic conditions (198). The lack of identification of classical virulence factors, e.g.,
those facilitating adhesion in colonization, was surprising given the abundance of
putative virulence factors predicted from the complete SK36 genome sequence (285). In
the described experiments the signature-tagged mutagenesis technique was modified for
a directed application to genes predicted to encode cell wall-associated proteins and
sortases. Through this comprehensive analysis we hoped to determine the role of S.
sanguinis cell wall-associated proteins in early IE.
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Results

Identification of putative S. sanguinis SK36 Cwa protein ORFs
The genome sequence of S. sanguinis SK36 is the largest (2.4 Mb) published for
a streptococcal species, and includes the most open reading frames (2,272) (285).
Search algorithms incorporating features characteristic of Cwa proteins were used to
identify ORFs encoding putative Cwa proteins. The patterns applied include the sorting
site LPXTG pattern, followed by a region rich in hydrophobic residues, and capped by
positively charged C-terminal residues. Two prediction patterns (in Materials and
Methods) were used to screen for putative Cwa proteins among the SK36 ORFs. Thirtyseven positive hits resulted from searching with the more stringent Fuzzpro pattern (B),
whereas 14 additional positive hits occurred when searching with pattern (A). Nterminal signal peptide prediction by SignalP differentiated between erroneously
identified cytoplasmic proteins, and proteins putatively undergoing Sec-mediated extracytoplasmic export. Protein sequences of SK36 ORFs positive by Fuzzpro prediction
and predicted to encode an N-terminal signal peptide were then visually inspected for
an LPXTG pattern. Three of the 33 remaining ORFs lacking a C-terminal LPXTG
pattern were likely multiple-pass integral cytoplasmic membrane proteins, as
determined by TMHMM analysis. Using these subtractive prediction methods, 30
putative cell wall-associated proteins were identified for SK36 (Table 4).
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Table 4. Predicted S. sanguinis Cwa proteins
Putative Cwa proteins were identified by two algorithms (described in Materials and
Methods). Proteins positive for algorithm (B) had four or less mismatches, whereas
proteins identified by algorithm (A) had five mismatches. Several proteins believed for
other reasons to be Cwa proteins were missed by the prediction method used (not
identified= NID), due to mismatches exceeding the threshold (¤), or lack of a predicted
N-terminal signal peptide (‡). The sorting signal for each ORF is shown, with the
LPXTG in bold. The SignalP server was used for prediction of N-terminal signal
peptides. For this purpose two algorithm were applied, the neural network (NN) for
detection of secreted (cell surface-targeted proteins), and the hidden Markov model
(HMM) that assigns a signal-peptide probability value to a given sequence. Numerical
values in the NN column are the ‘D score’; referred to as the average of the signal
peptide algorithm and the predictive cleavage site algorithm score. Proteins with NN
cutoff values greater than 0.45 were considered positive for a signal peptide (Y=Yes).
The (HMM) probability value is also given, with 1 meaning a sequence is extremely
probable for containing a signal peptide (Y=Yes). The TMHMM server was used for
prediction of the number of helices (potential transmembrane domains). The number of
predicted helices for each protein is given in the THMMM column. Proteins lacking an
LPXTG pattern were discarded from the list of putative Cwa proteins. Discarded
proteins with greater than two predicted transmembrane domains, and a predicted Nterminal signal peptide are listed are putative integral membrane proteins.
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Table 4.
SignalP
Ss Gene

NN

HMM

TMHMM Fuzzpro

Mismatches

Putative Cwa proteins

SSA_0146

0.616 Y

1.000 Y

1

LPHTGQASNALLTVAGVISALGTAGLSLRSRKKED

2

SSA_0167

0.893 Y

1.000 Y

2

LPATGTNQSFLALIGTVMLSVLAFVGFKRKKN

0

SSA_0243

0.811 Y

1.000 Y

0

LPVTGEKTSSLGLLGLVMTGLAGIFTFKKRERQ

1

SSA_0227

0.857 Y

1.000 Y

2

LPKAGENASWIMIAAGVALVGLVGFIVFRAKKK

1

SSA_0273

0.617 Y

1.000 Y

1

LPKTGSQSSLLTNLLGLGLLGLGAGFLGLKKKS

0

SSA_0303

0.691 Y

1.000 Y

0

LPETGAKDAVYLPYLGLAAIIGALGLGKLKGKED

3

SSA_0453

0.416 N

0.999 Y

1

LPKTGTSTSLLALLGGFLAFLAGLLTFRKSNN

1

SSA_0565

0.795 Y

1.000 Y

0

LPKTGENSSWLLLAGQMLLLMAMKLFYKKRSLD

3

SSA_0684

0.561 Y

0.996 Y

2

LPKTGQDTSVWMLILGFLTFGGAVGLTKRQRD

2

SSA_0805

0.771 Y

1.000 Y

2

LPKTGQETTLWLSVAGLAILVGFGSYVFLQKKTR

3

SSA_0829‡

0.318 N

0.000 N

0

LPQTGETESKASILALGLGALGLAFKRRKKKSDSEE

5

SSA_0904¤

0.681 Y

1.000 Y

1

LPKTGTEETSYLAASLLAGVSGLGLIGLEKRKKSLKTKR

NID

SSA_0905

0.703 Y

1.000 Y

0

LPKTGTEETSYLAASLLAGLSGLGLIGLEKRKKKSED

2

SSA_0906

0.678 Y

1.000 Y

0

LPKTGTEETSYLAASLLAGVSGLGLIGLEKRKKKSED

2

SSA_0956

0.708 Y

1.000 Y

0

LPKTGSNASSLLIYLGFAALLASAGFRLSKKES

3

SSA_1019

0.787 Y

1.000 Y

1

LPKTGSETSIFAIAAGFALILLSALAYRFKKAN

2

SSA_1023

0.696 Y

1.000 Y

0

LPNTGNTNSSFLGVAIISLLASIGLLHSKKERKK

3

SSA_1063

0.670 Y

0.999 Y

1

LPKTGSSEKAVYSVVGLGLLLAGLGLGISVRKSKEQ

1

SSA_1065

0.910 Y

1.000 Y

2

LPKTGDSSSLFLVLLGALFLFGAVYLYDLSSRRL

4

SSA_1112

0.785 Y

1.000 Y

2

LPKTGEAQTSTATIGFFGLALAGILGFLGLKEKQKD

1

SSA_1234

0.825 Y

1.000 Y

0

LPQTGSESAVALSLVGMVLGFFGLAGIKKSHKED

1

SSA_1301

0.341 N

0.997 Y

0

LPNTGSEAERLAIFGMALGAAAFLGTNKRRRRDEDYN

5

SSA_1591

0.804 Y

0.927 Y

1

LPSTGEQVTIMGLAGLIILAGVFILLKKTNKN

1

SSA_1632

0.796 Y

1.000 Y

2

LPNTGGIGTTILYLIGTSLVLGAGVLFIIKKRADSR

1

SSA_1633

0.833 Y

1.000 Y

2

LPNTGGIGTTILYLVSTSLVLGAGVLFVVKKRVSTK

1

SSA_1634

0.879 Y

1.000 Y

2

LPNTGGIGTTILYLSGTGLVLGAGILWMLKKRVNKK

2

SSA_1635¤

0.569 Y

0.997 Y

2

LPETGGNGTLLYLWGGSVITLGSAIWLIVRNKLYRKFQ

NID

SSA_1663

0.772 Y

1.000 Y

2

LPFTGTEISFTLLAFGLILIVGCGVYFGIRFKK

4

SSA_1666

0.254 N

0.999 Y

2

LPATGSAESLGLVLAGLVVLALLGLYRKTRLSK

2

SSA_1750

0.814 Y

1.000 Y

2

LPKTGQNTSGWAVLGLTLLMFAFTLKKRSRN

2

SSA_2020

0.664 Y

1.000 Y

1

LPETGSQETRASFVLAGLLVAGAAGLFLLKKKED

0

SSA_2023

0.472 Y

0.999 Y

1

LPKTGNQEDKFLPLAGLAFLGMGLLAGRKKQED

2

SSA_2121

0.884 Y

1.000 Y

2

LPRTGQEENLLVTILGFLAALLAGGMLVAKAKCS

3

Putative Integral Membrane Proteins
SSA_0614

0.619 Y

0.955 Y

10

LWNMNASWLIFIIIGVIALLLSIEKKKDIKER

5

SSA_0871

0.472 Y

1.000 Y

4

DPKLFSPIMIAALFVLGILIGSLGSIISMRRFLKI

4

SSA_1049

0.625 Y

0.111 N

6

LTTQNWGMGSTIGVVLIVAMLFTMWATKERRGR

5
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Two proteins not identified by the Fuzzpro pattern searches due to mismatches
exceeding the permitted threshold, SSA_0904 and SSA_1635, appeared to be cell wallassociated based on homology and gene location (NID, Table 4). SSA_0904 encodes
CrpA (Csh-related protein A) and exists in an operon with additional Csh-like proteins
CrpB (SSA_0905), and CrpC (SSA_0906), both of which were identified as Cwa
proteins. A gram-positive N-terminal signal peptide was predicted for this ORF, and
SSA_0904 was included in the comprehensive analysis of S. sanguinis Cwa proteins in
vivo.
SSA_1635 is putatively the first gene in a cluster of predicted Cwa protein
encoding genes including SSA_1634, SSA_1633, and SSA_1632. ORFs SSA_1632,
1633, and 1634 exhibit amino acid sequence identity ranging from 48 % to 62 % over
the entirety of the protein sequences. Identity with SSA_1635 is restricted to the Cterminus of the protein and a unifying LPXTGGXG sorting pattern. The genomic
clustering of SSA_1635-1632 and the proximity of these genes to a gene encoding a
putative sortase, SSA_1631 (sortase C class) (Fig. 33C), suggests these genes encode
cell wall-anchored protein substrates recognized by SSA_1631. From this locus
SSA_1631, 1632, 1633, and 1634 were included in the comprehensive in vivo analysis.
One protein positive by Fuzzpro analysis, SSA_0829, was not predicted by
SignalP to include a gram-positive N-terminal signal sequence (Table 4). In the case of
SSA_0829, this may be attributed to transport via an alternative accessory Sec-mediated
pathway, as described for an SSA_0829 homolog in S. gordonii, GspB. This
SecA2/SecY2 dependent mode of extracytoplasmic export is reliant upon conserved
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Gly residues within a hydrophobic region proximal to the amino terminus of the
cytoplasmic, precursor Cwa protein (16, 17). SSA_0829 is a member of the serine-rich
glycoprotein family, which includes Fap1 of S. parasanguinis, SrpA of Streptococcus
cristatus, SraP of S. aureus, Srr proteins of S. agalactiae, and Hsa of S. gordonii
Challis, in addition to GspB, discussed above (89, 230, 234, 247, 284). In keeping with
the repeating serine residues of this protein, SSA_0829 was designated serine-rich
protein A, SrpA, by Plummer et al (204).

Identification of unique Cwa proteins of S. sanguinis
The Cwa protein repertoire predicted for S. sanguinis exceeds predictions for
related streptococcal species. Application of identical bioinformatics to S. gordonii CH1
subsp. Challis, S. mutans UA159, and S. mitis NCTC 12261 predicted 23, 6, and 15 cell
wall-associated protein encoding ORFs, respectively (Tables 5, 6, and 7). The degree of
relatedness between these species is reflected in the number of shared Cwa protein
homologs. Eighteen of 33 predicted S. sanguinis Cwa proteins have significant
homology to putative S. gordonii Cwa proteins. These include the previously
characterized S. gordonii antigen I/II homologs SspA and SspB, cell surface
hydrophobicity associated proteins A (CshA) and CshB, and serine-rich protein, Hsa. In
addition four S. sanguinis uncharacterized proteins with putative enzymatic functions
have homologs in S. gordonii, and four proteins containing CnaB-like collagen domains
are conserved between the two species (Table 5).

Table 5. Predicted Cwa Proteins of S. gordonii CH1 (Sg)
Sg Gene ID

Description

gi_157151510
gi_157151208
gi_157151122
gi_157150004
gi_157151439

Serine protease
Nuclease/phosphatase domain
Collagen binding domain
Glycosyl hydrolase family
SspA

gi_157150597

SspB

gi_157150159
gi_157151265
gi_157151173
gi_157150906
gi_157151454
gi_157150739
gi_157149904

Serine protease
Exo-beta-D-fructosidase
Zinc carboxypeptidase family
Beta-N-acetylhexosaminidase
Cell wall surface protein
Cell wall surface protein
CshA

gi_157151344
gi_157150914
gi_157150842

Collagen binding domain
Streptococcal hemagglutinin
CshB

gi_157150937
gi_157150885
gi_157150970
gi_157150569
gi_157151048
gi_157150237
gi_157150742
gi_157150875

Cell wall surface protein
5'-nucleotidase
X-prolyl dipeptidylaminopeptidase
Beta-galactosidase
Cna protein B-type domain
Collagen binding domain
Cell wall surface protein
Cell wall surface protein

Ss
SSA_1750
SSA_1019
SSA_0303
SSA_0956
SSA_0303
SSA_0956
SSA_2023
SSA_2020
SSA_2023
SSA_0565
SSA_0684
SSA_0904
SSA_0905
SSA_0906
SSA_0805
SSA_0829
SSA_0904
SSA_0905
SSA_0906
SSA_1112
SSA_1234
SSA_2023
SSA_1663
SSA_1666
SSA_0565

NN

SignalP
HMM

0.267
0.245
0.259
0.253
0.561

N
N
N
N
Y

0.000
0.000
0.003
0.000
1.000

Fuzzpro
N
N
N
N
Y

LPNTGQAGDGMSLLGLFLSLCTFGLIRQRGKEEQD
LPATGEQRGHWVAFGFLVLIFAYPLSRKSKKSSNL
LPKTGTAESSAFSVLVGFLLLVASVFLYRTKKVN
LPNTASQETAFVAEAVLLAALGGLLLAGKKKED
LPKTGTNDSSYMPYLGLAALVGVLGLGQLKRKEDE

0.548 Y

1.000 Y

LPKTGTNDATYMPYLGLAALVGFLGLGLAKRKED

0.223
0.448
0.266
0.445
0.865
0.610
0.522

0.000
1.000
0.000
1.000
1.000
1.000
1.000

N
Y
N
Y
Y
Y
Y

LPKTGQEDQTSLALSLFGITSLALAGMVIHKKREE
LPKTATQEDKFLPLAGLAFLGMGLLAGRKKQED
LPKTGTQEMTEGFKLASILIACSAGLFLLKKKED
LPQTGTTSAWPITLLGTALALIGLGGRKKRKG
LPNTGSRLSVWAMMSGILALVSGFALLIWKHKKES
LPNTGETSTVLLSMIGFAFAGLVGYVVRKKGKA
LPRTGSQTSDQTASGLLAAIASLTFFGLANRKKKS

0.276 N
0.240 N
0.528 Y

0.000 N
0.000 N
1.000 Y

LPKTGEQAAIWLSVAGVSILVILGGVFVVLRKKNK
LPRTGESESKASILALGIGALGLAFKKRKKNESED
LPRTGSQTSDQTASGLLAAIASLTFFGLANRKKKS

0.538
0.590
0.167
0.546
0.211
0.222
0.459
0.619

1.000
1.000
0.000
1.000
0.000
0.003
0.756
1.000

LPNTGEAQTATATIGFFGLALAGLLGLLGLKEKQK
LPETGTKESPALLIVTLFTAFLGIFGFKKSQED
LPETGQKENSWSIYGMLSLLLAGLWKVISGRKEEK
LPNTGSQSDQAAITTGLALLGLGASLVAGKRRKED
LPLTGTELSFTLLALGLTMIVGWGVYYGTRFKN
LPNTGSSDSKFIFVVGLATLMLLGLVWKKKHS
LPNTGEHANGFAALLGLVLASVTAFFNFRRKKH
LPKTGTSATMVNEVIIGMILVLMGLLLRRKPKH

N
N
N
N
Y
Y
Y

Y
Y
N
Y
N
N
Y
Y

Y
Y
N
Y
N
N
Y
Y

The sorting signal for each predicted Sg ORF is shown, with the LPXTG in bold. The SignalP server was used for prediction
of N-terminal signal peptides by both NN and HMM algorithms (descriptions of values are given in Table 4). The S. gordonii
protein annotation is listed (270). S. sanguinis (Ss) SK36 protein homologs were identified by BLASTP analysis.
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Table 6. Predicted Cwa Proteins of S. mutans UA159 (Smu)
Smu Gene ID
gi_24378602
gi_24379087
gi_24379427
gi_24379528
gi_24379801
gi_24380381

Description
FruA
SpaP
WapA
WapE
GbpC
Dextranase

Ss
SSA_2023
SSA_0303

NN
0.529
0.789
0.931
0.594
0.823
0.175

SignalP
HMM
Y 0.989
Y 1.000
Y 1.000
Y 1.000
Y 1.000
N 0.000

Y
Y
Y
Y
Y
N

Fuzzpro
LPDTGDHKTDLSQLGVLAMIGSFLVEIAGYFKKRKD
LPNTGVTNNAYMPLLGIIGLVTSFSLLGLKAKKD
LPSTGEQAGLLLTTVGLVIVAVAGVYFYRTRR
LPDTGVQKNNQLALIALGTGLILLSGLLLSKRKSLK
LPHAGAAKQNGLATLGAISTAFAAATLIAARKKEN
LPQTGDNNETRSNLLKVIGAGALLIGAAGLLSLIKGRKKD

The sorting signal for each predicted Smu ORF is shown, with the LPXTG in bold. The SignalP server was used for
prediction of N-terminal signal peptides by both NN and HMM algorithms (descriptions of values are given in Table 4). The
S. mutans protein annotation is listed (3). S. sanguinis (Ss) SK36 protein homologs were identified by BLASTP analysis.
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Table 7. Predicted Cwa proteins of S. mitis NCTC 12261 (Smi)
Smi Gene ID
SMT0163
SMT0272
SMT0737
SMT0779
SMT0780
SMT0787
SMT0793
SMT0819

SMT0925
SMT1139
SMT1189
SMT1291
SMT1537
SMT1642
SMT0785

Description
Ss
Amylopullulanase
SSA_0453
Glycosyl hydrolase family 85 family
Cell wall surface protein
Muramidase-released protein
Muramidase-released protein
Mucus binding protein precursor (Mub)
Surface protein C (PspC)
CshA
SSA_904
SSA_905
SSA_906
ABC transporter efflux protein
R5 protein
PspA
Cell wall surface protein
Bovine homologue of human Hr44
Cell wall surface protein
SSA_1112
Cell wall surface protein
SSA_0829

SignalP
NN
HMM
0.791 Y 1.000
0.113 N 0.000
0.466 Y 1.000
0.601 Y 1.000
0.638 Y 1.000
0.496 Y 1.000
0.781 Y 1.000
0.456 Y 1.000

0.440
0.532
0.917
0.398
0.294
0.123
0.491

N
Y
Y
N
N
N
Y

0.543
1.000
1.000
0.999
0.000
0.000
1.000

Y
N
Y
Y
Y
Y
Y
Y

Fuzzpro
LPNTGTKNDHKLLFAGISILALLGLGFLLKNKKEN
LPNTGTVDANEALIAGLASLGLASLALTLKQKKEDED
LPNTGTEDHANLVVLGLLGVLSGFGFLAHKKKEVEK
LPNTGTEANASLAALGLLGALGGFGLLARKKKED
LPNTGTEANASLAAFGLLGALGGFGLLARKKKED
LPKTAGHSSGMAHVLGVFGLIAGFSLVGKAKRDE
LPETASHDSILLVVGFLSALSGVLLFKVKKD
LPNTGTEDNASLAALGLLGVLSGFGLVARKKKED

Y
Y
Y
Y
N
N
Y

LPNIGVLLVFLVALTVLNIVGLRRYRKV
LPNTGTADNASLAALGLLGVLSGFGLVARKKKED
LPNTGGKDNVAIASLGFLGLLLGALPFVKRKN
LPNTGTESNAALAAFGFVGILSGLSIVLRKKDNE
LPNTGTEDHASLAALGLLGALSGFGLIARKKREDEE
LPYTGEAQTSMATLGFFGLALAGLLGGLGLKAKKEEND
LPNTGIQEDRTTGTVGVLSLLGAFGLLFAKKKKDDEEEA

The sorting signal for each predicted Smi ORF is shown, with the LPXTG in bold. The SignalP server was used for
prediction of N-terminal signal peptides by both NN and HMM algorithms (descriptions of values are given in Table 4). The
S. mitis protein annotation is listed online (http://www.tigr.org/). S. sanguinis (Ss) SK36 protein homologs were identified by
BLASTP analysis.
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Four predicted S. sanguinis Cwa proteins are conserved in S. mitis, and two conserved
between S. sanguinis and S. mutans (Tables 6 and 7, respectively). A putative alkaline
amylopullulanase (SSA_0453) is unique to S. sanguinis and S. mitis of the four species
compared. Comparative analysis suggests the majority of predicted Cwa proteins of S.
sanguinis (18 of 33) are homologous to predicted proteins of similar spp., suggesting
conservation of specific fitness factors during species divergence.
We then sought to determine whether the remaining 15 proteins with no
homologs in S. gordonii, S. mutans, and S. mitis were actually unique to S. sanguinis. A
comparison of the S. sanguinis genome to complete genome sequences of 55 other
gram-positive spp., related and unrelated oral microbes, and unrelated causative spp. of
infective endocarditis indicated that 8 predicted Cwa proteins are unique to S. sanguinis.
These include the ORFs SSA_1632, SSA_1633 and SSA_1634, described above, in
addition to SSA_0146, SSA_0167, and SSA_0273, SSA_1063, and SSA_1023.
SSA_1063 has been previously described as the platelet aggregating surface protein,
CbpA. SSA_1023 was unique to S. sanguinis among the 55 species compared, yet has
some sequence similarity to the muramidase released protein (Mrp) of S. suis, and von
Willebrand factor binding protein (vWf1) of S. lugdunensis. Although these analyses
are predictive in nature they do suggest multiple mechanisms of acquisition of S.
sanguinis cell wall associated protein ORFs. While many were likely inherited from a
common ancestral species, some—in particular, unique, uncharacterized, hypothetical
proteins—were likely acquired by horizontal gene transfer and therefore may be unique
to S. sanguinis within the viridians group of streptococci.
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Identification of putative S. sanguinis SK36 sortases
Gram-positive sortases may be divided into sub-families based on conserved
residues surrounding the LXTC active site, distinctive transmembrane topology, as well
as genomic clustering with putative substrates (49, 59). Three sortase-like proteins of S.
sanguinis SK36 were identified by homology searches with 45 publicly available
sortase sequences. The S. sanguinis sortase-like proteins were annotated based on
similarity to one of three subfamilies, SrtA, SrtB or SrtC (Table 8). SSA_1219 was
homologous to the majority of published SrtA sequences queried, with the exception of
the prototypical SrtA of S. aureus. As previously documented for this subfamily, within
the active site residues (LXTC) X is a Val residue (Fig. 31A). (Iso or Thr are also
common.) This protein subfamily is also characterized by an N-terminal signal
peptide/transmembrane domain directing type I membrane topology (59). Hydropathy
analysis of the S. sanguinis SrtA sequence identified a single transmembrane domain,
restricted to the N-terminus of the protein (Fig. 31B). Finally, the SSA_1219 gene
encoding SrtA is not clustered with any putative substrate, suggesting that activity of
this sortase is not limited to a subset of Cwa proteins (Fig. 31C).
Of the three sortase-like proteins identified, SSA_0022 had the greatest
sequence identity to previously published SrtB sequences. These characterized and
uncharacterized SrtB-related proteins were grouped based on a conserved Ser residue
proximal to the catalytic TLSTC Cys residue (Fig. 32A) (199). A Ser residue also
occurs in the LXTC of SSA_0022, suggesting that this protein may be similar in
function to other SrtB homologs. Yet the SSA_0022 genomic locus presents a paradox.
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Table 8. Identification of S. sanguinis sortase-like ORFs

Sortase A class:
GI:3238307_S. aureus subsp. aureus COL
GI:1201902_E. faecalis V583
GI:1028429_S. mutans UA159
GI:2650068_C. diphtheriae NCTC 13129
GI:1088124_B. anthracis str. Ames
GI:111657852_S. pneumoniae TIGR4
GI:901269_S. pyogenes M1 GAS
GI:1201386_E. faecalis V58
Sortase B class:
GI:2859503_S. aureus subsp. aureus
MRSA252
GI:891152_B. halodurans C-125
GI:1083901_B. anthracis str. Ames
GI:900461_S. pyogenes M1 GAS
GI:4962816_S. pyogenes str. Manfredo
GI:4916727 C. difficile 630
Sortase C class:
GI:3036999_A. naeslundii T14V
GI:1199996_E. faecalis V583
GI:2650116_C. diphtheriae NCTC 13129
GI:2650498 C. diphtheriae NCTC 13129
GI:2650495_C. diphtheriae NCTC 13129
GI:2650024_C. diphtheriae NCTC 13129
GI:2650023_C. diphtheriae NCTC 13129
GI:930405_S. pneumoniae TIGR4
GI:930404_S. pneumoniae TIGR4
GI:930406_S. pneumoniae TIGR4
GI:1116387_C. acetobutylicum ATCC 824
GI:939748_B. subtilis subsp. subtilis str. 168

SSA_1219 SSA_0022 SSA_1631
●
●
●
○
○
○
●
●
●
●

●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●

The sortase GIs used to identify S. sanguinis sortase-like proteins are shown. The S.
sanguinis SK36 protein best matching a given query sequence is indicated (●). Queries
lacking a homolog in S. sanguinis are also indicated (○).
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Figure 31. Characteristics of a SrtA-like protein
A) A ClustalW alignment of SrtA sequences from S. mutans UA159 (SMU_1113), S.
pyogenes M1 GAS (SPY_1154), S. pneumoniae TIGR4, S. sanguinis SK36, E. faecalis
(EF_3056), and B. anthracis str. Ames highlights conserved residues at the LXTC
active site (indicated by asterisks), as well as similar neighboring residues (indicated by
periods and colons)
B) A tmap hydropathy prediction of the SrtA sequence highlights a single hydrophobic
region at the N-terminus of the protein, suggesting a type I topology of this
transmembrane protein.
C) The S. sanguinis SK36 srtA locus is shown. In dark grey are neighboring genes, ldh
and gyrA conserved in S. gordonii Challis CH1, S. mutans UA159, S. pyogenes M1
GAS, and S. agalactiae NEM16. SSA_1218, putatively encoding radC is conserved
between S. sanguinis and S. gordonii. SSA_1217, encoding a putative glutamine
amidotransferase, is not conserved at this locus. Putative promoter and terminator
elements are depicted.
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Figure 31.
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In Staphylococcus aureus, Bacillus spp., and Listeria monocytogenes SrtB is encoded in
an iron regulated operon and recognizes a unique sorting signal (NPxyTN) on its
cognate substrate, the heme-iron binding protein IsdC (157, 165, 187) (Fig. 32B). The
genomic clustering of SrtB with IsdC in S. aureus, B. anthracis, and L. monocytogenes
suggests a highly specific activity for this protein. In S. pyogenes strains Manfredo and
M1 GAS, and S. sanguinis SK36 the srtB gene is not in an operon with putative Cwa
proteins with the NxyTN sorting signal. In the case of S. pyogenes Manfredo srtB is
flanked by genes encoding putative Cwa proteins bearing an LPXTG sorting signal
(SPYM50104), the sorting signal LPLAG (SPYM50106a), and a putative novel sorting
signal of QVXTG (SPYM50106). A similar genomic arrangement exists in S. pyogenes
M1 GAS (Fig. 32C). In S. pyogenes strain AM3 this sortase transpeptidase, containing
catalytic site residues characteristic of SrtB (TLSTC) is annotated as SrtC1. Is has been
demonstrated that SrtC1 is required for cell surface anchoring of a proximal ORF with
the QVPTGV sorting signal (11). Further investigation of the homologous ORF in S.
pyogenes M1 GAS, Spy0128, revealed this SrtC1 substrate to be the backbone
component of a gram-positive surface pilus, decorated by Spy0130 subunits (175). It
appears that in streptococcal species SrtB homologs are required for surface assembly
of Cwa proteins with functions unrelated to substrates of analogous sortases in S. aureus
and B. anthracis.
In S. sanguinis the srtB ORF is not proximal to any genes encoding Cwa
proteins with the conventional recognition sequence NxyTN. If streptococcal
SrtB homologs recognize a deviant signal sequence, then PcsB (SSA_0019) may be the
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Figure 32. Characteristics of a SrtB-like protein

A) SSA_0022 was annotated SrtB due to the conservation of a Ser residue in the LXTC
catalytic site. A ClustalW alignment with characteristic SrtB sequences of S. aureus
subsp. aureus MRSA252, B. anthracis Ames, as well as SrtB-related proteins of S.
pyogenes M1 GAS (GI: 900461) and S. pyogenes Manfredo (GI: 4962816) reveals
similarity in these catalytic site residues.
B) In S. aureus, B. anthracis and L. monocytogenes srtB is within a Fur regulated
operon. The candidate SrtB substrate, IsdC is indicated in green. In L. monocytogenes
SvpA anchoring to PG is dependent on SrtB; a putative additional L. monocytogenes
SrtB substrate, encoded by lmo2186 has 33 % identity to IsdC and contains a potential
SrtB sorting motif, NKVTN (22, 187). Additional conserved genes at this locus in S.
aureus, B. anthracis and L. monocytogenes are indicated by like color-coding, genes not
conserved are in black.
C) In streptococcal species the srtB locus is arranged differently. In green are genes
putatively coding for cell wall-associated proteins with the LPXTG motif (spyM50104,
Spy0130), or an LPLAG sorting signal (spyM50106a). In blue are genes putatively
encoding candidate SrtB substrates which contain a sorting signal QXXXG. The
anchoring of a SrtB substrate with this sorting pattern has only been demonstrated for S.
pyogenes AM3 (11).
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Figure 32.
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candidate substrate for the transpeptidase. This protein includes the residues QPEVG
near the C-terminus, and has 44 % sequence identity to the S. agalactiae PcsB protein.
Altered morphology of S. agalactiae and S. mutans PcsB-related protein mutants
suggests the protein acts as a murein hydrolase to split the division septum between
adjacent daughter cells. Streptococci are globular cells that typically divide in
approximately the same plane at each cell cycle, producing elongating chains. In
contrast S. mutans sagA and S. agalactiae pcsB mutants exhibit division in multiple
planes (44, 212). The loss of PcsB expression has also been linked to enhanced
susceptibility to cell wall-targeting antibiotics, as well as antibiotics with intracellular
targets, suggesting that additional defects in the cell wall exist beyond proper cell
division (212). Likewise an S. mutans sagA mutant exhibited greater sensitivity to
osmotic stress, increased temperatures, and low pH (44). These observations have
resulted in the suggestion that PcsB is a general stress-related protein. Interestingly
PcsB is essential in S. pneumoniae, but related proteins are not essential for growth of
either S. agalactiae or S. mutans (44, 172, 212). Therefore additional species-specific
activities may be attributable to PcsB. S. pneumoniae PcsB cell localization analysis by
cell fractionation and Western blotting indicated the protein was predominately
localized to the plasma membrane or secreted from the cell (172). The exposure of PcsB
to extracellular milieu has also been inferred by the protective effect garnered by this
protein in pneumococcal vaccine studies (82). Though it remains unconfirmed, it is
possible that PcsB may additionally be anchored to the PG of the cell wall during
trafficking from the plasma membrane to secretion from the cell. Cell localization,
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general function, and the relationship between pcsB and the neighboring srtB ORF
remain uncharacterized in S. sanguinis.
SSA_1631 was annotated as SrtC based on translated sequence conservation
with the Sortase C-group/subfamily 3 transpeptidases proposed by Dramsi and
colleagues (59). Sortase C transpeptidases are characterized by a C-terminal
hydrophobic domain that may act as a membrane anchor to drive type-II membrane
topology of this protein. Hydropathy analysis of the S. sanguinis SrtC amino acid
sequence predicted both N- and C-terminal hydrophobic regions (Fig. 33B). As sortases
act on proteins at the cell surface it is likely that the N-terminal hydrophobic region
drives Sec-dependent export of the enzyme, whereas the C-terminal region determines
membrane topology. In addition a conserved proline residue following the LXTC
catalytic site links the S. sanguinis SrtC to previously described SrtC enzymes (Fig.
33A). As previously mentioned, SSA_1631 is clustered with the putative Cwa protein
encoding genes: SSA_1635, SSA_1634, SSA_1633, and SSA_1632 (Fig. 33C). In S.
pneumoniae, C. diphtheriae, and E. faecalis the Cwa genes flanking SrtC encode grampositive pilin subunits. The polymerization of pilus subunits is dependent on the
adjacent sortase in these species (13, 183, 256).
Patterns predictive of the pilin motif (“WxxxVxVYPK”) and the E box
(“YxLxETxAPxGY”) were screened against the putative S. sanguinis Cwa proteins
neighboring SrtC. Similar to E. faecalis pilus associated proteins EbpA, EbpB, and
EbpC, E box determinants were identified in SSA_1635, SSA_1634, SSA_1633, and
SSA_1632 with almost perfect fidelity to the E box motif (183).
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Figure 33. Characteristics of a SrtC-like protein

A) The S. sanguinis SrtC homolog SSA_1631 catalytic site includes conserved residues,
indicated by red coloring. The active site encompasses LXTC with a conserved Pro
distal to the essential Cys residue. In the case of sortase C group the charge and polarity
of X is conserved and is represented by green text.
B) A tmap hydropathy analysis revealed two discrete regions of hydrophobic residues,
one at the extreme N-terminus (a signal sequence for extra-cytoplasmic export), and a
C-terminal region that may define the membrane topology of the transpeptidase.
C) In the chromosome of S. sanguinis SK36 srtC is grouped with potential substrates,
SSA_1635, SSA_1634, SSA_1633, and SSA_1632.
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Figure 33.
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SSA_1634 contained a putative pilin motif with the least deviations from the consensus
pattern (259) (Table 9). These results suggest these putative Cwa proteins may undergo
SrtC dependent polymerization in S. sanguinis to form a gram-positive surface pilus, as
has been previously described for other gram-positive species.
Genes encoding sortases have been identified in almost all gram-positive
bacteria (49, 185). Pallen et. al observed that genomes including a sortase enzyme
invariably were predicted to encode at least two, and sometimes many more (199). The
abundance of sortases and multitude of Cwa precursors suggests that sortases act nonredundantly to the benefit these organisms.

Annotation of identified Cwa protein ORFs
BLASTP and CDD searches enabled annotation of predicted S. sanguinis Cwa
proteins. Of the 33 proteins identified, 4 did not have adequate similarity to suggest
homology, nor conserved domains suggestive of protein function, and are described as
hypothetical in Table 10. Proteins described as conserved uncharacterized in Table 10
were detected by MudPIT (described below). The majority of remaining proteins could
be grouped functionally into two groups that are not entirely exclusive; putative
adhesins, or putative enzymes. Putative enzymatic Cwa proteins include SSA_0243,
SSA_1065, SSA_1234, SSA_1591, SSA_1750, and SSA_2023. Proteins with
homology to SSA_0453, and SSA_1591 suggest these proteins may confer both
enzymatic and adhesion properties.

Table 9. Conserved motifs exist in the pilin-like proteins of SK36
Features of the major pilin protein
Strain

Name

CWSSa

Pilin motif

E box

References

C. diphtheriae NCTC13129

SpaA

LPLTGG

WLQDVHVYPK

FCLVETATASGY

(256)

C. diphtheriae NCTC13129

SpaD

LPMTGG

WNYNVVAYPK

FCLKETKAPAGY

(256)

C. diphtheriae NCTC13129

SpaH

LPLTGG

WLYDVNVFPK

YVLVETEAPTGF

(256)

S. pneumoniae TIGR4

RgrB

IPKTGE

DVVDAHVYPK

(13)

E. faecalis V583

EbpA

LPETGG

KYGEIHYAGK

YYLEETKQPAGY
YTLTEVKAPAGH
YVLTETFTPEGY

EbpB

LPKTNE

SLTHIHLYPK

(183)

EbpC

LPSTGG

ELAVVHIYPK

YFLEEISAPKGY
YILEEVKAPNNA
YYLEETVAPDDY

SSA_1634

LPNTGG

YNNDVQVYLK

YKLVETITPKGY

This study

SSA_1633

LPNTGG

AGAGFTLYKK

YKLVESTTPAGY

This study

SSA_1632

LPNTGG

YVQDVKVSSK

YKLVESTVPSGY

This study

SSA_1635

LPETGG
LPXTG

WNFQEYEKPK
WxxxVxVYPK

YALNETLVDNKT
YxLxETxAPxGY

This study

S. sanguinis SK36

Consensus sequenceb

(183)
(183)

a. CWSS, cell wall sorting signal
b. Consensus sequences of the sorting signal (226), gram-positive pilin motif (259), and E box motif (256). Residues
that are highly conserved are indicated by bold lettering (229).
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Cwa proteins with putative enzymatic functions
Putative nucleotide phosphoesterase and 5’ nucleotidase activities were predicted
for two identified Cwa protein ORFs, SSA_0243 and SSA_1234. The B. subtilis YfkN
homolog of SSA_0243 (62 % sequence similarity) has tri-functional nucleotide
phosphoesterase activity (41). The purified YfkN enzyme can release inorganic phosphate
from 2’, 3’ cyclic nucleotide phosphates (cyclic 2’, 3’ NMP), which requires both 2’, 3’
phosphodiesterase activity and 2’ or 3’ nucleotidase activity. YfkN has an additional lesser
activity as a 5’ nucleotidase (41). Both domains conferring these functions to YfkN were
identified in S. sanguinis SSA_0243 (pfam00149: phosphoesterase family including 2’, 3’
CAMP phosphodiesterase, and pfam02872: 5’ nucleotidase C-terminal domain) (156). The
multifunctional enzyme YfkN is supposed to have resulted from fusion of two genes
conferring the separate functions (41).
SSA_1234 is similar (41 %) to the UshA, 5’ nucleotidase of B. cereus (228). This
nucleotidase was previously demonstrated to have 5’, and 3’ nucleotidase and
phosphotransferase activities. However UshA lacks sugar hydrolase and cyclic
phosphodiesterase activities (228). Similar 5’ nucleotidases have been reported for many
gram-negative species including the NucA protein of H. influenzae. One putative
biological role of these proteins is hydrolysis of extracellular nucleotides, and subsequent
intracellular transport of hydrolytic products for use as substrates of cell wall synthesis
(291).
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Table 10. S. sanguinis Cwa protein annotation
S. sanguinis
Gene ID
SSA_0227¤

Gene

Ortholog

Bacterium

SSA_0303¤

sspC

sspA, B

S. gordonii

spaP/pac

S. mutans

pula

S. pyogenes

spuA

S. pneumoniae

Has

S. gordonii
S. gordonii

SSA_0453¤¥

SSA_0805¤
SSA_0829¤

srpA

SSA_0904¤

crpA

cshA

SSA_0905¤
SSA_0906¤

crpB
crpC

cshB

SSA_0956¤

sspD

sspA, B

S. gordonii

vwb1

S. lugdunensis

mrp

S. suis

S. gordonii

SSA_1019¤
SSA_1023¤

SSA_1063¤

Description
Collagen binding domain;
pfam05737 (156)
Antigen I/II, Promotes binding to
collagen, dentinal tubule
invasion(152); coaggregation with
P. gingivalis (153); binding to
sAG (110)
Adherence to sAG; cariogenicity
(52, 152); adherence to fibronectin,
collagen and fibrinogen (14);
bacteremic virulence
Amylopullulanase, hydrolysis of
pullulan and starch at neutral
pH, independent glycoprotein
binding capacity (108)
Immunogenic; pullulan degradation
Collagen binding domain;
pfam05737 (156)
Platelet binding and aggregation
(122, 204); HUVEC invasion (241);
endocarditis virulence (248);
binding to sAG (110)
Adherence to A. naeslundii, S.
oralis and immobilized
fibronectin (169); invasion of
HUVEC cells (241); platelet
adhesion (cshA) (98)
Antigen I/II, Promotes binding to
collagen, dentinal tubule invasion;
coaggregation with P. gingivalis;
binding to sAG
Collagen binding domain;
pfam05737 (156)
Von Willebrand factor (vWf)
binding protein (188)
Immunodominant protein expressed
during S. suis swine infection (252,
283)
Von Willebrand factor type A
domain; cd00198 (156)
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S. sanguinis
Gene ID
SSA_1632¤

Gene

Ortholog
rrgA, rrgB

Bacterium
S. pneumoniae

SSA_1633¤
SSA_1634¤
SSA_1635¤
SSA_1663¤

cbpA

SSA_1666¤
SSA_0243¥

yfkN

B. subtilis

SSA_1234¥

ushA

B. cereus

SSA_1591¤¥
SSA_1750¥

abpB
ssnA

S. gordonii
S. suis

SSA_2023¥

fruA

S. mutans

SSA_0565
SSA_0684

prgA
fibA

E. faecalis
P. micros

SSA_1065¥

SSA_1301
SSA_1112
SSA_0273
SSA_2020
SSA_0167
SSA_0146

Description
Surface pilus locus; in vitro
adherence to A549 epithelial
cells; colonization and virulence in
vivo; proinflammatory response
mediator (13)
Platelet aggregation; endocarditis
virulence; collagen binding domain;
pfam05737 (156)
Collagen binding domain;
pfam05737 (156)
5' nucleotidase, 2', 3'
phosphodiesterase and 2' (or 3')
nucleotidase for reprocessing
extracellular nucleotide phosphates
under restrictive growth; binding to
HA (41)
Beta-hexosaminidase A; glycosyl
hydrolase 3 family NTD
(pfam00933); glycosyl hydrolase 3
family CTD (pfam01915);
extracellular hydrolysis of (1,3 and
1,4) β-D-glucans (156), (267)
Nucleotidase; hydrolysis of 5' and 3'
nucleotides (228)
Dipeptidase (156)
Immunogenic, extracellular
nuclease (74)
Fructan hydrolase; synthesis of
inulin-type β2,1- linked fructose
polymers for extracellular storage
(23); Cariogenicity (32)
Surface exclusion protein (61)
Fibril-like structure subunit, selfaggregation (131)
Conserved uncharacterized
Hypothetical
Hypothetical
Hypothetical
Hypothetical
Hypothetical
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S. sanguinis
Gene ID
SSA_2121

Gene

Ortholog

Bacterium

Description
Conserved uncharacterized

Cwa proteins are grouped by general functions, as putative enzymes (¥), or adhesins (¤).
Proteins lacking sufficient sequence identity by BLASTP analysis are listed as
hypothetical. Previously hypothetical proteins detected by MudPIT are listed as conserved
uncharacterized. Portions of this table were adapted from (285).
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SSA_1750 shares 60 % amino acid sequence similarity with the previously
described extracellular nuclease of S. suis, SsnA, which targets single-stranded, doublestranded and linear DNA for degradation. In S. suis SsnA is cell wall anchored and
prevalent among porcine isolates from internal sites including joints, brain and organs (74).
SsnA is expressed during infection, as has been previously documented for DNA nucleases
produced by GAS, and staphylococci (9, 43, 74). The function of SsnA was determined to
be Ca2+ and Mg2+ dependent (74); similarly the pfam03372 Mg2+ dependent catalytic
domain was identified for SSA_1750 (156). Extracellular nuclease production is elaborated
during lethal murine staphylococcal infection, suggesting nuclease production may be a
virulence mechanism (43). However nuclease production may be more indirect, possibly
for nutrient acquisition at the site of infection or for competition with resident flora, by
degradation of extracellular DNA to impact the transformation capacity of other bacteria.
The SSA_1065 amino acid sequence contains both pfam00933 and pfam01915
(156), which comprise the N-terminal and C-terminal domain, respectively of the family 3
glycosyl hydrolases. The function of family 3 glycosyl hydrolases was previously
described for germination and elongation of barley (Hordem vulgare) in formation of
coleoptiles (267). The exohydrolase enzyme, ExoI of barley is a 2-domain globular protein
that contains a catalytic site for hydrolysis between the two domains, in addition to a
secondary binding site for β1,3 and β1,4 β-D glucans (267). The surface production of
bacterial glycosyl hydrolases is thought to aid the organism in degradation of
environmental oligosaccharides for liberation of a valuable cellular carbon source (46).
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SSA_2023, the FruA (S. mutans) homolog likely serves a similar valuable function
in nutrient acquisition. In S. sanguinis and S. mutans fructan hydrolases generate
extracellular inulin-type polymers composed mainly of β2,1-linked fructose (23). This
function is putatively for storage of extracellular polysaccharide in biofilms that may be
catabolized during nutrient deprivation (83, 100). FruA of S. mutans has the capacity to
release fructose from levan, inulin, and raffinose, and can cleave sucrose to form fructose
and glucose. The expression of FruA is tightly controlled and repressed when S. mutans is
cultured in the presence of hexose sugars (33). Finally, FruA production contributes to
dental caries development in the rat model of this disease (32).
SSA_0453 encodes a putative pullulanase, based on conservation of four highly
conserved regions that form the catalytic domain of pullulanase enzymes. The pullulanase
PulA enzyme of S. pyogenes is also referred to as a “strepadhesin”, since this protein is
associated with binding of S. pyogenes to thyroglobulin, submaxillary mucin, fetuin and
asialofetuin in vitro (108). PulA additionally hydrolyses pullulan and starch at a neutral
pH. The dual properties of this protein led Hytonen and colleagues to suggest that PulA
may not be as important for nutrient acquisition, as for colonization by degrading host
glycoconjugates to reveal specific binding sites. Additional purported functions of PulA
include modification of self cell surface carbohydrates, or cell surfaces of other bacteria
(108).
SSA_1591 encodes a putative dipeptidase (pfam03577) (156), with 60 % protein
sequence similarity to the amylase binding protein B (AbpB) of S. gordonii. (Another S.
sanguinis AbpB homolog, SSA_1593, shares 62 % sequence similarity.) The amylase
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binding capacity of streptococci is critical for colonization of the oral cavity, as only
animals secreting sufficient amounts of salivary α-amylase are colonized by bacteria
capable of binding this protein (224, 253). AbpB has been demonstrated as an important
mediator of rat oral cavity colonization in rats consuming a diet void of sucrose. However,
AbpB was not required for oral colonization in rats consuming a sucrose diet, and the
contribution of AbpB to colonization may be secondary to glucosyltransferase activity
(253). AbpB is also predicted to act as a dipeptidase, though this function has not been
characterized. In general cell surface exposed dipeptidases may mediate the local
extracellular free amino acid concentration and assist in scavenging of proteins around the
cell. Additional contributions may include proteolysis of imported peptides, and general
cell maintenance by assisting in surface protein turnover (84).

Putative S. sanguinis Cwa protein adhesins
Five predicted S. sanguinis Cwa proteins contain the domain mediating collagen
binding of the S. aureus adhesin Cna. Cna of S. aureus is an important virulence factor for
multiple infections attributed to this organism, including infective endocarditis (99, 214).
Cna is an MSCRAMM that contains two major domains, A and B, in addition to features
directing extra-cytoplasmic export and cell wall anchoring. The collagen binding function
has been localized within the A domain (245), and a trench that occurs within this domain
accommodates the collagen triple helix. The A region can be subdivided into three
sequential domains (N1, N2, then N3) that differentially contribute to collagen binding.
Zong and colleagues deduced the “collagen hug” model of Cna binding to collagen (295).

209
The authors described progressive associations with collagen leading to secure
sequestration of the collagen ligand. To summarize, binding is initiated by hydrophobic
interactions between the N1-N2 subdomains and the collagen ligand. The N1 and N2
subdomains then wrap around the collagen triple helix and progressively hug the ligand
until an extension of the N2 subdomain, referred to as “the latch” inserts into a trench on
the N1 subdomain surface, resulting in secure ligand binding (295). Cwa proteins:
SSA_0227, SSA_0805, SSA_1019, SSA_1663, and SSA_1666 are all predicted to contain
an A domain-like region permitting collagen adhesion (pfam05737) (156). Additional
members of the collagen binding MSCRAMM family have been identified in grampositive pathogens including E. faecalis, S. equi, S. mutans, and E. faecium, which contain
a region resembling the N1N2 domain (141, 184, 215, 223). Thus the proposed “collagen
hug” model may be a conserved mode of collagen association in this protein family.
The B domain contains multiple repeats that are not required for collagen adhesion.
Instead the B region is thought to provide flexibility and stability to Cna for projection of
the A region away from the cell surface (53). Only S. sanguinis Cwa proteins containing
pfam05737 were annotated as putative collagen binding proteins; of these SSA_0227,
SSA_1663, and SSA_1666 also include a Cna B domain-like region (pfam05738) (156).
Only the Cna B-like region was identified in Cwa protein SSA_2121; as this region alone
is insufficient for collagen binding, SSA_2121 was not annotated as a collagen binding
protein. The multitude of collagen adhesins predicted for S. sanguinis suggests that this
phenotype is important for colonization and persistence in the oral cavity, and may
contribute to development of IE.
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SSA_1663, annotated as CpbA has also been shown to induce platelet aggregation
(98). Expression of SSA_1663, and putatively the platelet aggregation phenotype attributed
to this protein was demonstrated as a virulence determinant for IE in a past study (96).
The Antigen I/II proteins of oral streptococci are a family of multifunctional
adhesins that promote fitness in the oral cavity. The antigen I/II proteins of S. sanguinis,
SspC and SspD are encoded by SSA_0303, and SSA_0956, respectively. The well
characterized antigen I/II proteins of S. gordonii, SspA and SspB have greater sequence
identity to SspC of S. sanguinis, than SspD. However it remains likely that S. sanguinis
antigen I/II homologs serve distinct functions, as has been described in S. gordonii.
Heterologous expression of SspA and SspB in L. lactis identified exclusive adhesive
characteristics of these proteins. In this heterologous system expression of SspA resulted in
enhanced binding to salivary agglutinin glycoprotein over SspB, whereas expression of
SspB resulted in enhanced adhesion to collagen I and C. albicans (102). Ssp polypeptides
of S. gordonii additionally mediate attachment to A. naeslundii, an organism important in
plaque development, and attachment to the periodontal pathogen, P. gingivalis (55, 136).
In S. gordonii sspA and sspB are clustered at the same genomic locus, with sspA preceding
the sspB gene. Despite this arrangement the genes are differentially expressed in response
to environmental stimuli including pH, temperature and osmolarity (69). In S. sanguinis
sspC and sspD genes are not clustered.
Antigen I/II was first described for S. mutans, in which the SpaP/Pac surface
protein was first considered to be two distinct antigens; however antigen II was later
determined to be a breakdown product of antigen I. This predominant surface protein of S.
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mutans is required for dentinal tubule invasion (as are SspA and SspB of S. gordonii), and
enhanced cariogenicity of this species (52, 152). The SpaP/Pac adhesin additionally
mediates binding of S. mutans to collagen type I, fibronectin and fibrinogen, potentially for
promotion of endodontic infection or adherence to fibrin clots (like those occurring in IE)
(14). The sequence similarity to these previously characterized proteins suggests that SspC
and SspD of S. sanguinis also mediate adhesion phenotypes.
SSA_0829 encodes the previously described serine rich protein, SrpA. SrpA of S.
sanguinis is a glycoprotein that has been shown to associate with the platelet von
Willebrand Factor receptor, glycoprotein Ib, in a sialic acid dependent manner, resulting in
acceleration of platelet aggregation (122, 204). The S. parasanguinis SrpA homolog, Fap1
was required for adhesion to PS and biofilm formation in the presence of glucose (76). An
additional SrpA homolog in S. gordonii, Hsa, was demonstrated to mediate invasion of
HUVEC cells, suggesting a role for this protein in pathogenesis and IE (241). Hsa was
shown to contribute to infectivity in the rat model of IE under competitive conditions
(248). The particular adhesive property attributed to Hsa and related serine rich proteins is
the recognition of sialoglycoconjugates. Binding of this ligand may mediate the multiple
functions described for this protein family to date. The contribution of SrpA of S.
sanguinis to IE was first investigated in the studies described here.
SSA_0904, SSA_0905 and SSA_0906 are homologous to the cell surface
hydrophobicity (Csh) proteins A and B of S. gordonii. CshA and CshB of S. gordonii are
antigenically related high molecular weight polypeptides that comprise fibrillar cell surface
extensions (168). Both CshA and CshB, as their name implies have been shown to infer
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hydrophobicity to S. gordonii, and expression of both proteins was shown to be necessary
for colonization of the murine oral cavity (170). It has also been demonstrated that CshA
and CshB of S. gordonii mediate invasion of HUVEC cells, as well as binding to
fibronectin, and inter-bacterial adhesion with A. naeslundii, and S. oralis (169, 241). A
CshA-related protein of S. sanguinis has also been implicated in aggregation of platelets, a
phenotype correlated with virulence in development of IE (98). The S. sanguinis Cshrelated proteins, SSA_0904, SSA_0905, and SSA_0906 were annotated as Csh-related
protein A (CrpA), B (CrpB), and C (CrpC), respectively. In S. gordonii the cshA and cshB
genes exist at distinct loci. In contrast the Crp encoding genes in S. sanguinis are clustered
at the same locus, with crpA most 5’ and crpC most 3’. Promoter and terminator elements
were predicted for the intergenic regions separating crpA, crpB, and crpC, indicating these
genes may not be co-transcribed. This possibility, in addition to adhesive properties
ascribed to S. sanguinis Crp proteins require further investigation.
The predicted homolog for SSA_1023 is the von Willebrand factor (vWf) binding
protein vWf1 of S. lugdunensis (188). vWf is a large glycoprotein occurring in plasma and
the storage granules of platelets. vWf mediates hemostasis by binding to exposed matrix
molecules, like collagen at sites of vascular endothelium damage to promote subsequent
platelet adhesion and aggregation (221). A repetitive region at the C-terminus of the S.
lugdunensis vWf1 mediates association with vWf. Recurring residues similar to the pattern
identified for vWf1 are in the C-terminus of SSA_1023. vWf1 of S. lugdunensis is
conserved among clinical isolates, suggesting a role for this protein in pathogenesis (188).
Specifically vWf1 interaction with vWf at sites of vascular injury may facilitate
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colonization of vascular lesions in the development of infection. For S. sanguinis and S.
lugdunensis this may be particularly relevant for progression of IE. A similar repetitive
region was identified in the immunodominant, muramidase released protein (Mrp) of S.
suis (188). SSA_1023 homology with Mrp is restricted to the repeats occurring at the Cterminus of the protein. Mrp is expressed during infection; however it is not required for
pathogenesis in porcine infection (236, 252).
A vWf type A domain (cd00198) was identified in SSA_1063 (156). The
implications of having a vWf like structure on the surface of S. sanguinis are numerous,
including enhanced platelet aggregation for colonization of vegetation components or
enlargement of the vegetation, as well as colonization of subendothelial extracellular
matrix proteins. Also, interaction between SSA_1023 and SSA_1063 might promote
aggregation of this species though specific ligand binding. These intriguing possible
attributes of a vWf-like streptococcal surface protein require further investigation.
SSA_1632, SSA_1633, SSA_1634, and SSA_1635 were described above in
reference to their putative cognitive sortase, SrtC (SSA_1631). The S. pneumoniae grampositive surface pilus was previously characterized (13). As in S. sanguinis, the
pneumococcal pilin subunit genes, rrgA, rrgB, and rrgC are clustered with sortase
enzymes mediating assembly of the pilus structure. Expression of this locus was associated
with colonization of A549 lung epithelial cells, as well as competitive colonization of the
murine respiratory tract. Expression of the surface pilus was shown to elicit a robust
inflammatory response in challenged mice, suggesting that this surface structure has a
profound impact on the severity of disease and the host response to infection (13).
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Similarly, gram-positive pilus structures described for GBS elicit a protective response
against re-infection (144). The E. faecalis endocarditis- and biofilm-related pilus locus
encodes a surface pilus and pilus related sortase (Bps), and is a determinant of E. faecalis
biofilm formation and virulence in vivo (121, 183). The contribution of a putative S.
sanguinis surface pilus in IE had not been investigated prior to this study.
SSA_0565 is annotated as a conserved hypothetical protein in GenBank; however
the protein sequence has 26 % identity and 42 % similarity to Sec10 of E. faecalis. In E.
faecalis Sec10 (also referred to as PrgA) is encoded by pCF10-borne prgA. The
components of pCF10 mediate gene transfer via pheromone inducible conjugative
plasmids (119). This event requires aggregation of donor (pCF10 encoding) and recipient
cells in liquid culture. The aggregation substance mediating mating aggregate formation
for genetic transfer, Asc10 (also referred to as PrgB) is also encoded on pCF10 (195).
Sec10 acts to promote genetic transfer to naïve cells by preventing conjugation between
donor cells (61). E. faecalis cell surface exposure of both Sec10 and Asc10 has been
demonstrated by SEM (194). Conjugative plasmids are not part of the genome of S.
sanguinis SK36; however the genetically competent Streptococcus may be capable of
DNA acquisition by this mechanism. If SSA_0565 has a similar function to Sec10, this
ORF may be a remnant of a past conjugative event. In the case of E. faecalis conjugative
plasmids are of clinical significance due to their role in dissemination of antibiotic
resistance cassettes; pCF10 confers tetracycline resistance to recipient cells (60).
A BLASTP search for homologs of SSA_0684 resulted in positive hits for an S.
pneumoniae FibA subunit-like protein (GI:147930705) (33 % ID, 49 % similarity in
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residues 766 – 1082 of SSA_0684), and the FibA-subunit of the fibril-like surface structure
of Peptostreptococcus micros (GI:4106521) (29 % ID, 39 % similarity in residues 500 –
800 of SSA_0684). P. micros is one of the causative agents of periodontal disease (87).
Two morphology types have been described for P. micros, a smooth and a rough type
(265). The rough type morphology is determined by production of FibA-containing
fimbriae (131). Interestingly, the rough type variants switch to the smooth morphology
when cultured in vitro (130). However, both variants produce abscess formation in a
murine skin model, and both have been isolated from periodontal patients (129, 264).
Differences between SSA_0684 and FibA occur at the extreme C-terminus of the
protein, in the region determining cell surface association. Specifically, the Cp1 family
sequence repeats reported for the extreme C-terminus of the 393 aa FibA protein are not
conserved in SSA_0684 (273). These repeats are thought to confer carbohydrate binding
capabilities to the protein, and in the case of S. pneumoniae PspA, this region is involved
in anchoring of the proteins to lipoteichoic acid in a choline-mediated interaction (273,
290). The lack of conservation of this region is unsurprising given the identification of an
LPXTG pattern at the C-terminus of SSA_0684. Similarity to the remainder of FibA
suggests the proteins may share other functional properties that remain to be determined.

Detection of S. sanguinis Cwa proteins by MudPIT
Multidimensional protein identification technology (MudPIT) was used for
detection of S. sanguinis proteins in two cellular fractions, a mutanolysin released cell wall
associated protein fraction, and the remaining protoplast fraction. The MudPIT technique
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requires proteolytic digestion of the protein pool into fragments that are separated by
strong cation exchange chromatography followed by reverse phase chromatography. The
peptides are then subjected to tandem mass spectrometry MS, for determination of the
mass-to-charge ratio of each fragment. Peptide information derived is searched against an
in silico proteolytic digestion database of predicted ORFs to identify actual ORFs detected.
The MudPIT analysis was performed with the assistance of Dr. Patricio Manque of the
Center for the Study of Biological Complexity at Virginia Commonwealth University.
Fourteen of the predicted S. sanguinis Cwa proteins ORFs were detected by
MudPIT technology (Table 11). Detection of the hypothetical protein SSA_1301 in both
protoplast and cell wall (mutanolysin released) fractions, and the hypothetical protein
SSA_2121 in the cell wall associated fraction resulted in reclassification of these ORFs as
conserved uncharacterized (reflected in Table 10). Antigen I/II homologs SspC and SspD
(SSA_0303, and SSA_0956, respectively) were both detected in the cell wall and
protoplast fraction suggesting that these proteins were abundant in the cell at the time of
sampling for MudPIT analysis. Proteins containing the collagen binding domain
pfam05737 (156) were also detected as being simultaneously present. CbpA (SSA_1663)
and SSA_0805 were detected in the cell wall associated fraction, whereas SSA_1019 was
detected in the protoplast fraction. SSA_1023, which shares homology with the S.
lugdunensis vWf1, and S. suis Mrp was detected in the cell wall fraction. The CshA related
proteins, CrpC (SSA_0906) and CrpA (SSA_0904) were both detected as being abundant
in the experiment. As for cell wall associated enzymes of S. sanguinis SK36, both
SSA_0243 (the putative cyclo-nucleotide phosphodiesterase), and SSA_1065 (putative
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Table 11. Detection of S. sanguinis Cwa proteins by MudPIT
S. sanguinis (Ss) Cwa proteins detected as abundant by MudPIT analysis of cell wallassociated proteins and protoplast proteins are described. The E-value given for each
protein reflects the probability that the protein was identified incorrectly. A smaller Evalue reflects a decreased probability that the protein was identified erroneously (cutoff
1.00E+00). Proteins not listed may have been expressed under the condition tested, but the
protein abundance may be under the limit of detection.
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Table 11.

Ss ORF

Description

SSA_1666
SSA_0805
SSA_1019
SSA_1632
SSA_0956
SSA_0303
SSA_1023
SSA_0904
SSA_0906
SSA_0684
SSA_1234
SSA_1065
SSA_0243
SSA_2121
SSA_1301

Collagen binding domain; pfam05737
Collagen binding domain; pfam05737
Collagen binding domain; pfam05737
Putative pilin subunit
SspD
SspC
Von-Willebrand factor binding protein
CrpA
CrpC
FibA fibril subunit-like protein
5' Nucleotidase
Beta hexosaminidase-like protein
Cyclo-nucleotide phosphodiesterase
Conserved uncharacterized
Conserved uncharacterized

Protoplast

Cell wall
7.56E-05
6.50E-06

1.00E+00
1.00E+00

1.00E+00
5.24E-03
7.41E-03
2.03E-03
6.37E-04
1.26E-05

2.69E-08
4.52E-03
6.89E-09
1.38E-03
1.60E-06
1.07E-04
8.56E-06
1.00E-02
1.52E-04
1.95E-09
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beta-hexosaminidase) were detected in the protoplast fraction. SSA_0243 was also
detected in the cell wall fraction. That additional predicted Cwa proteins were not detected
does not exclude the possibility of their expression or presence at the time of protein
fractionation. This method is particularly sensitive to the concentration of the protein
mixture analyzed, proper denaturation of proteins prior to digestion, and detection of
proteins that are abundant in the sample.

In vitro transposition to create an STM mutant pool
The 31 predicted cell wall-associated protein encoding ORFs, and 3 sortase-like
ORFs described above were subjected to in vitro transposition. Each ORF was PCR
amplified to create a 2.5 kb product, which was subsequently used as a target for in vitro
transposition with the pJFP1 encoded magellan2 mini-transposon containing a unique
signature tag. The target amplicon size of 2.5 kb was of conscious design based on
previous experiments in the lab indicating that regions of homology ≥ 1kb flanking nonconsensus sequence yield greater transformation efficiency (Dr. Todd Kitten, personal
communication). With this in mind, primers used for target gene amplification were
designed with the preferred insertion site roughly equidistant from either end of the
amplicon. Following end-filling and ligation reactions, transposition products were
transformed into S. sanguinis SK36. A diagnostic PCR reaction coupling ORF-specific
flanking primers (up or dn) with a transposon inverted repeat primer (Mout) was used to
estimate the site of transposon insertion site in Cmr transformants. Among the clones
screened those with predicted insertion within the ORF, close to the 5’ end of the ORF
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were selected for further studies. The estimated insertion site for each ORF targeted, as
well as the signature tag used is indicated in Table 12. The accuracy of diagnostic PCR for
prediction of the transposon insertion location was tested for 7 STM mutants. In all strains
analyzed DNA sequencing confirmed that transposon insertion occurred very close to, if
not within the predicted interval obtained from diagnostic PCR (Table 12).
The signature tags used in mutant generation were prescreened by Todd Kitten for
consistent and specific DNA hybridization. For simplicity each of the 40 tags approved for
mutagenic application were assigned a number between 1 and 40. STM mutant strain
designations reflect the signature tag number employed, as well as whether the target ORF
coded for a Cwa protein (CWA), or a sortase enzyme (SRT).
Successfully mutagenesis of all 34 predicted proteins by the directed STM
technique resulted in the creation of a 34-strain mutant library.

In vivo screening of the STM pool
In previously described pilot studies the rabbit model of IE was optimized for
evaluation of S. sanguinis virulence factors (198). This model of infection was superior to
the rat model of IE (179, 180) due to apparent bottlenecking during STM trials in the rat
model, not observed in the rabbit model (198). The S. sanguinis inoculum size was also
previously optimized for the rabbit model. In three inocula tested, 2 x 108, 2 x 109, and 2 x
1010 CFUs, the highest inoculum proved lethal within 24 hours of injection, whereas the
other two inoculum sizes had no effect on the observed results. All doses of bacteria
administered resulted in infection, and reproducible recovery as detected by dot blot

221

Table 12. Estimation of mini-transposon insertion location
For each predicted Cwa protein or sortase ORF in vitro transposition was performed with a
different magellan2 mini-transposon incorporated signature tag (signature tag #).
Following transformation of transposition products, PCR amplification of cells from Cmr
transformants was used for estimation of the transposon insertion site. Mutants were
chosen for in vivo testing based on the presence of the transposon insertion within the gene
of interest and its proximity to the start of the ORF, with preference given to mutants with
interruption closer to the beginning of the gene. The estimated distance between the
transposon insertion site and the start site of the gene is indicated for each selected mutant.
For several mutants, the actual insertion site was determined by DNA sequencing. PCR
estimation was quite accurate, with the actual site of insertion very close to, if not within
the predicted interval.
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Table 12.

SSA gene #
SSA_1112
SSA_2023
SSA_1663
SSA_1591
SSA_0805
SSA_1634
SSA_1633
SSA_1632
SSA_0956
SSA_0227
SSA_0565
SSA_1301
SSA_0303
SSA_0273
SSA_1023
SSA_1019
SSA_1631
SSA_0905
SSA_0906
SSA_1219
SSA_0684
SSA_1234
SSA_0022
SSA_1063
SSA_2020
SSA_0167
SSA_0146
SSA_0453
SSA_1666
SSA_1065
SSA_0904
SSA_1750
SSA_2121
SSA_0243

Signature Tag #
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
33
34
38
40

ORF size (bp)
1575
4215
4533
2046
1674
1458
1437
1437
4113
2081
2583
2559
4518
1413
2673
2382
885
5898
8007
753
3819
2424
840
1350
3105
999
2391
3699
1935
2790
8970
2247
4683
2409

Estimated site
413 - 445
879 - 916
924 - 935
549 - 600
183 - 369
187 - 234
376 - 477
380 - 425
327 - 333
1065 - 1081
452 - 490
87 - 181
445 - 480
196 - 204
883 - 894
394 - 535
512 - 567
1114 - 1157
1223 - 1254
175 - 279
366 - 412
401 - 414
416 - 489
318 - 372
808 - 853
311 - 397
196 - 237
365 - 435
560 - 579
835 - 885
824 - 869
417 - 510
322 - 362
364 - 400

Actual site

923
190

1085
478
113

485

569
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hybridization (198). In the STM screens described below the inoculum administered
ranged from 1 x 107 CFUs to 2 x 108 CFUs.
Three independent in vivo screens were conducted for analysis of the STM mutant
pool. Each strain was tested in at least two independent experiments, in at least three
rabbits in each experiment. The dot blot DNA hybridization technique used for detection
of strains inoculated into the rabbits (the input pool), and strains recovered from the rabbits
(the output pool) is depicted in Figure 30. Figure 34 presents a summary of strains tested in
each experiment, and the results obtained. The first STM experiment was conducted with a
portion of the strains composing the final, complete pool. The pool tested included
previously unevaluated strains CWA4, CWA9, CWA10, CWA12, CWA13, CWA14 and
CWA15. Dot blot hybridization confirmed the recovery of STM mutants CWA4, CWA10,
CWA13 and CWA9, suggesting that ORFs mutagenized in these strains are not essential in
the rabbit model of IE. The competitiveness of CWA15 was difficult to determine, as
detection of this strain among recovery pools was inconsistent (data not shown). CWA12
displayed a strong signal in the input pool, yet weak signal in the recovery pools,
suggesting that this strain did not survive negative selection in vivo.
The next STM in vivo analysis was conducted using the entire 34 strain mutant
pool. Of the five rabbits tested in this experiment two had shorter infection duration than
others, as a result of apparent animal duress. The study was carried to 20 hours postinoculation for the remaining rabbits. Despite shorter duration of infection in two of the
rabbits, the hybridization patterns of these rabbits were consistent with those experiencing
20 hours of infection. Unfortunately the interpretation of results was confounded by
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variability in signature-tag hybridization observed for the input pool dot blot. Because
conclusiveness is dependent on presence of the strain in the inoculum, definitive results
were obtained only for strains exhibiting a strong signal on the input blot (data not shown).
Strains retaining virulence are indicated in Figure 34.
Results representative of the final independent experiment, in which the entire
mutant pool was screened, are shown in Figure 35. Bacterial recovery from one of the
three rabbits tested was below the range yielding reproducible results; therefore only
results from rabbits with higher recoveries are included. The input blot of this experiment
showed minimal variability with high signature-tag chemiluminescent signal intensity of
signature tags for the majority of strains analyzed. Likewise, the majority of strains tested
were recovered, indicated by the strong chemiluminescence observed in the output blots.
Of 34 mutants screened, 29 retained virulence as detected by signature-tag hybridization
(Figure 34).
Relative comparison to the negative control pJFP1 signature tags (‘N’, Fig. 35)
highlights differences among strains. For example, signature tag 12, representing strain
CWA12 exhibited stronger signal intensity in the input blot, but negative control signal
intensity in the recovery blots. That this tag was not detected in the recovery pool
suggested that this strain did not survive negative selection in vivo. Results for four strains,
SRT21, SRT24, CWA15 and CWA30 were inconclusive due to low signal intensity of
signature-tag hybridization on the input pool membrane.
An in vitro growth study performed in conjunction with the animal study suggests
that poor detection is not entirely reflective of reduced growth in vitro (Fig. 36).
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Figure 34. Summary of STM screen results

S. sanguinis ORF
SSA_1112
SSA_2023
SSA_1663
SSA_1591
SSA_0805
SSA_1634
SSA_1633
SSA_1632
SSA_0956
SSA_0227
SSA_0565
SSA_1301
SSA_0303
SSA_0273
SSA_1023
SSA_1019
SSA_1631
SSA_0905
SSA_0906
SSA_1219
SSA_0684
SSA_1234
SSA_0022
SSA_1063
SSA_2020
SSA_0167
SSA_0146
SSA_0453
SSA_1666
SSA_1065
SSA_0904
SSA_1750
SSA_2121
SSA_0243

STM Experiment
1
2
3
Tag
1
ND
●
●
2
ND
●
●
3
ND
●
●
4
●
●
●
5
ND
◘
●
6
ND
●
●
7
ND
●
●
8
ND
●
●
9
●
◘
●
10
●
●
●
11
ND
●
●
12
○
◘
○
13
●
●
●
14
●
●
●
15
◘
◘
◘
16
ND
●
●
18
ND
●
●
19
ND
◘
●
20
ND
●
●
21
ND
◘
◘
22
ND
●
●
23
ND
●
●
24
ND
◘
◘
25
ND
◘
●
26
ND
●
●
27
ND
●
●
28
ND
●
●
29
ND
●
●
30
ND
◘
◘
31
ND
●
●
33
ND
◘
●
34
ND
●
●
38
ND
●
●
40
ND
●
●

Key:
ND Not determined
● Competitive
◘ Inconclusive
○ Not competitive
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Figure 35. Representative dot blot hybridization results
A) The layout of STM-plasmid containing membranes is shown. Each number represents a
Cwa protein mutant bearing that unique signature tag. Tags not used for mutation are
negative controls (N), and are indicated by purple boxes.
B) Actual hybridization results are shown for the input pool (at the left), and output pools
of bacteria recovered from rabbits. The presence of a strain is indicated by strong
chemiluminescent signal intensity. Low signal intensity indicates diminished presence of a
strain or poor hybridization for other reasons. Purple boxes indicate background signal
intensity of negative control plasmid DNA.
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Figure 35.

A. STM dot blot layout:
1

9

N 25 33

2 10 18 26 34
3 11 19 27 N
4 12 20 28 N
5 13 21 29 N
6 14 22 30 38
7 15 23 31 N
8 16 24 N 40

B. Hybridization results:
Input

Output 1

Output 2
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Figure 36. In vitro growth of STM strains
STM strains were grown in vitro overnight concurrent with the third rabbit experiment.
Strains retaining competitiveness in vivo are in gray symbols. Strains requiring further
analysis, due to apparent avirulence, CWA12, or poor signal intensity in the inoculum,
CWA15, SRT21, SRT24, and CWA30 are indicated by colored symbols. Each strain is
indicated by its signature-tag number.
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Figure 36.
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Strains CWA15, CWA24 and CWA30 grew comparably to the parental strain SK36,
whereas SRT21 grew more slowly than wild-type. An alternate explanation for low signal
intensity in the input blot is degradation of signature tag DNA impeded DNA:DNA
hybridization required for detection. To eliminate this complication strains yielding
inconclusive results were further analyzed by competitive index assays.

Re-evaluation of STM strain stability without antibiotic selection
Before further testing of STM mutants we wanted to establish stability of the
mutation without antibiotic selection of the transposon. Cells harvested from overnight
cultures of each STM strain in BHI (no antibiotic) were used as template in PCR. The
region of transposon insertion in each strain was PCR amplified by specific primers 5’ and
3’ to the ORF interrupted (Appendix B). The presence of the transposon was suggested by
the size of the PCR product obtained. Maintenance of the transposon results in an amplicon
of 3.5 to 4 kb, whereas absence of the transposon is indicated by a smaller band of 2 to 2.5
kb. For all strains evaluated, a larger band of ~3.5 to 4.0 kb was detected which represents
the ORF containing the transposon. For CWA11, CWA12, CWA14 and SRT21 an
additional smaller band of was observed (data not shown). The double band pattern
observed in these strains may be attributed to non-specificity of primers used, or the
presence of more than one genotype. To confirm these results four colonies of strains
CWA11, CWA12, CWA14 and SRT21 grown in the presence of Cm were subsequently
cultured in liquid BHI with Cm overnight. The stationary phase cells were then
subcultured in BHI without Cm for a second overnight period. Cells were harvested from
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the plus and minus Cm conditions and used as template for PCR, as described above. The
two conditions tested would indicate the dominant allele in the presence and absence of
antibiotic selective pressure. PCR products observed for CWA11, CWA12, and CWA14
were identical in the presence and absence of antibiotic (Fig. 37A and 37B), thus
confirming the stability of the mutant allele without Cm selection. However the mutant
allele was not detected for strain SRT21 in the absence of Cm (Fig. 37B). To correlate
these findings with animal experiment data the strains CWA11 and CWA14, with
signature-tags 11 and 14, respectively, exhibited strong DNA hybridization signal intensity
in both input and output blots (Fig. 35B). CWA12, with signature-tag 12 showed strong
signal intensity in the input blot, but not in output blots (Fig. 35B). Transposon
maintenance in strain CWA12 independent of Cm selection suggests that low signal
intensity of this strain following in vivo competition is cannot be attributed to genotypic
changes in this strain. In contrast the apparent loss of the mutant allele in SRT21 could
explain the poor dot blot hybridization observed for this strain during in vivo screening
(Fig. 35B, tag 21). For STM screening strains were cultured in vitro without antibiotic for
3 hours prior to inoculation, which could provide adequate time for out-growth of the
strain lacking the selective marker.
To address this issue a new srtA mutant was developed in the SK36 genetic
background. A gene SOEing construct was designed for insertion of aad9 of pR412
between the first 29, and last 23 codons of srtA, to couple the deletion of srtA with the
insertion of a selective marker. The inconclusive in vivo results obtained for another
sortase STM mutant, SRT24 led to the decision to generate a novel srtB mutant as well.
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Figure 37. Detection of the transposon in the absence of Cm selection
Four colonies (1 to 4) of S. sanguinis strains CWA11, CWA12, CWA14 and SRT21 were
analyzed by PCR product size determination for the presence of the transposon in strains
cultured in the presence of Cm (selective for the transposon) (A). Stationary phase cells in
BHI containing Cm were subcultured in the absence of Cm (B). Sizes of PCR products for
CWA11, CWA12, and CWA14 were similar (~ 4 kb in size) in the presence and absence
of selective antibiotic (A and B), indicating the presence of the transposon in these strains
under both growth conditions. In contrast, a smaller dominant band (~ 2 kb) is observed for
SRT21 after growth in Cm overnight (A), which becomes the only observable band
following subculture in BHI without Cm (B). The amplicon size expected for
srtA::magellan2 was 3.459 kb, the anticipated amplicon for WT srtA was 2.077 kb.
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Figure 37.

A. PCR amplification of strains from BHI with Cm

B. PCR amplification of strains from BHI
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Gene SOEing was used to create a mutant construct by insertion of the kanamycin
resistance cassette kan between the fist 27 and last 16 codons of srtB, thus combining
deletion of srtB with the insertion of a selective marker for kanamycin resistance. S.
sanguinis SK36 was transformed with the gene SOEing mutagenic constructs, and
transformants selected by spectinomycin or kanamycin resistance conferred by mutation of
srtA or srtB, respectively. The resulting srtA mutant was designated JFP42, and the srtB
mutant designated JFP44.

Competitive index studies
Dot blot hybridization qualitatively differentiated between STM mutants that
retained competitiveness in the rabbit model of IE, a single putatively uncompetitive strain
(CWA12), and strains of inconclusive competitiveness (CWA15, CWA30, SRT21 and
SRT24). These results are merely suggestive of exploitive vs. underrepresented strains, and
relative attenuation for particular strains is difficult to determine. A competitive index (CI)
assay was used to assign a quantitative value to the competitiveness of CWA strains
requiring further testing. The previously described Emr derivative of SK36, JFP36
(Chapter IV) was used as the competitive control strain in these experiments. In the CI
algorithm the ratio of mutant/control strain CFUs recovered from rabbits is divided by the
ratio of mutant/control strain CFUs administered to rabbits. A CI value of 1 indicated equal
competitiveness between the mutant and WT control. A CI value less than one indicated
reduced competitiveness of the mutant vs. the WT control. A CI value greater than one
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suggests that mutant competitiveness exceeds that of the WT control. Statistical analyses
were then applied to determine whether the difference in competitiveness was significant
CI analysis of CWA12
To determine the competitiveness of CWA12 relative to the virulent control,
JFP36, the two strains were co-inoculated into three catheterized rabbits in two
independent studies. Contrary to preliminary evidence from dot blot hybridization
implicating CWA12 as a noncompetitive strain, the mean competitive index value obtained
for this strain relative to JFP36 was 0.959 (Fig. 38). Therefore CWA12 was equally
competitive to the control strain. The conflicting results from these assays may be
attributed to reduced plating efficiency of this strain as a function of increased chain
length. In dot blot hybridization, signature tag probes are developed from strains in liquid
culture for the input pool, vs. in vivo recovered colonies subsequently sub-cultured in
liquid media for the output pool. If a strain exhibits a poor plating efficiency (forms fewer
colonies) at the same optical density as other strains, then it may be construed that the
strain is not present, or is diminished in the pool. The design of the CI study would account
for differences in plating efficiency of strains, as the ratios of CFUs of strains both
inoculated into and recovered from rabbits are compared. When viewed by phase contrast
microscopy early stationary phase cultured CWA12 formed much longer chains that the
competitive control, JFP36. In addition CWA12 formed roughly 0.5 colonies for every 1
colony of JFP36 at an equal optical density of 0.8. That dot blot hybridization is
sufficiently sensitive to detect and translate this difference is very encouraging. Our
findings from the CI assay, coupled to observations regarding chain length and plating
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efficiency of CWA12 confirm that expression of the ORF mutated in CWA12 is not
required for full competitiveness in vivo.
CI analysis of CWA15
The competitiveness of CWA15 relative to JFP36 was tested in three rabbits
between two CI experiments. The two strains were co-inoculated into catheterized rabbits,
with competitiveness assessed 20 hours later. In contrast to the inconclusiveness of dot blot
hybridization results, the CI assay definitively showed CWA15 to be significantly more
competitive than JFP36 in vivo, with a mean CI value of 1.547 (Fig. 38). This result
suggests the ORF interrupted in CWA15, SSA_1023, is not required for full
competitiveness, and in fact expression of SSA_1023 may impede competitiveness in
experimental early infective endocarditis.
CI Analysis of CWA30
Inconclusiveness of CWA30 in the initial STM screen prompted further
investigation of this strain in a CI assay. A CWA30 and JFP36 co-inoculum was tested in
two rabbits in a single animal trial. The mean CI value obtained for CWA30, 1.120
suggests that expression of SSA_1666, the putative Cwa protein ORF mutated in this strain,
does not contribute to competitiveness in vivo (Fig. 38). SSA_1666 was annotated as a
putative collagen binding protein, based on identification of conserved domains of the Cna
collagen binding protein of S. aureus, pfam 05737 and 05738 (156). At least four
additional putative collagen adhesins and homologs of two characterized collagen adhesins
have been identified in S. sanguinis SK36. The abundance of Cna-like proteins of S.
sanguinis suggests that collagen adhesion is important for fitness in the oral niche.
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Figure 38. CI analysis of S. sanguinis SK36 derivatives
CI comparisons were performed for S. sanguinis STM mutants, CWA12, CWA15, and
CWA30 relative to the Emr competitive control JFP36. Isogenic derivatives of SK36,
JFP44 and JFP42 were also compared to JFP36. Competitiveness of the srpA mutant
VT1614 was determined relative to SK36. The scatterplot includes the CI calculated for
each animal (symbol), and the mean CI value for the mutant (bar). The dotted line at a CI
of one represents the CI value for equal competitiveness. The STM strain CWA15 was
significantly more competitive than JFP36 (*= P = 0.0421). The srtA mutant JFP42 was
significantly less competitive than JFP36 (**= P < 0.0001). The table includes the CI
phenotype for each strain, a description of the mutagenized ORF, the mean CI value for
each strain, and the range of CI values obtained.
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Figure 38.

CI Value

10

*

1

**

0.1

0.01
CWA12 CWA15 CWA30 VT1614 JFP44

JFP42

S. sanguinis

Mutant
CWA12
CWA15
CWA30

Phenotype
Competitive
Hyper-competitive
Competitive

VT1614
JFP44
JFP42

Competitive
Competitive
Noncompetitive

Description ORF
Conserved Uncharacterized
FibA/MRP-like
Collagen binding domain
(pfam05737)
SrpA
SrtB
SrtA

Mean CI (Range)
0.959 (0.63 - 2.03)
1.547 (1.28 - 1.69)
1.120 (1.04 - 1.20)
1.588 (1.15 - 2.12)
1.011 (0.91 - 1.21)
0.167 (0.05 - 0.27)
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Whether this phenotype correlates with development of infective endocarditis has yet to be
tested. One complication of such a study would be the abundance of proteins mediating
such an interaction, and likelihood of functional redundancy among these proteins.
CI analysis of VT1614
To determine the contribution of SrpA in competitiveness in vivo a previously
described isogenic srpA mutant of SK36, VT1614 (204) was compared to the parental
strain in three rabbits in a single CI experiment. At twenty hours of infection bacteria were
recovered and plated to determine the CI value of VT1614. The mean CI value for
VT1614, 1.58 demonstrates that mutation of srpA does not negatively affect
competitiveness in vivo (Fig. 38). This is particularly interesting given evidence that the S.
gordonii SrpA homolog, Hsa contributes to competitiveness in the rat model of IE (248).
However, the previous evaluation did not account for the number of CFUs administered by
computation of a CI value; instead only recovery was expressed as CFUs/mg vegetation.
CI analysis of JFP44
The SSA_0022, srtB homolog mutant, JFP44 was compared to JFP36 in three
rabbits in a single CI experiment. The mean CI derived for JFP44, 1.02, confirms that
expression of srtB is not required for early infective endocarditis (Fig. 38). The wild-type
competitiveness exhibited by JFP44 suggests that proper cell localization of the unknown
SrtB transpeptidase substrate(s) is not required for the onset of disease.
CI analysis of JFP42
Initial competitive index analysis of the srtA mutant JFP42 in three rabbits revealed
the strain to be significantly less competitive that the competitive control strain, JFP36
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with a mean CI value of 0.07 (P= 0.0061). This experiment was repeated in two additional
independent experiments with three rabbits each. The subsequent studies confirmed that
JFP42 showed a significant reduction in competitiveness, with an overall mean CI value of
0.167 (P < 0.0001) (Fig. 38). The competitive phenotype of this mutant suggests the
expression of srtA is required for full competitiveness in vivo. SrtA is likely the major,
housekeeping sortase in S. sanguinis, responsible for anchoring the majority of Cwa
proteins. The observed decrease in competitiveness for JFP42 in conjunction with results
from the comprehensive analysis of S. sanguinis Cwa proteins suggests that development
of S. sanguinis IE is a multi-factorial process mediated by more than one Cwa protein
dependent on SrtA.

In vitro CI comparison of JFP42 and JFP36
An in vitro CI assay was used to determine whether JFP42 exhibited a general
growth defect in vitro owing to mutation of srtA. A mutant with a general growth defect
would be expected to perform less well in a CI assay, and this experiment would indicate
whether the described in vivo findings were attributed to attenuated growth rather than
reduced colonization efficiency or virulence. For this experiment strains were adjusted to
an equal optical density and then co-cultured for the typical infection duration (~20 hours).
The in vitro CI value was derived by comparing CFUs of strains prior to co-culture to
CFUs following co-culture. The mean in vitro CI value obtained for JFP42 vs. JFP36 from
five independent experiments was 0.58. If co-culture had no effect on growth as
determined by CFUs, a mean CI value of 1.0 would be expected. As 0.58 (range: 0. 2 –
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1.302) is less than 1.0, it appears that JFP42 exhibits a slight growth defect in vitro during
co-culture with JFP36. However the CI value is not significantly different from a value of
equal competitiveness (P= 0.2185), and it is unlikely this in vitro effect accounts for the
reduced CI value for JFP42 in vivo. While this type of assay indicates strain-specific
growth deficiencies, it does not replicate the selective pressures encountered by strains
during infection.

Individual inoculum comparison of JFP42 and SK36
One possible complication of co-inoculation of strain in the CI assay is phenotypic
complementation of the mutant by the presence of the WT strain. For example, if a mutant
is capable of adhering to the WT strain (i.e. piggybacking), then it would benefit from
adhesins required for colonization of the vegetation expressed by the wild-type. Also,
secreted proteins from the WT strain might also prove advantageous to the mutant during
co-infection. The possibility of complementation was examined by single-strain infections.
Four catheterized rabbits each were inoculated with JFP42 or SK36, and recovery
of bacteria was assessed 20 hours later. In our hands vegetation size is often an indicator of
bacterial recovery, with larger recoveries yielding more reliable results obtained from
larger vegetations. To control for differences in the size of vegetations recovered, CFUs
were normalized by vegetation weight.
In this study four rabbits received 1.84 x 108 CFUs of JFP42, and four rabbits
received 6.55 x 107 CFUs of SK36. The mean recovery for rabbits receiving JFP42 was
8.69 log CFU/g vegetation. The mean recovery for rabbits receiving SK36 was 9.03 log
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CFU/g vegetation (Fig. 39). The difference in recovery between the two rabbits was not
significant (P= 0.1036), and therefore virulence of JFP42 is similar to SK36 when
monitored 20 hours after infection. This is in contrast to CI studies in which JFP42 was
significantly less competitive. The actual defect for JFP42 may be in competitive
colonization of the vegetation, as it is apparent that in the absence of competition JFP42
can develop an infection similar to wild-type. An alternative possibility is that JFP42 is
attenuated for vegetation colonization, yet grows to levels similar to wild-type in the
intervening period between colonization and termination of the experiment.
In an in vivo experiment of shortened infection duration (2 hours) we examined
whether JFP42 exhibited attenuated colonization of the vegetation in the absence of a
competitor. Four catheterized rabbits received 1.35 x 107 CFUs JFP42, and four
catheterized rabbits received 2 x 107 CFUs SK36. Two hours later the infection was
terminated, and recovered bacteria were normalized to the vegetation weight collected. At
two hours of infection the mean recovery for JFP42 was 3.03 log CFU/g vegetation (range:
2.7 – 3.68 log CFU/g). The mean recovery was greater for SK36, 4.314 log CFU/g
vegetation (range: 3.47 – 5.3 log CFU/g) (Fig. 39). This difference is statistically
significant (P= 0.0422), and suggests that JFP42 is attenuated for colonization of the
vegetation relative to the parental strain, SK36. This deficiency is likely exacerbated when
JFP42 is competed against a control in an experiment requiring co-inoculation of bacteria.
In this scenario the control with an arsenal of Cwa proteins lacking in the srtA mutant
would be better suited for adherence to or association with vegetation components in the
colonization process and would readily out-compete a strain lacking these determinants.
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Figure 39. Individual inoculum comparison of JFP42 and SK36
Catheterized rabbits received a single strain inoculum of JFP42 or SK36 and infection
proceeded for 20 or 2 hours prior to recovery of bacteria. CFUs obtained were adjusted by
the gram vegetation weight recovered. At 20 hours the difference in the mean log CFU/g
vegetation recovered from rabbits receiving JFP42 vs. SK36 was not quite significant (P =
0.1036). In contrast, at two hours post-infection significantly more CFUs were recovered
from rabbits receiving SK36 than rabbits receiving JFP42 (*= P= 0.0422).
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Evaluation of S. sanguinis sortase mutant biofilm formation
A semi-quantitative static biofilm formation assay was used to determine the
contribution of S. sanguinis Cwa proteins to biofilm formation. Sortase mutant derivatives
of S. sanguinis SK36; JFP42, JFP44, and SRT18, were compared to the parental strain and
wild-type competitive control, JFP36. The srpA isogenic mutant of SK36, VT1614 was
used as a negative control in this experiment (204). The S. parasanguinis SrpA homolog,
Fap1 was previously shown to be required for wild-type biofilm formation in the presence
of 1 % glucose (76). Biofilm formation was measured in the wells of PS plates following
20 hours of static culture in BM supplemented with 1 % sucrose or 1 % glucose.
When cultured in the presence of glucose, biofilm formation as quantified by CV
staining was similar for SK36 and its Emr competitive derivative, JFP36. VT1614 was
most attenuated for biofilm formation (P < 0.001) relative to wild-type (Fig. 40A). The
srtA mutant JFP42 also exhibited a significant reduction in biofilm formation, though the
amount of biofilm detected for JFP42 exceeded that for VT1614. Biofilm formation of the
srtC STM mutant, SRT18 was also significantly decreased relative to SK36. In contrast,
the srtB mutant JFP44 exhibited significantly greater biofilm formation than wild-type, and
far exceeded biofilm mass detected for other sortase mutants tested (Fig. 40A). From this
experiment it is apparent that Cwa proteins of S. sanguinis are required for biofilm
formation in glucose supplemented media in vitro. This phenotype is most attributable to
Cwa proteins dependent on SrtA for surface localization, of which SrpA is critical.
However Cwa protein substrates of SRT18 also appear to mediate biofilm formation. In
other gram-positive spp. expression of a class A sortase enhances cell surface exposure of
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Cwa proteins polymerized by a class C sortase (244). If this is also the case for S.
sanguinis the phenotype exhibited by SRT18 could be attributed to the lack of pilus
assembly, whereas JFP42 would reflect the loss of the pilus from the cell surface. This is
the first instance of assessment of SrtB in biofilm formation. The enhanced biofilm
formation in this strain suggests that SrtB or SrtB substrates are required for maintenance
of WT biofilm development.
Biofilm formation in sucrose-supplemented BM revealed carbon source-dependent
intricacies of this process. In the presence of sucrose biofilm formation of VT1614, SK36,
and JFP36 was similar; suggesting that under this growth condition SrpA is dispensable
(Fig. 40B). Akin to this, SRT18 biofilm formation was similar to wild-type, and therefore
pilus assembly may not be required for development of biofilms in sucrose. However,
biofilm formation was significantly greater for JFP42 over wild-type, so SrtA-dependent
Cwa proteins may impede development of the sucrose biofilm. This phenomenon was also
observed for JFP44, with a significant increase in biofilm formation resulting from the loss
of srtB expression (Fig. 40B).
In the presence of sucrose the glucosyltransferase of S. sanguinis generates water
soluble glucans (WSG) that are thought to contribute to the synthetic exopolysaccharide
glucan matrix in the complex dental plaque biofilm (7, 251). With glucose as a carbon
source WSG is not produced, and instead it appears that Cwa proteins are essential. These
proteins may enhance primary adhesion of streptococci to the PS surface, and stabilization
of the biofilm mass. Results for glucose biofilms indicate that sortases of S. sanguinis have
drastically different roles in this process. Additional interplay between extracellular
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Figure 40. Sortase mutation affects static biofilm formation
A) Biofilm formation of S. sanguinis SK36 derivatives was determined in a semiquantitative static assay. S. sanguinis strains were subcultured in BM with 1 % glucose for
20 hours before decanting and washing to remove planktonic cells. The remaining sessile
cells were quantified by CV staining. Cell associated CV was suspended in 30 % acetic
acid and the optical density recorded at 600 nm. Biofilm formation of JFP42 was
diminished and similar to the previously described biofilm deficient mutant, VT1614.
SRT18 also formed significantly less biofilm than wild-type. ***= P < 0.001, **= P <
0.01
B) S. sanguinis strains were subcultured in BM with 1 % sucrose for determination of
biofilm formation n as described above. In BM with sucrose JFP42 and JFP44 formed
significantly more biofilm than the WT strain, SK36. ***= P < 0.001, **= P < 0.01
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determinants of exopolysaccharide production and Cwa proteins is suggested by JFP42
biofilms grown in sucrose, when the loss of Cwa proteins caused greater biofilm formation
over WT.

S. sanguinis adhesion to PS is decreased for JFP42
A short time-course study was used to determine whether reduced adherence to PS
accounted for decreased biofilm formation for JFP42. Late stationary phase S. sanguinis
strains were sub-cultured in BM with 1 % glucose for 4 hours, and adherent bacteria
determined by CV staining. Adhesion to PS was unaffected in JFP36 and JFP44 relative to
SK36 (Fig. 41B). Adherence to PS was slightly higher for the SrtC mutant, SRT18, which
is surprising given lower biofilm formation detected for this strain at 20 hours. While
adhesion to PS is unaffected in this strain, the evolving biofilm post adhesion may not be
as stable due to mutation of srtC. Attenuated biofilm formation has been previously
described for a class C sortase mutant of E. faecalis (121). JFP42 was significantly
attenuated for adhesion to PS relative to other strains tested (Fig. 41B). This phenotype is
likely responsible for the decreased biofilm formation phenotype for JFP42 cultured in
glucose supplemented BM (Fig. 40A). Total growth of strains (planktonic and sessile cells)
in BM with 1 % glucose was measured at 450 nm prior to removal of non-adherent cells.
Growth of JFP42 was significantly less than SK36; however the difference observed
suggests that decreased growth does not account for the adhesion phenotype (Fig. 41A).
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Figure 41. PS adhesion of S. sanguinis sortase mutants
A) S. sanguinis strains were compared for adhesion to PS by subculture in PS plates for
four hours in BM with 1 % glucose. The total growth (both planktonic and sessile cells) in
biofilm medium was measured by an optical density reading at 450 nm. Growth of JFP42
was significantly less than SK36; however JFP42 was capable of growth in BM with 1 %
glucose. ***= P < 0.001
B) Following removal of non-adherent cells, remaining streptococci were determined by
CV staining. CV extracted from each well was measured by recording the optical density
at 600 nm. The srtA mutant, JFP42 exhibited a significant decrease in adherence to PS vs.
the other strains tested. ***= P < 0.001
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Complementation of JFP42
Complementation of the srtA mutation was required to confirm that in vivo and in
vitro phenotypes of JFP42 were attributed to loss of srtA expression. In S. sanguinis and
related streptococci, the srtA locus is 17 bp downstream of gyrA, which encodes DNA
gyrase. The proximity of srtA and gyrA, suggests these genes are co-transcribed. Cotranscription through the intergenic region of gyrA and srtA was confirmed by RT-PCR
(Fig. 42A). gyrA is the first gene in this operon, as the proximal gene 5’ to gyrA is encoded
on the opposite strand from gyrA and srtA. A putative promoter of gyrA expression was
predicted in the online S. sanguinis genome annotation (http://watson.vcu.edu:81/cgibin/gbrowse/sanguinis). This promoter element is separated from gyrA by a predicted
ribosome binding site (RBS). In the first complementation strategy employed (depicted in
Fig. 7) the predicted RBS of srtA, and the srtA coding region were fused to the predicted
promoter for the gyrA operon by PCR amplification with a long primer including at the 5’
end the promoter for gyrA and the sequence just upstream from srtA at the 3’ end. This
amplicon was then fused to the kan cassette for antibiotic selection, and 5’ and 3’ flanking
regions of SSA_0169 by multiple step gene splicing by overlap extension (Gene SOEing)
PCR amplification. Flanking SSA_1069 sequences permitted homologous recombination of
the PCR product into the gene into which antibiotic resistance cassettes were inserted in
the creation of strains JFP36, JFP56, and JFP76 (Chapter IV). Studies of JFP36, JFP56 and
JFP76 show that mutagenesis of SSA_0169 does not affect relevant phenotypes like growth
in vitro, and competitiveness in vivo. Therefore phenotypes observed following
recombination of the PCR amplicon into this locus would only reflect restoration of
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chromosomally encoded srtA. By restoration of srtA in single copy we intended to avoid
potential effects of complementation by a plasmid encoded srtA, including multiple copies
of srtA, and slower growth due to plasmid replication. In the resulting strain, S. sanguinis
JFP47, the srtA mutation was maintained and selected for through Scr, and the wild-type
srtA was maintained by selection for Knr.
A CI assay was used for comparison of competitiveness of JFP47 relative to the
competitive control JFP36. Three catheterized rabbits received an inoculum comprising
both strains at equal optical densities. JFP47 was significantly less competitive than JFP36,
with a mean CI value of 0.12 (range: 0.04 – 0.23). The similarity of the CI value for JFP47
to that obtained for JFP42 (CI of 0.16) demonstrates that competitiveness in vivo was not
restored by insertion of srtA at the SSA_0169 locus. qRT-PCR was used to determine
whether the lack of complementation was attributed to lack of srtA expression in JFP47.
The primer set used for detection of srtA transcript anneals to sequence deleted in creation
of JFP42; therefore only transcript of the complete srtA gene was measured in JFP47 (Fig.
42B). The srtA transcript abundance was compared between SK36, JFP36, JFP42 and the
complementation strain JFP47. In JFP36 srtA transcript abundance was roughly half of that
detected for SK36 (mean= 0.55) (Fig. 42C). The srtA transcript in JFP47 was roughly twothirds less abundant than in SK36 (mean= 0.3) (Fig. 42C). The decreased amount of
transcript detected for JFP47 suggests that expression of srtA is impaired. This may be
attributed to duplication of the gyrA promoter and titration of regulatory proteins and
transcription factors between the two identical promoter sequences. In addition, SrtA
production cannot be assumed from detection of srtA transcript.
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Figure 42. Analysis of srtA transcription
A) RT-PCR was used to determine whether srtA and gyrA are co-transcribed. Primers
within the 3’ end of gyrA and 5’ end of srtA were used for PCR amplification of the
intergenic region between the two genes, with cDNA synthesized from RNA of SK36 and
JFP36 as template. As a control for DNA contamination RNA not treated with reverse
transcriptase (RT) was also used as template. A transcript was detected for both SK36
and JFP36 cDNA templates, confirming that gyrA and srtA are cotranscribed.
B) Primers specific for srtA were used to detect srtA transcript in cDNA prepared from S.
sanguinis SK36, JFP36, JFP42, JFP47. The srtA transcript was missing from JFP42 (as
expected), but present in cDNA synthesized from SK36, JFP36 and JFP47 RNA.
C) The level of transcription of srtA was determined in SK36, JFP36, JFP42 and JFP47 by
qRT-PCR. Samples were normalized by the total amount of cDNA synthesized to control
for differences in reverse transcription efficiency. Transcript level relative to SK36 is
shown. The transcript level of srtA was one half or one third as abundant in JFP36, or
JFP47, respectively.
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Additional phenotypes observed for JFP42 were not restored in JFP47, providing further
evidence that functional SrtA is not produced (data not shown). One alternative, albeit less
attractive possibility is that mutation of srtA in JFP42 resulted in polar effects unrelated to
the loss of srtA expression.
To negate potential effects of duplicating the gyrA promoter, an alternative strategy
was used for complementation of JFP42. In S. mutans a putative srtA promoter occurring
within gyrA was reported. In this genetic background plasmid-borne srtA preceded by the
putative promoter sequence caused partial restoration of the srtA mutant phenotype of
decreased biofilm formation (146). A region corresponding to the predicted promoter for S.
mutans UA159 was identified in S. sanguinis, 187 bp upstream of srtA, within the 3’ end
of gyrA. A PCR amplicon of the putative promoter and the srtA coding region was cloned
into the shuttle vector pVA838, resulting in pJFP50. Clones of JFP42 containing pJFP50
were screened for restoration of the in vitro srtA mutant phenotype, adhesion to PS.
Adhesion to PS of JFP42 was not restored by pJFP50 in any clone screened, and presence
of pJFP50 did not affect the capacity of SK36 to adhere to PS (data not shown). The
phenotypes of JFP42 (pJFP50) and JFP47 suggested that complementation of srtA was
impeded by unsuccessful expression of the ORF. As promoter elements in these constructs
were speculative, we sought to design a different complementation construct in which srtA
would be expressed from a previously characterized promoter. The pCM18 vector was
used for this purpose. Strong expression of the green fluorescent protein encoding reporter
gene, gfpmut3 has been described for the pCM18-encoded L. lactis synthetic promoter,
CP25. Green fluorescence of S. gordonii containing pCM18 confirmed that transcriptional
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and translational signals are also recognized in streptococci (90). The promoter was
manipulated for expression of srtA of S. sanguinis SK36 by cloning of srtA between the
ribosomal binding site (RBSII), and gfpmut3 (Fig. 9). The resulting plasmid, pJFP52 was
transformed into JFP42. Five clones of S. sanguinis JFP42 harboring pJFP52 were
screened for restoration of PS adhesion, a phenotype attributed to loss of srtA expression.
Compared to JFP42, all five clones exhibited restoration of binding equivalent to the WT
vector control strain, SK36 (pCM18) (data not shown).
The pCM18 vector was designed for stability in both gram-positive and gramnegative species. Plasmid stability is critical during in vivo analysis as antibiotic selection
cannot be used to ensure plasmid maintenance. Stability of this complementation plasmid,
pFP52 in JFP42 was determined by growth of JFP52 in the absence of antibiotic selection
(BHI alone), followed by plating of cells in the presence and absence of the plasmid
selective antibiotic Em. A ~8 fold decrease in plating efficiency was observed for JFP52
when plated in the presence of Em vs. on Sc plates alone. This difference in CFUs reflects
the instability and loss of pJFP52 in the absence of antibiotic selection. Since this
phenotype would negatively affect in vivo analysis, a final complementation strategy was
employed.
In the final scheme for JFP42 complementation, the CP25 promoter and srtA
coding region were cloned from pCM18 into the stable shuttle vector, pVA838. This
strategy addressed both concerns regarding the stability of the vector used, and the capacity
for srtA expression. The resulting plasmid, pJFP62 was transformed into JFP42, and clones
screened for adherence to PS. The complementation strain JFP62 showed adherence to PS
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comparable to WT and the WT vector control vs. the srtA mutant, JFP42 (Fig. 43). With
adherence to PS restored, the possibility of co-integration of the plasmid was determined.
Genomic DNA preparations of SK36, JFP42, both strains with the vector alone (pCM18),
and the complementation strain JFP62 were compared by gel electrophoresis. When
compared to the plasmid alone (pJFP62) and the vector control (pCM18) it was clear that
the plasmid in JFP62 was maintained as an episomal element, and contained the srtA insert
(data not shown).
CI analysis was used to compare the competitiveness of JFP62 or JFP42 to the Tetr
competitive control, JFP76. The mean CI value for JFP62 vs. JFP76 (0.53) was
significantly greater than the mean CI for JFP42 vs. JFP76 (0.29) (Fig. 44A). Therefore
competitiveness attributable to srtA was confirmed via complementation in the JFP42
background. However, JFP42 and JFP62 were both significantly less competitive than the
control, JFP76 (P < 0.001).
That competitiveness of JFP62 was not completely restored may be attributed to
slower growth of this strain as a result of maintenance of the episomal plasmid. In vitro
growth studies comparing SK36, SK36 (pVA838), JFP42, JFP42 (pVA838), and JFP62
demonstrated that strains harboring pVA838 grew slower (Fig. 44B). In summary, the
partial complementation of JFP42 competitiveness by pJFP62-borne srtA suggests this
phenotype is likely attributed to srtA, and not a polar effect of the srtA mutation in JFP42.
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Figure 43. Expression of srtA from pJFP62 restores adherence to PS
The PS adherence assay was used to select a strain complementing the srtA mutant
phenotype. Adherence was restored to levels similar to WT by expression of srtA from
pJFP62. The presence of the vector, pVA838 alone did not affect adherence to PS in the
SK36 and JFP42 genetic backgrounds.
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Figure 44. Competitiveness is partially restored in JFP62
A) Competitiveness of JFP42 and JFP62 was determined relative to the virulent control
JFP76 (Tetr SK36) with bacterial recovered at 20 hours post-infection. JFP62 was
significantly more competitive than JFP42 (*= P= 0.0046), suggesting that reduced
competitiveness of JFP42 is attributed to loss of srtA expression. However JFP62 was
significantly less competitive than the control, JFP76 (**= P= 0.001).
B) The lesser competitiveness of JFP62 is likely attributed to slower growth as a result of
maintenance of pJFP62. JFP62 was compared to JFP42 and SK36 harboring pVA838 in an
in vitro growth study. Strains adjusted to an equal OD were diluted 200-fold and growth
monitored overnight. The growth curves of strains harboring pVA838 or its derivative,
pJFP62 are prolonged, suggesting that maintenance of the plasmid results in slower
growth.
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In vitro phenotypes related to SrtA
The assumption that in vivo and in vitro phenotypes of JFP42 were attributed to
aberrant cell surface characteristics resulting from the loss of Cwa protein anchoring
required further investigation. In past studies the approaches used to study gram-positive
cell surface characteristics owing to sortases have included immunogold labeling for
visualization of specific proteins by electron microscopy, catalysis of substrates by sortaseanchored enzymes, Western blotting of cell wall protein fractions obtained by digestion
with enzymes including lysostaphin, and mutanolysin, as well as flow cytometry of
bacterial cells (61, 121, 123, 189). These methods require knowledge of Cwa protein
substrates as well as tools for detection.
To demonstrate altered cell surface localization as a result of srtA mutation we
focused on the most well characterized S. sanguinis Cwa protein, SrpA. In vitro
phenotypes attributed to this protein have been previously described, and the mechanisms
of export and glycosylation of the S. parasanguinis homolog, Fap1 revealed. A SrpA mAb
(generously provided by Dr. Hui Wu, University of Alabama, in Birmingham, AL) was
used to detect cell surface exposure of this protein by whole cell ELISA, and by Western
immunoblotting of S. sanguinis cellular fractions.

CwFrac for general detection of whole cells by ELISA
Polyclonal CwFrac antisera generated against Cwa proteins was used to detect
differences in the amount of S. sanguinis whole cells present during the whole-cell ELISA.
S. sanguinis JFP42 exhibits diminished adhesion to PS due to srtA mutation; therefore cells
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of each strain were fixed to wells by 0.25 % glutaraldehyde by a previously described
method to ensure a similar cellular density for each strain (103, 189). In the first
experiment reactivity to serially diluted antibody was used to determine the non-saturating
dilution of antibody for use. For this purpose CwFrac antisera was serially diluted 5,000
fold, 10,000 fold, 50,000, fold 100,000 fold and 200,000 fold, and reactivity to the
different dilutions of antisera determined for S. sanguinis strains SK36, JFP36, JFP76,
JFP44, SRT18, JFP42 and VT1614. The range of reactivity for each strain over the
dilutions used is shown in Figure 45. Near saturation was observed at a 5,000 fold dilution
of antisera, whereas reactivity was undetectable at the 100,000 fold dilution of antisera.
The linear trend between a 10,000 and 50,000 fold dilution of antisera represents the range
of antibody dilution permitting specific and non-saturating detection of S. sanguinis. Based
on these results the CwFrac antisera dilution of 1:25,000 was chosen for detection of S.
sanguinis cells.
We then wanted to determine whether ELISA with CwFrac antisera could
differentiate between differences in the number of whole cells present. Starting at the cell
density used for SrpA ELISA (OD660 of ~0.9), cells of each strain were serially diluted
two-fold across the plate, and then fixed to the wells by 0.25 % glutaraldehyde. Results
showing reactivity to CwFrac (1:25,000) of serially diluted strains are shown in Figure
46A. The stepwise decrease in reactivity with increasing serial dilution proves that CwFrac
can be used to detect differences in the amounts of cells present. At the cell density
examined by SrpA ELISA similar reactivity to CwFrac was demonstrated for each strain
tested (Fig. 46B).
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Figure 45. General detection of whole cells by CwFrac
Serial dilutions of CwFrac were tested against glutaraldehyde fixed whole cells of S.
sanguinis strains shown in a whole cell ELISA. The diminishing reactivity observed as a
function of antisera concentration reflects specific association with the S. sanguinis cell
surface.
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Figure 45.
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Whole cell ELISA for detection of SrpA
To demonstrate difference in cell surface SrpA localization, S. sanguinis strains
SK36, JFP36 (Emr SK36), JFP76 (Tetr SK36), JFP44 (ΔsrtB), and SRT18 (ΔsrtC) were
compared to the srtA mutant JFP42, and the srpA mutant VT1614. The presence of SrpA
on whole cells was determined by an ELISA with a SrpA monoclonal antibody. Wild-type
levels of cell surface SrpA are demonstrated by SK36 and the competitive controls JFP36
and JFP76 (Fig. 46C). The srtB and srtC mutants, JFP44 and SRT18 showed similar levels
of SrpA to wild-type, confirming that SrpA cell surface localization is not dependent on
these sortases. As expected the srtA mutant, JFP42 exhibited a significant reduction in cell
surface exposed SrpA, that was restored in the complementation strain JFP62. Thus
mutation of the putative major housekeeping sortase in S. sanguinis, SrtA, resulted in loss
of cell surface localization of a Cwa protein substrate, SrpA.
Reactivity of JFP42 was slightly higher than the negative control strain, VT1614,
deficient for SrpA production as a result of srpA genetic mutation (Fig. 46C). The defect in
JFP42 is likely in SrtA-dependent covalent linkage of Cwa protein substrates, and not
synthesis or extra-cytoplasmic export of precursor Cwa proteins. The limited amount of
SrpA detected on the cell surface of JFP42 is likely residual extra-cytoplasmic, membrane
associated protein and not protein covalently linked to PG. In the absence of the anchoring
process, this protein is probably shed into the supernatant as previously described for other
streptococcal SrtA mutants (189). This fate of SrpA in JFP42 was further investigated by
immunoblotting of S. sanguinis cell fractions.

268

Figure 46. Mutation of srtA affects cell surface exposure of SrpA
A) To demonstrate that CwFrac could be used for detection of different amounts of fixed
cells in an ELISA, serially diluted S. sanguinis strains were detected with CwFrac antisera
(1:25,000). Undiluted cells at an optical density (OD) at 600 nm of ~ 0.9 (indicated by 1),
were diluted 2-fold, 4-fold, 8-fold, and 16-fold to establish the reactivity as the number of
cells present decreased. A stepwise decrease in reactivity was observed with each dilution
for all strains tested.
B) The CwFrac reactivity for the dilution of cells used for detection of SrpA (undiluted
cells at an OD at 660 nm of ~0.9) is shown.
C) The reactivity of S. sanguinis whole, fixed cells to the α-SrpA mAb is shown. Mutation
of srtA resulted in a significant decrease in surface exposed SrpA, comparable to the srpA
mutant, VT1614. Expression of srtA from pJFP62 in the JFP42 background resulted in a
restoration of wild-type levels of surface exposed SrpA. The amount of SrpA detected for
in JFP44 and SRT18 suggests that cell surface exposure of SrpA is entirely dependent on
SrtA. ***= P < 0.001
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SrpA immunoblot of S. sanguinis cellular fractions
To demonstrate the localization of SrpA in JFP42, S. sanguinis stationary phase
cultures were used for preparation of supernatant containing secreted proteins, mutanolysin
extracted cell wall-associated proteins, or proteins interior to the cell wall (protoplast
proteins). Immunoblotting of the resulting protein fractions confirmed the presence of
SrpA in the protoplast fraction, cell wall fraction and supernatant fraction of SK36 (Fig.
47A). The immunoreactive bands in Figure 47 are typical of this glycosylated protein, and
similar to those observed in characterization of orthologous proteins in S. parasanguinis
and S. gordonii (240, 247, 284). The srpA gene is predicted to encode a protein of ~150
kDa; however the carbohydrate moieties associated with this protein result in diffuse
mobility by SDS-PAGE. SrpA was exclusively detected in the supernatant fraction of
JFP42, suggesting that mutation of srtA results in the shedding of SrpA from the cell
surface (Fig. 47A). This phenotype was partially complemented in JFP62, which exhibited
enhanced cell wall association of SrpA.

n-Hexadecane phase partitioning of S. sanguinis
In addition to the specific detection of a SrtA substrate described above, we also
wanted to investigate a general cell surface phenotypes associated with expression of SrtA.
One general property previously ascribed to Cwa proteins is hydrophobicity of the cell
surface. In S. gordonii the property is partially conferred by CshA and CshB. This property
is thought to be important for colonization of the tooth surface and maintenance as a
member of the oral flora (278). Cell surface hydrophobicity of S. sanguinis strains was
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Figure 47. Mutation of srtA causes extracellular accumulation of SrpA
Stationary phase S. sanguinis cells were fractionated for detection of SrpA by
immunoblotting. Supernatant associated proteins were precipitated with TCA (S), cell
wall-associated proteins were extracted by mutanolysin treatment (M), and protoplast
associated proteins were prepared by lytic methods (CL). In panel A the SrpA
immunoblotting of the three protein fractions for S. sanguinis SK36, VT1614, JFP42, and
JFP62 is shown. Mutation of srtA in JFP42 resulted in accumulation of SrpA in the
supernatant fraction. In panel B the general protein stain SYPRO Ruby was used for
observance of dominant protein bands in each fraction. SrpA was not readily detected by
SYPRO Ruby, putatively attributed to the extensive glycosylation of this protein.
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determined by n-Hexadecane phase portioning. The percent affinity for hexadecane of each
strain tested is shown in Figure 48. S. sanguinis SK36, competitive controls JFP36 and
JFP76, sortase mutants JFP44 and SRT18, and the SrtA complemented strain JFP62 all
exhibited similar, high affinities for hexadecane indicative of a strongly hydrophobic cell
surface. Mutation of srtA resulted in significantly decreased affinity for hexadecane for
JFP42. The shift in this cell surface property suggests deletion of srtA results in the loss of
cell wall incorporated Cwa proteins conferring cell surface hydrophobicity. In a previous
study the repeated in vitro passage of S. sanguinis oral isolates resulted in decreased cell
surface hydrophobicity, and reduced adherence to hydroxyapatite (278). Therefore the loss
of surface anchored Cwa proteins and the general shift of the cell surface of JFP42 to more
hydrophilic state may account in part for reduced in vitro adherence phenotypes described
above.
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Figure 48. n-Hexadecane phase partitioning of S. sanguinis strains
Early stationary phase cells were vortexed with n-hexadecane (A0) for 1 minute, or left
untreated (A), and then incubated at room temperature for 25 minutes. The optical density
of the aqueous phase was then used to determine the percent affinity for hexadecane by the
equation: 100 x [1 – (A0/A)]. The percent affinity for hexadecane of JFP42 was
significantly reduced (*= P < 0.05 ), relative to JFP36, JFP76, JFP62, JFP44 and SRT18.
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Discussion

From the first identification of the cell wall-associated protein class of surface
proteins it was recognized these proteins act as mediators of gram-positive disease
phenotypes (227). The wealth of information currently available points to diverse functions
attributed to Cwa proteins, including cell envelope maintenance, essential cofactor
acquisition, and adhesion (157, 184, 222). We sought to determine the role of S. sanguinis
Cwa proteins in IE through a comprehensive analysis of predicted Cwa proteins and
sortases of S. sanguinis SK36. The studies described here were the first to test the
biological relevance of in vitro phenotypes previously attributed to S. sanguinis Cwa
proteins that were thought to be important in development of IE.
In total 33 Cwa proteins were predicted for S. sanguinis SK36. The repertoire of
predicted Cwa proteins exceeds that of other gram-positive oral streptococci with the same
predictive patterns applied. S. sanguinis is first and foremost a colonizer of the oral cavity,
and member of the oral flora. The genome of S. sanguinis SK36, an oral isolate, was surely
shaped by selective pressures encountered in this niche. Many Cwa proteins identified in S.
sanguinis share homology with proteins described for closely related oral streptococci.
However the identification of a small number of unique Cwa proteins for S. sanguinis
suggests that horizontal gene transfer and genetic transformability of this strain further
shaped the Cwa proteins encoded. S. sanguinis is a prominent streptococcus in dental
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plaque (1), and a frequent agent of streptococcal IE (57, 67, 181). The abundance of Cwa
proteins predicted for this species may confer a selective advantage to S. sanguinis for
these phenotypes. Factors mediating S. sanguinis colonization of the oral cavity may serve
dual functions to promote IE as well. For example, multiple previously described Cwa
proteins have been shown to adhere to salivary agglutinin, as well as extracellular matrix
proteins (110, 152, 241). In the case of SrpA, and its homolog in S. gordonii, Hsa, the
mode of interaction for seemingly distinct phenotypes is actually quite similar. The
recognition of sialylated glycoconjugates by Hsa has been shown to mediate association
with salivary proteins MG2 and SAG, binding to the sialylated GP1bα platelet receptor,
and adherence to the α2, 3 linked sialic acid of glycophorin A, an erythrocyte membrane
protein (249, 250, 286). Recognition of sialylated glycoproteins by Hsa provides the basis
for explanation of how this oral microbe is well suited for development of a cardiac
disease.
To elucidate the role of S. sanguinis Cwa proteins and sortases in early IE STM
was applied to 31 Cwa protein and 3 sortase ORFs predicted by bioinformatics. The
resulting pool was screened in the rabbit model of IE. Replicate, independent experiments
confirmed that of the 31 identified Cwa protein ORFs, 28 were not required for the
development of IE. CI assay of the remaining 3 mutants, CWA12, CWA15 and CWA30
revealed that no single Cwa protein was required for the onset of disease. Rather than
refuting in vitro phenotypes of S. sanguinis Cwa protein mutants considered relevant for
disease, reduced competitiveness of the srtA mutant indicates S. sanguinis Cwa proteins
contribute to IE, yet these proteins may perform redundant functions. Previous studies of S.
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sanguinis platelet interaction identified 3 different Cwa protein mutants attenuated for this
phenotype (97, 98). Simultaneous expression of these proteins during IE might negate the
mutation of a single ORF, as additional proteins provide the same function. Perhaps the
most striking evidence of functional redundancy comes from real-time PCR analysis of
Cwa protein transcript levels in an isogenic mutant of S. gordonii DL1 lacking expression
of antigen I/II homologs. Herzberg and colleagues found that with the loss of SspA and
SspB expression, transcript abundance of other cell surface adhesins increased (292).
Therefore an additional, unaccounted cellular response may be induced in mutants under
selective conditions encountered in vivo and in vitro for compensation of the introduced
mutation.
MudPIT analysis of S. sanguinis cell wall and protoplast fractions identified several
Cwa proteins with similar putative functions as being simultaneously abundant. Among the
proteins detected were three Cwa proteins containing the A domain of Cna (pfam05737).
In total 5 putative Cwa proteins of S. sanguinis were predicted to include this collagen
adhesion domain. Two additional Cwa proteins, SspC and SspD may share this capacity as
collagen adhesion has been described for S. gordonii antigen I/II homologs (152).
Therefore it is possible that S. sanguinis encodes 7 proteins promoting collagen binding.
This arsenal of putative collagen adhesins suggests that these determinants are very
strongly selected in the oral niche. A more detailed analysis of the expression pattern and
collagen adhesion potential of predicted adhesins is required to determine whether these
proteins are functionally redundant or act cumulatively. The functional redundancy
hypothesis does provide further explanation of previous findings in a random STM
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analysis of S. sanguinis SK36, in which no Cwa protein was identified as a virulence factor
(198).
The analysis of an S. sanguinis srtB mutant, JFP44, and srtC mutant, SRT18
provided additional insight to the unique role of S. sanguinis sortases during early IE. In E.
faecalis, an unrelated common causative agent of IE, expression of SrtC was determined to
be required for competitiveness in development of IE (183). Analysis of the S. pneumoniae
pilus locus has also indicated that pilus polymerization is required for virulence in vivo
(13). The arrangement and constituents of the srtC locus in S. sanguinis suggests this
protein also acts in polymerization of Cwa protein subunits to create a pilus structure.
However STM screening of the srtC mutant SRT18 revealed that expression of SrtC is not
required for competitiveness in vivo. If SrtC of S. sanguinis does catalyze pilus assembly,
then this function is not required for the onset of disease. Putative pilin subunit mutants
CWA6, CWA7 and CWA8 also maintained competitiveness in vivo. However the effect of
mutation on cell surface structures was not investigated. In C. diphtheriae, S. pyogenes and
S. pneumoniae a dominant pilus subunit that composes the pilus shaft has been identified
which contains conserved motifs directing pilus polymerization (pilin motif) and
association with accessory pilus proteins (E box) (13, 175, 256). All putative pilus proteins
identified for S. sanguinis were predicted to include the E box and some variation of the
pilin motif. It is possible that these proteins are interchangeable in pilus assembly, or
compose distinct pilus structures. The presence and composition of a pilus on the surface
of S. sanguinis requires further investigation.
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Expression of srtB was determined to be dispensable for development of IE by CI
analysis of JFP44. SrtB is conserved in S. gordonii; however the Cwa protein substrate(s)
for this sortase have yet to be identified. The work conducted in this chapter was restricted
to putative Cwa proteins containing the LPXTG pattern. If SrtB of S. sanguinis is similar
in function to characterized SrtB proteins of other gram-positive spp., it may anchor
proteins with a sorting pattern deviating from LPXTG. The potential substrate PcsB,
containing the C-terminal pattern, QPEVG and an N-terminal signal peptide (as assessed
by SignalP), is encoded upstream of srtB. If this ORF is surface anchored by SrtB, the
experiments described provide evidence that it is not required for establishment of disease.
As the most pronounced in vivo phenotypes were observed for the srtA mutant, this
strain as well as srtB and srtC mutants were used for further characterization of cell surface
phenotypes. Cell surface hydrophobicity was significantly decreased following mutation of
srtA. Bacterial cell surface hydrophobicity is commonly used as an indicator for the
propensity of bacteria to interact with the surrounding environment. In fact, cell surface
hydrophobicity is correlated with co-aggregation between bacterial cells, adherence to
hydrophobic surfaces, and adherence to fibrin in vitro (101, 168). S. sanguinis binding to a
highly hydrophobic polystyrene surface was also decreased by mutation of srtA. These
findings suggest that expression of SrtA and potential Cwa protein substrates of SrtA
confer this cell surface property. Cell surface expression of the Cwa protein SrpA was also
tested in isogenic mutants of S. sanguinis SK36. SrpA was not cell surface exposed
following mutation of srtA, the putative major sortase of S. sanguinis SK36. The defect in
Cwa protein substrate surface anchoring coupled with a global shift to a more hydrophilic
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cell surface following deletion of srtA suggests that reduced competitiveness observed for
JFP42 may be attributed to the loss of more than one Cwa protein virulence determinant
from the cell surface.
The studies described here established that SrtA is required for full competitiveness
in development of IE. This is in keeping with previously described analyses of SrtA
homologs in other gram-positive pathogens. In fact, the clearest evidence of Cwa protein
contribution to disease has been gleaned from in vivo characterization of sortase mutants
(113, 135, 145, 200). The 10-fold reduction in competitiveness for JFP42 and persistence
of this strain in individual inoculum assays indicates that S. sanguinis IE is a process
mediated by multiple factors additional to Cwa protein and sortase expression. This is in
contrast to a lipoprotein mutant identified for S. sanguinis which exhibits a 3,000-fold
reduction in competitiveness in vivo (Dr. Sankar Das, personal communication).
The observation that SrtA expression is required for normal colonization
phenotypes does introduce a possible target for preventative therapies. A combination
multi-gene DNA vaccine combining plasmid-encoded clumping factor A (ClfA),
fibronectin binding protein A (FbpA), and SrtA was demonstrated to elicit a protective
response against S. aureus and increased survival in a murine infection model (78). This
presents a possibility for advancement of preventative measures against S. sanguinis IE.

GENERAL DISCUSSION
The incidence of infective endocarditis has remained unchanged over the past two
decades, despite advances in diagnostics methods, antimicrobial and surgical therapies, and
complication management (176). The undeterred rate of infection is in part due to changing
risk factors for this disease. In the pre-antibiotic era the predominant risk factor for IE was
chronic rheumatic heart disease, which is now rare in industrialized countries (171). This
risk group has been replaced with persons vulnerable due to high-risk behaviors, or more
aged populations prone to pre-disposing cardiac risk factors. The majority of IE cases (~70
% of NVE episodes) are attributed to staphylococci and streptococci. As for the new risk
groups, intravenous drug users are most commonly afflicted with S. aureus IE, with skin
flora as the major source. The incidence of Streptococcus bovis as a causative agent of
disease increases proportionally with age–an observation potentially attributed to a greater
rate of digestive tumors in the elderly (176). These emerging trends are reflective of
changing population dynamics in developed countries and imply that IE will remain a
health-care concern in the future.
Viridians streptococci are the most common causative agents of streptococcal IE (at
least 50 % of community acquired NVE cases not associated with drug use; 282) and
multiple reports implicate S. sanguinis as the most common causative agent of viridans
streptococcal IE (57, 67, 216, 272). American Heart Association guidelines for patients at
282
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risk for IE undergoing dental procedures have shifted drastically in the past 60 years in
concert with the recognition that most cases of IE cases are not attributed to dental
treatment, but are more likely caused by daily activities. The latest guidelines noted that
both dental treatment and daily tasks induce similar densities of bacteria in the blood, yet
routine activities are much more likely to cause bacteremic events resulting in IE. The
authors suggested that the risk of bacteremia associated with IE would be better prevented
by improved oral health care in at-risk patients with underlying heart conditions. In
patients most at risk, antibiotic prophylaxis may still be recommended, with the
acknowledgement that only a small number of cases are preventable by this strategy (281).
Antimicrobial therapy for treatment of IE is equally complex, with extensive
treatment regimens suggested. One complication of this therapy is penetration of
antimicrobial compounds within the fibrin-platelet meshwork of the vegetation, which has
been demonstrated as refractory to antimicrobials in the past (51). This observation, in
addition to the risk of increased antimicrobial resistance among bacterial agents of IE
highlights the critical importance of development of prophylactic measures against IE for
at-risk groups. Thus far the most promising vaccine candidate for viridans group
streptococci is the lipoprotein FimA of S. parasanguinis. Expression of FimA was required
for development of S. parasanguinis IE (34). Administration of a FimA immunogen was
found to be protective against S. parasanguinis IE, as well as IE caused by additional
viridans streptococcal species predicted to encode FimA homologs including S. mitis, S.
mutans, and S. salivarius (127, 271). Further molecular characterization of S. sanguinis IE
determinants is necessary for advancement of our understanding of this disease. The aims
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of experiments described here included the characterization of a previously described IE
virulence determinant, the development of genetic tools facilitating the screening and
identification of virulence factors for IE, and identification of putative adhesins required
for development of IE through a comprehensive analysis of S. sanguinis Cwa proteins in
vivo.
In Chapter III the requirement of NrdD for anaerobic growth of S. sanguinis SK36
was explored. As documented for L. lactis, S. aureus and E. coli, evaluation of NrdD in S.
sanguinis was complicated by residual function of the Class Ib RNR under microaerophilic
conditions. Instead of supplementing growth media with class I RNR inhibitors, fully
reduced soft-agar was used for evaluation of nrdD mutant strains. Transposon insertion
and in-frame deletion mutagenesis of nrdD both resulted in arrested anaerobic growth,
confirming the requirement for NrdD expression in the absence of oxygen. In an STM
analysis of genes required for Proteus mirabilis urinary tract infection an attenuated nrdD
mutant was also identified. The authors suggested that oxygen-limiting conditions may
develop during urinary tract infection as a result of high bacterial cell density (31). This
may also be the case in IE, in which bacteria have been documented to grow within the
vegetation to reach cell densities of 108 to 1011 CFU per gram of vegetation (64). The
bacteria likely proliferate, protected from circulating host defense mechanisms by layered
fibrin-platelet matrices. The aerobic metabolism of the streptococci may generate a
progressively reduced condition that can not be relieved by oxygenated blood surrounding
the vegetation. This study was not the first to propose anaerobiosis of the infective
vegetation; a previous screen of S. aureus STM mutants in the rabbit model of IE
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demonstrated that anaerobic/microaerophilic mutants were attenuated in vivo (50).
However, staphylococcal and streptococcal pathologies in IE are quite different in that
staphylococcal infection is typically more acute and invasive, whereas streptococcal IE
infection often presents as sub-acute, with some features of chronic disease. In addition,
the attenuated staphylococcal mutants were not characterized, and therefore the nature of
mutations conferring anaerobic sensitivity is not known. In vitro characterization of the
avirulent nrdD mutant (198) provided further insights to streptococcal factors required for
persistence in vivo. The extreme measures required for demonstration of anaerobic
sensitivity of S. sanguinis nrdD mutants suggest that anaerobiosis occurs within the
infective vegetation–and the time course of in vivo infection confirms that this occurs
within 20 hours of the onset of bacteremia. Although oxygen levels within the infective
vegetation have not been measured, the findings described suggest a restriction of oxygen
availability at the site of infection.
The publication of the SK36 S. sanguinis genome sequence in 2007 realized the
possibility for greater characterization of this species, with this strain serving as the model.
Of particular interest to the medical community is identification of S. sanguinis virulence
determinants that may serve as targets for prophylaxis of IE. In keeping with this goal, in
Chapter IV a locus was identified that may be used for genetic manipulation without
directly affecting important cellular phenotypes including in vitro growth, genetic
competence, biofilm formation, and competitiveness in the rabbit model of IE. The
plasmid repertoire developed for this purpose, with three different antibiotic resistance
determinants, could be expanded to include additional selective markers, or for ectopic
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expression of native genes to allow for complementation of mutations elsewhere on the
chromosome. Two of the strains developed in Chapter IV, JFP36 and JFP76 were used as
controls for competitive index analyses in Chapter V to establish the competitiveness of
Cwa protein mutant or sortase mutant strains–with successful discrimination between
differing levels of competitiveness in mutants tested. Therefore a genetic tool has been
developed which will facilitate the future screening and identification of S. sanguinis
virulence determinants.
In Chapter V the contribution of S. sanguinis Cwa proteins to early experimental IE
was investigated. Cwa proteins are attractive vaccine targets as they are surface exposed,
and have been demonstrated to interact with host cell surface receptors and extracellular
matrix proteins. S. sanguinis SK36 putatively encodes 33 Cwa proteins; mutants defective
for production of 31 of these proteins were included in a comprehensive STM screen. A
srpA mutant (204), which lacks the 32nd Cwa protein, was also tested in the rabbit model of
IE by competitive index analysis. The in vivo experiments described demonstrated that no
single Cwa protein was required for development of IE–a finding that is counterintuitive
given past characterization of this protein family in animal infection models. Among the
predicted Cwa proteins encoded by S. sanguinis it is likely that SrtA is responsible for cell
surface localization of the majority. Competitive index analyses of a srtA mutant
determined expression of srtA to be required for full competitiveness in vivo, with Cwa
proteins dependent on SrtA for surface-anchoring putatively mediating initial contacts for
colonization of the sterile thrombus. Homology searches of predicted S. sanguinis Cwa
proteins indicate that several proteins may be grouped by functional similarity, and may be
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redundant in vivo. This possibility is most clearly evidenced by the srtA mutant strain,
which would likely be defective for surface localization of the majority of Cwa proteins
(including groups of putatively functionally redundant proteins). The srtA mutant does
provide an opportunity for further characterization of the general contribution of S.
sanguinis SrtA-dependent Cwa protein substrates to IE. Of particular interest is
characterization of streptococcal-host factor interactions, including the assessment of
platelet-interaction, adherence to fibrin-platelet matrices, and resistance to phagocytosis.
Expression of SrtA has also been linked to infectivity in S. aureus IE, with lesser
srtA mutant bacterial recovery following 2 days of infection (276). In contrast to S. aureus,
srtA expression in S. sanguinis may be important for colonization of the vegetation, but not
in replication following colonization, in that bacterial numbers recovered from rabbits
infected at 20 hours were not significantly different between the srtA mutant and a wildtype strain. These findings imply that SrtA, in addition to unidentified SrtA-dependent
Cwa proteins mediating vegetation colonization may serve as candidates for prevention of
IE onset.
Gram-positive Cwa proteins have been tested as vaccine candidates in the past,
with some success (35, 78, 178, 225). However several complications arise in developing a
Cwa protein based preventative strategy for S. sanguinis IE. S. sanguinis is benign in the
oral cavity and may actually be beneficial in this niche through competitive inhibition of
oral pathogens (132). An optimal vaccination strategy would balance the advantageous
contribution of S. sanguinis in the oral flora while reducing the propensity for IE by
targeting surface proteins specifically expressed in transient bacteremia. Thus far S.
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sanguinis proteins uniquely expressed during bacteremia have not been described, and it is
possible that few candidates will arise as S. sanguinis is an opportunistic agent of IE that
evolved primarily for maintenance in the oral cavity. A future direction for prophylaxis
research should include expression analysis of S. sanguinis genes during bacteremia for
identification of proteins that are enhanced under these conditions relative to growth in an
oral biofilm. Such a study would require the development of an adequate control condition
for relative expression analysis; however it is feasible given the availability of a genomic
microarray for S. sanguinis SK36.
Additional considerations for prophylactic strategies include identification of
vaccine candidates shared among S. sanguinis endocarditis isolates to identify those most
common in nature, and the use of proteins conserved among common causative agents of
viridans IE. Acknowledgement of the natural complexity of resident flora is required for
production of an efficacious preventative strategy. In addition, the protection afforded by
the previously identified immunogen FimA warrants further investigation (127, 271). Of
particular interest is the immunology governing the inhibition of IE by vaccination with
FimA. Identification of specific immunological factors that potentiate this response may
direct the conception and optimization of future preventative strategies.
Experimental analyses of antibody penetration within the vegetation have shown
the fibrin-platelet matrices to form a sheath that limits access of antibody to bacteria within
the vegetation (166). Due to the complications with identification of an optimal IE-specific
virulence candidate described above, an attractive alternative may include the development
of vegetation diffusible small-molecule inhibitors against prokaryotic genes known to be
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expressed during IE. One potential target includes NrdD, which has no eukaryotic
counterpart. The time course of anaerobiosis in IE would require further monitoring to
assess the feasibility of this. If anaerobiosis within the vegetation occurs within hours of
colonization, then progressive vegetation enlargement owing to reseeding of bacteria at the
site of infection, or outgrowth of bacteria within the vegetation may be avoided. However
if anaerobiosis occurs later in infection, after the vegetation has achieved a mass resulting
in frequent septic embolization, then efficacy would be diminished.
Conclusions derived from experiments performed here, in combination with the
previous random STM screen for S. sanguinis virulence determinants present a model of
streptococcal transition between initial colonization of the vegetation and growth following
colonization. During transient bacteremia the streptococci express and utilize surfaceexposed proteins, including SrtA-dependent Cwa proteins, for colonization of the site of
endothelial damage in a process that may be dependent on a sterile thrombus. Surface
localization of these proteins does not appear to be important for growth following
adherence, at 20 hours post colonization. Instead genes encoding for cytoplasmic proteins
with housekeeping functions like bacterial cell wall synthesis, generation of nucleic acids
and amino acids, and anaerobic condition-specific genes are required for persistence (198).
Expression analyses of streptococcal genes at different times post-infection may aid in
understanding of this complex and multi-factorial disease, as well as identification of
future therapeutic targets.
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APPENDIX A
Oligonucleotides for PCR amplification
ARTR-SalI-24495-up ... GCTTTTGGTCGACAATATCGCAGCCAAG
ARTR-23327-dn ........... AGCCATTCATATGCTTGACTGGAGCAGTTTCAAACTTC
ARTR-21212-up ........... GTCAAGCATATGAATGGCT
ARTR-SalI-20031-dn ... TGGTGCGTCGACTGGCTTCGTTGTCTTC
ARTR-EcoRI-up1......... AAAACAGTCAGCCGAATTCTATTT
ARTR-EcoRI-up2......... AGGTTTAAAGAGAATTCATTTGTCCTAAGGG
ARTR-EcoRI-dn........... TTCGAATTCTGGTCGTCTCAGCTCC
spcUP............................ CCGCTCTAGAACTAGTGGATCC
spcDO ........................... CAATTTTTTTATAATTTTTTTAATCTG
DAM303 ....................... AAGGGCCCGTTTGATTTTTAATG
DAM347 ....................... CCGAATTCTAGGTACTAAAACAATTCATCCAGTAA
0169-SalI-up ................. CCGGTCGACTGTCTATGGTGGACAGCGTCC
0169-SalI-dn ................. CCGGTCGACTCGTGACGGAAGCAGACTTGG
pSerm-NcoI-up ............. CATGCCATGGCCGGGCCCAAAATTTGTTTGAT
pSerm-NcoI-dn ............. CATGCCATGGAGTCGGCAGCGACTCATAGAAT
1069RE-up.................... CATGGGTGACGCGGCCGCTGCAGGCGCGCCTGCGAACA
1069RE-dn.................... CATGTGTTCGCAGGCGCGCCTGCAGCGGCCGCGTCACC
Sc-NotI-up .................... CCGGCGGCCGCCCGCTCTAGAACTAGTGGATCC
Sc-NcoI-dn.................... TCTCGACCATGGCAATTTTTTTATAATTTTTTTAATCTG
Tet-NotI-Up .................. CAGTCGGCGGCCGCCTAGGTTGATTTTCGTTC
Tet-NcoI-Dn ................. TCTCGACCATGGCTAGGTCACTAAGTTATTTT
TetMF1 ......................... TGTGTGTGACGAACTTTACCGA
TetMF2 ......................... TCTGCAAAAGATGGCGTACAAGC
6-26-BamHI-up............. AAGCGGATCCAGTACGCCTGGGCGAAGACC
6-26-BamHI-dn............. TGGCGGATCCTTTCCCACGCGCAGAGGGAC
srtA1 ............................. GTAATAGCGAAACGGACGCAGAAGC
srtA2 ............................. GGATCCACTAGTTCTAGAGCGGAAAGATTAAGCCTAGGGCCAC
srtA3 ............................. CAGATTAAAAAAATTATAAAAAAATTGGTCGAGTATGACAAGGCT
CCT

srtA4 ............................. TGAGGGTGTCAAAGAAGTTGGCGGA
srtB1.............................. TCATCCAGTCTTATCTGGTCCTGCT
srtB2.............................. CATTAAAAATCAAACGGGCCCTTGCAAATGCCAACAACAAAGAGC
TGT

srtB3.............................. TTACTGGATGAATTGTTTTAGTACCTAGAATTCGGGATTTTCTGGA
CAAGCATGGCAAG

srtB4.............................. AATCGTCTCCATACTAGCCGCATAG
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Oligonucleotides for PCR amplification
0169-2 ........................... CTTCCCAGTTGTAATCCAAGA
0169-3 ........................... TTACTGGATGAATTGTTTTAGTACCTAGAATTCGGATATTTCTTAT
CATCGGGTTT

0169srtAP ..................... TCTTGGATTACAACTGGGAAGGCGATGTAAACGTTTTTACAAACG
GTTCAAAATACTGAAAAATTAAAGAAAATGTCGAATCGTAAAAG
AGGACCTC
kansrtA.......................... CATTAAAAATCAAACGGGCCCTTCGGAAAAAGAGTCAAAATCAG
CAAG
srtA-EcoRI-up............... AAGCGAATTCTAGCTAGTGAGTATC
srtA-EcoRI-dn............... GTTAGAATTCTTTCTAACCTTTGGAGTG
srtA-SphI-up ................. GGACGCATGCATGGTACAAGGA
srtA-SphIdn................... GAGTGCATGCTAACCTTTGGAGTG
pJFP52srtA-up .............. CCGGCTCGTATGTTGTGTGG
pJFP52EcoRI-dn........... GTCTGAATTCTTACGCATGCTAACCTTTGG

Oligonucleotides for transcript detection
0169-F........................... ATGAAGCAAAAACCCGATGA
0169-R .......................... TTTTCTGGAAGCTGTTCTGGA
1220-IG-1219 F ............ TTTACAAGCGTCGAAGCAGA
1220-IG-1219 R............ AAGCCTAGGGCCACAAAAAT
1219-F (srtA) ................ GGCATCACAGGGGCTAGTAA
1219-R (srtA) ................ CGCAGCATCCTCACAAGTAA
16S-F ............................ TTCGGATCGTAAAGCTCTGTTG
16S-R ............................ GTAGTTAGCCGTCCCTTTCTGG

Oligonucleotides for screening and sequencing
Jxn-up ........................... GTCCTGCTTTATGCTCGACTG
Jxn-dn ........................... CGCATCCAGTAAAGTGCTGG
Mout ............................. CCGGGGACTTATCAGCCAACC
PB1 ............................... GATCTCTACAACCTCAAGC
PB2 ............................... TCCATTCTAACCAAG
PB11 ............................. TCTACAACCTCAAGC
PB12 ............................. TCCATTCTAACCAAG
spc246 ........................... TCAATGGTTCAGATACGACGACT
spc638 ........................... GCCGTATGATTTTAACTATGGAC
kan306R........................ AGCCATCATGCCGTTCAAAGTGC
kan637F ........................ CACGGCGACCTGGGAGACAGCAA
CP25 ............................. CTTTGGCAGTTTATTCTTGA
gfpmut........................... TTGTGCCCATTAACATCACC
pVA838-2245 ............... AGGCGTTTAAGGGCACCAAT
pVA838-2939 ............... GTAACACGCCACATCTTG
pVA838-5331 ............... CCAATGGCATCGTAAAGAAC
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APPENDIX B
Oligonucleotides for directed signature-tagged mutagenesis
SSA_1112-up................ TGACGATGGCAGCAGTGACTC
SSA_1112-dn................ ACACTCCCCGATACGAGCCTC
SSA_2023-up................ AGTTTCAAATCACGGAGCCGCTGC
SSA_2023-dn................ ACGTAGTAAGTCATGGCCGCA
SSA_1663-up................ TTTGGGAGAAATTGAGGCCGCT
SSA_1663-dn................ ACAAACCCAGTAGGAGCAAGGCTC
SSA_1591-up................ GTGTCAACCGTTGCCAATCAC
SSA_1591-dn................ TCTTTGGATAGCTGGCGGAGC
SSA_0805-up................ GCTGTGACAGCAGTTGGTG
SSA_0805-dn................ TCAGGGTACGCAGGCCCTC
SSA_1634-up................ GACGGTTACACCGGATTCC
SSA_1634-dn................ CTTGTTCGCCCAGCAGCAG
SSA_1633-up................ CGGGACAACACCCCAAAGC
SSA_1633-dn................ AGCTTTGACCTCCGCAGAG
SSA_1632-up................ AGTGCTACCTTAGGAACGACC
SSA_1632-dn................ TCCCTTGACCGCCAACTGG
SSA_0956-up................ CCTTGGATGAACTGTTAGCGAC
SSA_0956-dn................ TGTCAAGACGGCCTGGGGCTC
SSA_0227-up................ CAAGAAGATGACGGAGGAAACG
SSA_0227-dn................ AAAGATGGTTACACACCGAGC
SSA_0565-up................ GCTCAACAGGTCGTCCAAACC
SSA_0565-dn................ TGTGCCTGAGCCAGTTGCTGG
SSA_1301-up................ TGGTCGGACTTTTGACCAAGC
SSA_1301-dn................ TGCTGCTAGAACTGCCTGAGC
SSA_0303-up................ TGATGAAGCCTTGACTGGTGC
SSA_0303-dn................ CCAAGCCTTATCATTGCGGAATTG
SSA_0273-up................ CCCATACTCCGATGCTGGACG
SSA_0273-dn................ AAAGTCCATCTCAAATGGCTCAG
SSA_1023-up................ TCTATGGAGACGGTCCTGACA
SSA_1023-dn................ CAAAGCGAGTCATTTCTAATACTGG
SSA_1019-up................ TCGCTCTTATGCAGACATGC
SSA_1019-dn................ TGAACGGCAGCACCGTCTG
SSA_1631-up................ CGATGATGCTGTTATGGGTGGTCT
SSA_1631-dn................ TCCTACTTTAGATGGCGGTGCT
SSA_0905-up................ CGATTCGGAAACTAAACGTCGGTG
SSA_0905-dn................ CTGCCTCATTAATTGGCACACG
SSA_0906-up................ AGGATTGGATTCACGAGGCGGACTC
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SSA_0906-dn................ TGACCGTCACCGAGGCTGGGGTTC
SSA_1219-up................ TTAATGTCCAGCAAGACCGCAGTG
SSA_1219-dn................ CCAGTATGATAGATGTCGCCAG
SSA_0684-up................ ACTTTGAAGTTCGTGAGCGTGCAG
SSA_0684-dn................ TTTAGCCGGCTGTGTCGGGGTGGCT
SSA_1234-up................ TCGCTCAGGATGGTCCTGC
SSA_1234-dn................ TCAAGGCAACTGCTGATTCG
SSA_0022-up................ TTTCACTTTTCGCGGCTGCTG
SSA_0022-dn................ AGCCGACAAGGCCTCTGTTGCGCCA
SSA_1063-up................ AGGTTCCACATCTAACGGACGTG
SSA_1063-dn................ AGGGTAAATACTACAGGGCGGACC
SSA_2020-up................ TTAACGTTGAGCACTTGGCCGA
SSA_2020-dn................ ATCAACCTGACTGGTCCGAGCAGC
SSA_0167-up................ AGCCTCTACTTCTAGCCCCATGG
SSA_0167-dn................ GGCTGATAGAATAAGCAGCTGCAC
SSA_0146-up................ AGGTAAAACGCGACCTGTC
SSA_0146-dn................ AGAGCCGCCATTTGAGGAGCGCT
SSA_0453-up................ TGCTCAATCTGGTCTCCGGTGTGGT
SSA_0453-dn................ GCACCGACAGATCCAGCCAAGCGCA
SSA_1666-up................ TATTGACCAAGGCGGAACTCC
SSA_1666-dn................ ATAGTCCGGATTCAGCGCCAG
SSA_1065-up................ CCCAACCGGTAGCGTTGGTTG
SSA_1065-dn................ TGATACCATCCTTGATGAGCGGCAC
SSA_0904-up................ TCCTTTTAGGTACTGCGGCTACAG
SSA_0904-dn................ ACCTTGAATGCCCTCGCTGCTGGCA
SSA_1750-up................ AGAAGGTAGCTATCAGCCAGC
SSA_1750-dn................ TTGAGACGGTTGGGAGCTGTC
SSA_2121-up................ TTCCTTTATGGTTGCGGCCAG
SSA_2121-dn................ TCCAACCGTTAGCAGCCGTCA
SSA_0243-up................ AGACATAGTCATGGCGAACCTC
SSA_0243-dn................ TGGTTGCTCAATAGGAACCGGT
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